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Single nucleotide polymorphisms (SNPs) and insertions/deletions (indels) constitute 
important sources of genetic variation which provide insight into disease aetiology 
and idiosyncratic differences in drug response. The analysis of such genetic variation 
relies upon the generation of allele-specific products, typically by enzymatic 
extension or the hybridization of allele-specific DNA probes. Herein, a distinct 
enzyme-free, dynamic chemistry-based method of producing allele-specific products 
for genotyping was developed. The approach was initially demonstrated in model 
systems using synthetic DNA, which was used as a template in a base-filling 
reductive amination reaction on a PNA backbone. The templated dynamic reaction 
between a free secondary amine at a ‘blank’ position on the PNA strand and four 
aldehyde-modified nucleobases drove selective formation of the ‘correct’ iminium 
intermediate according to Watson-Crick base-pairing rules. In a blind trial, the 
method was extended to genotype twelve cystic fibrosis patients for two mutations 
(one SNP and one indel) linked to this disease. Enzyme-free dynamic chemistry thus 
permitted successful genotyping in both singleplex and duplex formats, 
demonstrating the application of dynamic chemistry as a distinct method of allele-
discrimination with certain advantages over those reported previously. The 
application of this method as a tool for the discovery of non-natural nucleobases with 
improved properties for antisense and genotyping applications was also investigated. 
Furthermore, progress was made towards the use of dynamic chemistry as a means of 
full nucleic acid sequence analysis, through the templated sequence-selective 
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1.1 DNA Sequencing and SNP Analysis 
1.1.1  Nucleic Acids 
The nucleic acids DNA (deoxyribonucleic acid) and RNA (ribonucleic acid) are 
linear heteropolymers of four different monomers, called nucleotides. Nucleotides 
are composed of a sugar (β-D-ribose in RNA, β-D-deoxyribose in DNA), one or 
more phosphate groups and a heterocyclic base (Figure 1.1). There are 5 commonly 
occurring bases in nature, two of which are derivatives of purine, namely adenine (A) 
and guanine (G), and three of pyrimidine, namely cytosine (C), thymine (T, present 
in DNA only), and uracil (U, present in RNA only).1 
 
 
Figure 1.1 Nucleic acid building blocks. A nucleotide consists of between one (shown 
above) and three phosphate groups, a sugar and a base. In RNA, the (ribo)nucleotide sugar 
has the 2'-OH shown, which is absent in the (deoxyribo)nucleotide of DNA. A base bound to 
a sugar without a phosphate group is termed a ‘nucleoside’. 
 
The nucleotide monomers are linked by 3’→5’ phosphodiester bonds to form 
the polymer. The famous double-helical structure of DNA, inferred by Watson and 
Crick in 1953 from (amongst other data) the X-ray diffraction patterns obtained by 
Franklin and Wilkins, arises from specific hydrogen bonding interactions between 
the base-pairs (Figure 1.2).2 G forms three hydrogen-bonds to C, and A forms two 
hydrogen-bonds to T (in DNA) or U (in RNA). In the DNA double-helix, two anti-
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parallel polynucleotide chains are coiled around a common axis, with the sugar-
phosphate backbones on the outside and the bases on the inside.1 
 
 
Figure 1.2 Base-pairing and hydrogen-bonding in the DNA double-helix.  
 
The sequence of bases in a DNA or RNA strand uniquely characterizes the 
nucleic acid and represents a form of linear information. This heritable genetic 
information is stored as DNA in the nuclei of living cells and serves as a ‘recipe’ for 
protein production (a three base sequence or ‘codon’ codes for one amino acid in a 
protein). Expression of proteins by a cell involves transcription of the relevant 
sections of DNA into a class of RNA molecules called messenger RNA (mRNA), 
which then leave the nucleus and travel to the cell cytoplasm where they are 
translated into proteins. This translation process involves further RNA molecules 
called transfer RNA (tRNA) and ribosomal RNA (rRNA).1 
During DNA replication, the helix is unwound and unzipped to expose the 
bases, and a DNA polymerase uses the original ‘mother’ strands as templates to 
prepare two new ‘daughter’ strands. The daughter strands are synthesized in a 5’→3’ 
direction from an RNA or DNA primer (a short or ‘oligonucleotide’ strand 
complementary to the preceding section of DNA) using the four nucleoside 
triphosphates. The new DNA chain grows as the free 3’-OH undergoes nucleophilic 
attack on the innermost (α) phosphate of an incoming nucleotide with the 
concomitant release of pyrophosphate (PPi). The result of such DNA replication is 
that two new DNA molecules are produced from the original, each containing one 
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mother strand and one daughter strand. The sequence of bases on each daughter 
strand is exactly determined by the sequence of its complementary mother strand, 
and it is this feature of DNA that enables the accurate transmission of hereditary 
information.1 
 
1.1.2 Early Sequencing Methods 
The elucidation of the structure of DNA in 1953 sparked a number of attempts to 
determine the sequence of bases in DNA molecules, but it wasn’t until the 1970s that 
the forerunners of modern sequencing technologies were developed.3 In 1975, the 
‘plus and minus’ method of Sanger and Coulson was the first such method to be 
reported.4 This technique relied upon polyacrylamide gel electrophoresis (PAGE) to 
fractionate DNA strands according to their size. A primer oligonucleotide (either 
synthetic or obtained from restriction enzyme digests) was hybridized to the DNA 
template to be sequenced then extended by DNA polymerase I (in the 5’→ 3’ sense) 
in the presence of the four nucleoside triphosphates, one of which was radiolabelled 
with 32P. Conditions were employed such that this chain extension was as non-
synchronous and random as possible, thereby producing a population of all possible 
lengths of extended oligonucleotide. This mixture of oligonucleotides was then 
divided into eight aliquots for a further extension by DNA polymerase, but this time 
chain extension was terminated in each case either by supplying only three of the 
four nucleoside triphosphates (the ‘minus’ method) or only one of the four (the ‘plus’ 
method). Denaturing PAGE separation of the resulting mixtures in adjacent lanes of 
the same gel gave rise to bands which could be imaged by autoradiography (due to 
the presence of 32P), and the relative positions of these bands enabled the base 
sequence to be determined.  
 The ‘plus and minus’ method allowed sequences of approximately 50 
nucleotides to be deduced within a few days, and was applied in the sequencing of 
bacteriophage φX174 (a single-stranded circular DNA molecule of 5386 bases).5 
However, neither the ‘plus’ nor ‘minus’ method was entirely accurate which is why 
both had to be used in conjunction to obtain meaningful sequence data. The main 
problem encountered was that of sequencing homopolymer runs (i.e. multiple repeats 
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of a given nucleotide), as run lengths often had to be deduced (somewhat unreliably) 
from the distances between the gel bands. 
 An alternative, predominantly chemical method was reported by Maxam and 
Gilbert in 1977.6 This involved radiolabelling a double-stranded DNA molecule at 
either the 3’ or 5’ ends with 32P. The DNA could then be denatured and the two 
strands separated by PAGE and extracted for sequencing, or alternatively the 
molecule could be cut in two by a restriction enzyme and the two ends resolved by 
PAGE and isolated prior to sequencing. The DNA was then subjected to chemical 
reactions designed to first damage then remove a base from its sugar, with the result 
that the DNA backbone would cleave at that position. The ‘damaging’ reactions were 
limited in so far as they affected only one in every 50 to 100 bases along the DNA. 
This partial cleavage at each base gives rise to a range of radioactive fragments 
extending from the radiolabelled end to each of the cleaved positions.  The DNA to 
be sequenced was subjected separately to four reactions: one cleaving at both purines 
but preferentially at adenine (A>G), one preferentially at guanine (G>A), one at both 
pyrimidines (C+T) and one at cytosine only (C). The purine-specific reactions 
involved methylation with dimethyl sulphate to weaken the glycosidic bonds prior to 
cleavage with alkali (the G>A reaction made use of the faster reaction rate of G 
methylation, and the A>G reaction utilized the fact that the glycosidic bond of 
methylated A is weaker than that of methylated G). The pyrimidine-specific 
reactions employed hydrazine to remove the bases before cleavage with piperdine 
(the C only reaction employed NaCl to preferentially suppress the removal of T). 
When the products of the four reactions were subjected to electrophoresis in adjacent 
lanes of a polyacrylamide gel and the gel imaged by autoradiography, a series of 
bands were produced, the pattern of which allowed determination of the DNA 
sequence.   
 The chemical method of Maxam and Gilbert permitted sequencing of at least 
100 bases from the point of labelling, and was an improvement on Sanger’s ‘plus and 
minus’ technique as it could be applied directly to double-stranded DNA. 
Furthermore, PAGE bands were produced for each base in a sequence (there are no 
problems with homopolymer runs), and the chemical treatment was readily 
controlled and optimized to yield an even distribution of labelled material across the 
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sequence. This chemical method found application in the sequencing of the simian 
virus SV40 in 1978.7 
In 1977, Sanger reported an improved method of sequencing which would 
ultimately lead to him receiving a share in the 1980 Noble Prize in Chemistry (his 
second) together with Gilbert "for their contributions concerning the determination 
of base sequences in nucleic acids".8, 9 This technique utilized chain-terminating 
nucleotide analogues whose incorporation into a growing DNA strand by DNA 
polymerase would prevent further chain extension. Both arabinoside triphosphates 
and 2’,3’-dideoxynucleoside triphosphates could be employed (Figure 1.3), with the 
latter dideoxy method proving the more useful. 
 
Figure 1.3 (a) Structure of 2’,3’-dideoxynucleoside triphosphates, ddNTP. (b) Structure of 
arabinoside triphosphates. Arabinose is a stereoisomer of ribose which serves as a chain-
terminating inhibitor of Escherichia coli DNA polymerase I. 
 
In the original incarnation of dideoxy ‘Sanger sequencing’, the single-
stranded DNA template to be sequenced was annealed to a primer, then divided into 
four aliquots. Each aliquot contained all of the ingredients necessary for DNA 
replication: the four 2’-deoxynucleoside triphosphates (dNTP), DNA polymerase and 
buffer. The dATP that was used was radiolabelled with 32P, although the technique 
was later improved by incorporating 35S (which emits lower energy β particles than 
32P and gives sharper bands in the resulting autoradiograph) into the primer instead.3 
Also added to each aliquot was one of the 2’,3’-dideoxynucleoside triphosphates 
(ddNTP) at a concentration such that it was only incorporated a fraction of the time. 
Incorporation of a ddNTP prevented further extension of the growing DNA chain by 
the polymerase, as there was no longer a free 3’-OH group available for nucleophilic 
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attack on the innermost (α) phosphate of an incoming nucleotide. Taking the reaction 
with ddCTP as an example (Figure 1.4a), the resulting mixture of oligonucleotides 
contained a range of molecules, each of which terminated following incorporation of 
a dideoxy cytosine derivative. PAGE of the four reaction mixtures in adjacent lanes 
gave rise to a series of bands which could be imaged by autoradiography and the 




Figure 1.4 (a) Preparation of fragments chain-terminated at ‘C’. (b) Analysis of the four 




1.1.3 Sanger Sequencing and the Human Genome Project 
Following its publication, the Sanger dideoxy method became the dominant DNA 
sequencing technique. Several improvements were made to the original method, such 
as the use of fluorescently labelled dideoxy nucleotides in place of radiolabelling (so-
called ‘four colour DNA sequencing’ which uses lasers to read the fluorophore 
signals and facilitate single-lane analysis), the development of more efficient 
polymerases and the addition of capillary electrophoresis for the separation of 
labelled fragments. The pre-eminence of Sanger sequencing was boosted when 
Applied Biosystems (ABI) began to produce automated DNA sequencers which 
incorporated this approach.3, 11 A drive towards high-throughput sequencing and 
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parallelism culminated in the launch of the ABI 3730xl DNA Analyzer. This 96-
capillary machine is the state of the art technology for Sanger sequencing and is 
capable of generating up to 6 Mb (i.e. 6 million base pairs) of sequence data per day, 
with average read lengths of up to 1000 nucleotides (nt).12 
 Automated Sanger sequencers were employed in the sequencing of the 
human genome. The Human Genome Project (HGP) was established in 1990 and 
was a publicly funded international collaboration to sequence the ~ 3 billion bases of 
the human genome using samples of DNA taken from several individuals. The HGP 
employed a ‘hierarchical shotgun sequencing’ approach and began by digesting the 
genome with restriction enzymes (which recognize and cleave at specific sequences 
within a DNA molecule) into large fragments several hundred thousand base pairs in 
length. These fragments were subsequently cloned into ‘bacterial artificial 
chromosomes’ (BACs) and mapped onto the chromosomes of the human genome by 
identifying ‘sequence tagged sites’ (STSs), which are specific sequences whose 
location had already been identified. The BAC clones were then digested further 
(‘shotgunned’) to produce much smaller fragments of only a few hundred bases that 
were small enough to be subjected to automated Sanger sequencing. Computer 
algorithms then pieced together the sequence data using areas of fragment overlap, 
thereby elucidating the sequence of the DNA inserted into each BAC. As the location 
of each BAC in the genome had already been mapped, the sequence of the whole 
genome could be deduced.13, 14 
 The HGP published a working draft version of the human genome in 
February of 2001, but a second draft was published simultaneously by a company 
called Celera Genomics.14, 15 Celera was founded in 1998 with the aim of sequencing 
the human genome, and its creation sparked a race with the HGP. This company 
employed a different strategy for sequencing called the ‘whole genome shotgun’ 
(WGS) approach, which skipped the BACs mapping stage and instead started by 
randomly fragmenting the genome directly into small fragments which could be 
cloned and sequenced (again with automated Sanger sequencers). The sequences 
obtained were then built up into larger ‘scaffolds’ by computer algorithms, and the 
positions of these scaffolds in the genome could be located through the identification 
of STSs. The entry of Celera onto the race to sequence the human genome brought 
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with it several methodological and technological innovations and ultimately speeded 
up the sequencing process. 
 
1.1.4 Next Generation Sequencing Technologies 
Sanger dideoxy sequencing has long been the dominant sequencing method, but 
despite numerous technological improvements to the original technique it remains 
costly, time-consuming and labour intensive to sequence large genomes like those of 
humans and other mammals. The sequencing of the diploid genome (i.e. both sets of 
chromosomes) of J. Craig Venter (co-founder of Celera) published in 2007 reputedly 
cost in the order of US $100 million.16, 17 However, recent years have seen the 
emergence of so-called ‘massively parallel’ sequencers that are capable of generating 
many more sequence reads in a single experiment than the 96 generated by modern 
Sanger sequencers. These massively parallel sequencers typically employ a WGS 
approach to generate fragments of genomic DNA, but these are no longer cloned in 
E. coli or any other host cell prior to sequencing. One common limitation of these 
‘next generation’ platforms is that the massively increased throughput comes at the 
expense of smaller individual read lengths and accuracies. This means that more 
reads are required, and that it is more difficult to piece together the reads into full 
genomic sequences. Thus Sanger sequencing may still be required for the more 
demanding applications, such as de novo sequencing of a large mammalian 
genome.18 
The first such method to become commercially available was developed by 
454 Life Sciences (now a subsidiary of Roche) and employed a pyrophosphate-based 
method termed ‘pyrosequencing’. This approach begins by randomly fragmenting 
double-stranded DNA and ligating each fragment to adapter fragments at each end. 
The double stranded DNA is then separated into single strands, and these single-
stranded fragments are bound to microbeads in an emulsion of water in oil. The 
concentration of beads and fragments is controlled such that only one fragment 
molecule is attached to each bead, and there is only one bead per water droplet. The 
water droplets then serve as microreactors in a polymerase chain reaction (PCR) step 
where the number of fragments per bead is amplified so that each bead carries 
millions of copies of a unique DNA template. These microbeads are subsequently 
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captured in picolitre-sized wells on a fibre-optic slide (one bead per well, ~ 1.6 
million wells per slide), then many smaller microbeads carrying immobilized 
enzymes are added to each well. The actual sequencing of the fragments is achieved 
by adding a primer fragment and polymerase and washing the four nucleoside 
triphosphates in series over the plate of wells. Incorporation of the correct nucleotide 
by the DNA polymerase (Figure 1.5) releases pyrophosphate (PPi) which is used by 
a sulfurylase enzyme to generate adenosine 5’-triphosphate (ATP) from adenosine 
5’-phosphosulfate (APS) present in the wash. This ATP is then used by a luciferase 
enzyme and luciferin to generate light which is detected by a charge-coupled device 
(CCD) sensor capable of capturing the photons emitted from the bottom of each 
individual well.19 In this way the 454 pyrosequencer is able to sequence each DNA 
fragment by detecting the light emitted on incorporation of a base into a growing 
strand.  
The most advanced platform produced by 454 (the Genome Sequencer FLX 
Titanium) can reportedly generate around 750 Mb of sequence data per day, with an 
average read length of ~ 400 bases.12 This compares favorably with the 6 Mb 
generated by a Sanger sequencer over the same period. However, this methodology 
does experience problems when sequencing homopolymer runs. Although there is a 
linear relationship between the intensity of light generated and the number of bases 
incorporated in a single wash, this linearity falls off at longer homopolymer runs 
with the result that errors can occur during the sequencing of such runs. 
 
Figure 1.5 Generation of light during base incorporation in the pyrosequencer. 
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The second of the next generation platforms was launched by Solexa (now 
owned by Illumina) and takes a cyclic reversible termination (CRT) approach (Figure 
1.6).20 As for the pyrosequencer, the genomic DNA to be sequenced is isolated, 
fragmented, ligated to adaptor fragments and separated into single strands (Figure 
1.7). The Illumina Genome Analyzer then requires that these single strands are 
bound to the surface of a glass flow cell which is coated with a dense lawn of adaptor 
fragments. The free end of a bound fragment can then bridge and hybridize to an 
adaptor fragment on the surface, which serves as a primer for a subsequent PCR 
amplification of the bound fragments. This amplification produces PCR colonies or 
‘polonies’ of cloned fragments.21 These clusters can then be sequenced by supplying 
a DNA polymerase and four differentially labelled fluorescent nucleotides which 
have been chemically blocked at the 3’-OH position such that only one base can be 
incorporated. This base incorporation step is followed by an imaging stage with 
lasers to identify the base incorporated at each polony, then a chemical deblocking 
step removes the fluorescent marker and liberates a free 3’-OH at each strand ready 
for the next sequencing cycle. Cycles of base incorporation, imaging and fluorescent 
marker removal/deblocking allow the sequence of the DNA at each cluster to be 
read.  
 
Figure 1.6 The CRT approach to sequencing. Either the primer (as shown) or template 
strand is attached to a surface. (a) Probing with reversibly terminating (i.e. blocked 3’-OH) 
fluorescently labelled nucleotides; (b) only the complementary nucleotide (according to 
Watson-Crick base-pairing) is incorporated into the growing strand by a DNA polymerase; (c) 









Figure 1.7 Sequencing with the Illumina Genome Analyzer. (a) Random fragmentation, 
ligation to adaptor fragments; (b) attachment to slide with lawn of adaptors/primers; (c) 
bridged PCR amplification to generate clusters or ‘polonies’ of identical templates; (d) chain 
extension with 3’-OH blocked, fluorescently labelled dATP, dCTP, dTTP, dGTP and imaging; 
(e) deblocking/removal of fluorophore and cycle repeat. 
 
 Both the 454 and Illumina approaches are often termed ‘sequencing by 
synthesis’ (SBS) as they involve the identification of a base immediately after its 
incorporation into a growing DNA strand. Unlike the 454 pyrosequencer system, 
however, Illumina’s CRT method has no problems with homopolymer runs. 
Furthermore, higher throughput is possible as the platform can reportedly generate 
up to 5 Gb of sequence information per day, and an improved version (the ‘HiSeq 
2000’ instrument) promising even greater throughput has recently been launched.12 
However, one drawback is that individual read lengths are much smaller (100 nt). 
This is because the reversibly terminating dye-labelled nucleotides are not 
incorporated efficiently by the modified polymerase that is employed. This enzyme 
also generates more base-substitution errors than is observed for the pyrosequencing 
approach.3, 12 
 A more recently developed massively parallel sequencing platform is Applied 
Biosystems’ Supported Oligonucleotide Ligation and Detection (SOLiD™) system.3, 
12, 20 This technique applies the specificity of a DNA ligase to sequencing. Initially 
the SOLiD™ approach is much like that for 454 pyrosequencing, in so far as the 
genome is fragmented randomly, ligated to adaptor fragments then attached to 
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microbeads and subjected to emulsion PCR so that each bead has millions of copies 
of a unique DNA template bound to the surface. However, at 1 µm in diameter these 
beads are much smaller than those employed in the pyrosequencer (26 µm). The 
templates on the beads are chemically modified at their free 3’-OH for attachment to 
a glass slide. The smaller size of these beads and their subsequent random attachment 
to the slide mean that the SOLiD™ platform is capable of much higher throughput 
than the Illumina Genome Analyzer. For sequencing, universal primers are annealed 
to the adaptor at the 5’-end of the bound fragments and a set of semi-degenerate 
8mer oligonucleotides are added along with a DNA ligase. The 8mer 
oligonucleotides are labelled with one of four fluorescent tags at their 5’-end which 
identifies two adjacent bases in the sequence (so-called ‘two base encoding’). If these 
two bases correspond to the template sequence (according to Watson-Crick base-
pairing), then the oligonucleotide hybridizes to the template and a DNA ligase seals 
the backbone of the growing strand. After imaging to determine the colour of the 
attached fluorophore, the newly incorporated oligonucleotide is cleaved to remove 
the fluorescent marker and the process is repeated several times. Finally, the new 
strand is removed by denaturation and washed away, and the whole process is 
repeated several times with primers of shorter length. This allows the sequence of the 
template to be built up.  
The SOLiD™ sequencer holds an advantage over earlier next generation 
platforms in that its two base encoding approach facilitates the checking of base-
calling errors.18 The throughput of these instruments is comparable to the Illumina 
Genome Analyzer, at 5 Gb per day, although only shorter read lengths of 25-75 nt 
are possible.12 It should be noted that a cheaper version of the SOLiD™ system is 
also available, namely the ‘Polonator’ developed by Dover Systems together with 
Church and colleagues of the Harvard Medical School. A similar chemistry has also 
been applied by Complete Genomics to the sequencing of arrays of so-called ‘DNA 
Nanoballs’ (DNB™) produced by rolling circle amplification of single-stranded DNA 
circles generated from genomic DNA.22  
 Most recently, a single-molecule DNA sequencer was launched by Helicos 
BioSciences (the HeliScope™) which applies an SBS approach to individual DNA 
molecules.23 This technique removes the need for PCR amplification of DNA 
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templates (which can introduce errors, template biases and extra cost) because 
sequencing is performed on individual DNA molecules as opposed to clusters or 
bead colonies. The application of single-molecule imaging promised a step-change in 
sequencing, but the high cost (around $1 million) of the HeliScope™ has limited its 
uptake, and read lengths (32 nt) are shorter than is possible with other instruments.24 
Throughput is comparable to the Genome Analyzer and SOLiD™ platforms, although 
error rates are reportedly higher.12 
When paired with advances in the field of bioinformatics and computing, the 
next or ‘second’ generation massively parallel technologies outlined above have 
greatly reduced the time, labour and cost associated with sequencing. In 2008, the 
diploid genome of James Watson was sequenced with the aid of the 454 
pyrosequencer at a reputed cost of less than US $1.5 million in 4 months.17, 25 This is 
substantially less than the US $100 million and 4 years required to sequence the 
diploid genome of J. Craig Venter using state of the art Sanger platforms, although 
with greater read lengths and lower error rates the Venter genome is arguably of 
better quality.16 Three human genomes were recently reported to have been 
sequenced using the Complete Genomics system (which has yet to be made 
commercially available and is instead used to provide a sequencing service by this 
company) with average sequencing consumables costs of under $4400. However, no 
mention was made of the presumably substantial costs associated with the 
sequencing platform, data management (high-throughput sequencing generates 
terabytes of data files which must be handled, stored and analysed), and personnel 
required to perform the analysis.12 The ultimate goal for sequencing has become the 
US $1000 genome, so despite the advances brought by these new technologies there 
is still some way to go. The ability to sequence a human genome for US $1000 or 
less would open the gateway to an era of genomic and personalized medicine, where 
patient treatment is informed and directed by the individual’s genome or perhaps the 
genomes of disease-causing pathogens.3 
 However, further improvements in sequencing may not be long in the 
pipeline. A ‘third’ generation of platforms is currently in development, which 
promises to achieve ultrafast sequencing with greater read lengths by combining 
single-molecule detection with real-time analysis (as opposed to the step-wise 
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reagent addition associated with current technologies). Examples include an 
instrument from Pacific Biosciences which makes use of zero-mode waveguide 
nanostructure arrays,26, 27 and platforms that make use of nanopores for 
sequencing.28-30 More recently, an instrument (developed by Ion Torrent) has been 
described that employs semi-conductors to analyse the real-time enzymatic 
incorporation of unmodified nucleotides for sequencing, thereby removing the need 
for optical sensing and (expensive) fluorophore-labelling.31, 32 
 
1.1.5 Single Nucleotide Polymorphisms 
A single nucleotide polymorphism (SNP) is a one-base position in the genome for 
which two or more alternative alleles (i.e. forms of a gene located at a specific 
position on a chromosome) are present at appreciable frequency (traditionally, at 
least 1%) in the human population.14 DNA sequencing has revealed approximately 
10 million common SNPs, defined as those with a minor allele frequency, or ‘MAF’, 
of 5 % or greater in the population.33 SNPs account for much of the genetic variation 
between individuals, and occur on average once in every 300 base pairs.34 However, 
it should be noted that SNPs are not the only source of genetic variation; a range of 
structural variations exist, such as insertion-deletions (or ‘indels’) of one or more 
bases, and copy number variants (CNVs; common CNVs may be referred to as copy 
number polymorphisms, or CNPs) in which a section of the genome ≥ 1 kb in size is 
present in differing numbers of repeats between individuals.34, 35 It is estimated that 
structural variations constitute around 20 % of the genetic variations between 
individuals, and 70 % of the variant nucleotides.35 Further genetic variation between 
individuals arises from so-called epigenetic modification of DNA, such as the 
methylation and hydroxymethylation of cytosine.36-38 
SNPs are not evenly distributed throughout the genome, and are more 
common in noncoding regions than in protein encoding regions. A SNP occurring in 
the regulatory site of a gene can alter the transcription rate of that gene, ultimately 
resulting in up- or down-regulation of the encoded protein. Similarly, a SNP in a 
protein encoding section can alter the amino acid sequence of the protein produced 
which can affect protein function and cause disease. So-called ‘genome-wide 
association’ (GWA) or ‘whole genome association’ (WGA)  studies are performed 
Chapter 1: Introduction 
 
 15 
with the aim of linking certain SNPs (identified during sequencing and reported in 
public databases) with particular disease states, with a view to understanding disease 
aetiology and designing suitable therapies. Furthermore, in the field of 
pharmacogenomics attempts are made to link SNPs with an individual’s response to 
particular drugs. In this way it is hoped that drug therapies can be tailored to 
individual patients, thereby ameliorating possible side-effects and heralding an era of 
personalized medicine.39-42 
 Of the myriad technologies available for SNP analysis, virtually all require a 
PCR amplification of the genomic DNA, incorporating, or prior to, some means of 
allele discrimination.43 At present there exist four general approaches to allele 
discrimination; primer extension, hybridisation, ligation and cleavage.44 Of these, 
methods based upon primer extension or the hybridisation of allele-specific 
oligonucleotide (ASO) probes have become the more widely adopted. Once allele-
specific products have been generated, fluorescence detection and mass spectrometry 
are commonly used as read-out tools. 
 
1.1.6 SNP Genotyping with Fluorescence Detection 
The technologies applied to SNP analysis in large scale, genome-wide association 
(GWA) studies typically utilize fluorescence analysis on DNA microarrays (see 
Section 1.2.2).40, 43, 45-47 A microarray is an ordered array of elements (i.e. collections 
of molecules in a microscopic spot) on a planar substrate such as glass, silicon or a 
polymer. The wide-ranging applications of microarrays stem from their facilitation of 
the automated and parallel testing and analysis of many samples in a single 
experiment.48 Two of the most widely used microarrays for GWA studies are 
competing technologies developed by Affymetrix and Illumina.  
The GeneChip system marketed by Affymetrix employs an allele-specific 
hybridisation approach (Figure 1.8) which makes use of differences in the thermal 
stability of matched and mismatched DNA strands to distinguish polymorphisms.  
Allele-specific 25mer oligonucleotide (ASO) probes are synthesized on a glass 
surface using photolithography to produce an ordered array. SNP-containing regions 
of an individual’s genome are amplified, fragmented and tagged before they are 
hybridized on the probe array. Mismatched probes hybridize less strongly, so that 
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subsequent washing and fluorescent labelling steps reveal the SNP genotype based 
upon the probes that have hybridized to base-matched genomic DNA. The 
Affymetrix Genome-Wide Human SNP Array 6.0 has probes for 906,600 SNPs. One 
intrinsic limitation to this hybridization approach is that the relative stabilities of the 
matched and mismatched hybrids is dependent on the base sequences flanking the 
SNP position, which can place limits on the SNPs that can be readily identified. 
Optimization of each hybridization system is required, and reaction conditions such 
as temperature and ionic strength must be stringently controlled. 
 
Figure 1.8 Hybridization approach to SNP genotyping, as employed in the Affymetrix 
GeneChip arrays. A single-base mismatch destabilizes the DNA duplex, so only fully 
matched target sequences will bind. In the GeneChip, the biotinylated (‘B’ = biotin) target 
sequences bind to fully matched probes on the array and are visualized using fluorophore-
labelled streptavidin. 
 
A different approach is employed by Illumina in their BeadArray platforms. 
In this case the microarray substrate is formed from dense bundles of 50,000 optical 
fibres that have wells etched into the tip to hold 3 µm microbeads. These microbeads 
each have hundreds of thousands of copies of a particular 50mer oligonucleotide 
probe covalently bound to their surface, providing specificity towards a particular 
SNP. The polymorphism detection can be based on either an allele-specific primer 
elongation as used in the Infinium I assay, or a single-base extension approach as 
employed in the Infinium II assay (Figure 1.9).47, 49 In both cases the system relies 
upon the ability of a DNA polymerase enzyme to recognize base mismatches. An 
example of this technology is Illumina’s Human1M-Duo BeadChip which 
interrogates more than 1.1 million SNPs per sample. 




Figure 1.9 Genotyping by (a) allele-specific primer elongation, and (b) single-base 
extension, as employed in the Illumina Infinium I and II assays respectively. 
 
Although these microarray-based platforms are useful for the high-throughput 
analysis of many thousands of SNPs simultaneously, a wide range of alternative 
fluorescence-based methods have been developed for more focused studies. These 
typically utilize real-time PCR, in which the increasing concentration of PCR 
amplicons is measured by a fluorescent read-out.50 An advantage of such assays is 
that genotyping can be performed in a single closed tube, thereby minimizing sample 
handling and reducing the risk of contamination with exogenous DNA. A widely 
adopted example is the TaqMan® assay (Applied Biosystems), which makes use of 
the 5’-exonuclease activity of Taq DNA polymerase (Figure 1.10a).51 As for the 
Affymetrix GeneChip, allele discrimination is achieved by hybridization. TaqMan® 
probes carry a fluorophore at one end and a quencher at the other, and the 
fluorescence is quenched by Förster Resonance Energy Transfer (FRET). Upon 
hybridization to a fully matched sequence, the probe is hydrolyzed by the polymerase 
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during PCR primer elongation, with the result that the fluorophore and quencher are 
separated. In this way FRET is eliminated and an increase in fluorescence is 
recorded. A single-base mismatch prevents stable hybridization with the amplified 
sequence and so reduces the efficiency of the hydrolytic probe cleavage.52 A number 
of improvements to the design of the original TaqMan® probes have been made, 
including the use of LNA (‘locked nucleic acid’, Figure 1.10b; LNA probes are 
commercially available from Exiqon) which improves mismatch discrimination and 
allows the use of shorter probes as a result of the greater duplex stability associated 
with this RNA analogue (in which the 2’-O is connected to the 4’-C via a methylene 
bridge).53, 54 
 
Figure 1.10 (a) Genotyping using TaqMan probes. A fully matched probe hybridizes and is 
hydrolyzed by the polymerase to generate a fluorescent signal, whilst a mismatched probe 
remains intact. (b) Structure of a locked nucleic acid nucleotide. ‘F’ = fluorophore, ‘Q’ = 
quencher. 
 
Other examples of probe designs that rely upon hybridization for allele 
discrimination during real-time PCR have been developed, including so-called 
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Scorpion primers and HyBeacons. Like TaqMan probes, Scorpion primers 
incorporate a fluorophore and quencher.55, 56 However, the probe sequence is tethered 
to a PCR primer (via a PCR-blocking linker to prevent copying of the probe 
sequence), such that enzymatic extension of the primer generates the target amplicon 
which then hybridizes to the probe. The distance between the donor and quencher is 
thus increased, thereby eliminating the collisional quenching and generating a 
fluorescent signal. The advantage of this approach is that the hybridization of the 
probe with the target is an intramolecular process, which gives a greater signal-to-
noise ratio and rapid signal generation. Allele discrimination using Scorpion primers 
may be achieved by a so-called ‘amplification refractory mutation system’ (ARMS), 
using two Scorpions bearing different primer sequences (which cover the SNP 
location) and different fluorophores.56, 57 Alternatively, a single Scorpion primer is 
employed wherein the SNP position is addressed thermodynamically using the probe 
sequence.55 In the second case the presence of the mutant allele is indicated by a 
lower fluorescence signal recorded at a temperature close to the probe/target Tm (i.e. 
the duplex melting temperature; the temperature at which 50 % of the DNA 
molecules are hybridized in a double-helix). In their original incarnation, Scorpion 
primers utilized a stem-loop in the probe sequence for quenching, but this design was 
improved through the use of a separate oligonucleotide quencher (Figure 1.11a).58 
These ‘duplex’ Scorpions (supplied commercially by Qiagen) are less complex than 
the original stem-loop design, and additionally have the potential for improved 
fluorescence signals. This is because the distance between fluorophore and quencher 
is hugely increased upon target binding, and re-annealing with the quenching 
sequence is now a kinetically disfavoured intermolecular process as opposed to the 
intramolecular re-annealing that is possible with stem-loop architectures.  
Unlike TaqMan probes and Scorpion primers, HyBeacons (Figure 1.11b and 
c; developed by LGC) do not possess secondary structure but instead make use of the 
enhanced fluorescence observed upon hybridization of linear probes functionalized 
with one or more fluorophores attached to internal nucleobases.59-62 The intrinsic 
fluorescence-quenching properties of the nucleobases and fluorophores within the 
probes results in a low fluorescence in the unhybridized, randomly coiled state. This 
fluorescence is enhanced upon hybridization with a target sequence and formation of 
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a more rigid double-helix which holds the fluorophores further from the nucleobases 
and one another. Allele discrimination can be achieved by melting curve analysis, 
exploiting the greater Tm values for the fully matched versus single-base mismatched 
sequences.  
 
Figure 1.11 (a) Genotyping using duplex Scorpion probes, in this example incorporating the 
ARMS approach to allele discrimination. Only the fully matched primer is extended, and a 
fluorescent signal is generated following intramolecular hybridization of the probe with the 
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target amplicon and displacement of the quencher oligonucleotide. (b) HyBeacons generate 
a fluorescent signal upon hybridization to the target sequence. A 3’-blocker is present to 
prevent copying of the probe during PCR. (c) Structure of fluorescein (6-FAM)-modified 
thymine, as employed in HyBeacon probes. Eight different fluorophores have been 
demonstrated to be effective in HyBeacon probes, facilitating sample multiplexing.
62
 ‘F’ = 
fluorophore, ‘Q’ = quencher. 
 
An altogether different method of allele discrimination is employed in the 
Invader® assay.63 This cleavage-based approach uses a flap endonuclease enzyme 
(FEN) together with a so-called upstream ‘invader’ and two allele-specific probes. 
The upstream invader is complementary to the region 3’ of the SNP site, and 
terminates at its 3’-end with a nucleobase non-complementary to the SNP. The 
downstream allele-specific probes are complementary to the region 5’ of the SNP, 
and differ in the nucleobase present at the SNP location. These downstream probes 
also bear a redundant, non-complementary 5’-arm. Upon hybridization of the invader 
and complementary probe, an overlap is produced that is recognized by the FEN, 
resulting in cleavage of the redundant 5’-arm of the probe. In the original design, this 
arm carried a fluorophore which formed part of a FRET system, such that cleavage 
eliminated FRET and generated a fluorescent signal. However, greater sensitivity is 
achieved if this cleaved product itself acts as an invader in a second FEN-mediated 
cleavage of a FRET incorporating probe (Figure 1.12).64 In this (isothermal) serial 
invasive signal amplification reaction (SISAR), many thousands of fluorophores are 
generated by a single molecule of DNA target, enabling the direct detection of as few 
as 1000 target molecules (i.e. zeptomolar amounts of target) without prior (PCR) 
amplification. In practice, however, PCR-free analysis requires the input of a 
relatively large amount of genomic DNA and long reaction times, so a short PCR 
amplification is often employed to overcome these limitations. 65 




Figure 1.12 Genotyping using the Invader assay by serial signal amplification. ‘F’ = 
fluorophore, ‘Q’ = quencher. 
 
1.1.7 SNP Genotyping with Mass Spectrometric Detection 
A range of SNP genotyping methods has been developed that employ matrix-assisted 
laser desorption/ionization-time-of-flight mass spectrometry, or MALDI-TOF MS, as 
a read-out tool.66, 67 MALDI-TOF MS is routinely employed for the analysis of a 
range of biomolecules (e.g. peptides, proteins and nucleic acids).68, 69 Briefly, laser 
energy is used to ionize the analyte which has been co-crystallized with a matrix of a 
small organic molecule, typically an acid. Different matrices are used depending 
upon the nature of the analyte. The matrix absorbs the energy of the laser and 
transfers some to the analyte, which is ionized. Since MALDI is a soft ionization 
technique it tends to produce little or no fragmentation. Although different analysis 
methods are possible, MALDI is usually coupled with time-of-flight (TOF) detectors 
that distinguish between ions of differing mass-to-charge (m/z) ratio by measuring 
the time it takes them to reach a detector after acceleration across a potential 
difference into a flight tube (ions with a larger m/z ratio take longer to reach the 
detector; the time-of-flight is directly proportional to the square root of m/z).   
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Following PCR amplification of genomic DNA, mass spectrometric SNP 
genotyping assays most commonly rely upon an enzymatic primer extension 
approach for allele-discrimination.66 These methods routinely require an initial clean-
up step of the amplified target DNA to remove unwanted dNTPs and PCR primers 
prior to single base extension. This can be done enzymatically using shrimp alkaline 
phosphatise (SAP) and exonuclease I to hydrolyze dNTPs and primers respectively, 
or alternatively by solid-phase capture of biotinylated amplicons on streptavidin 
functionalized beads followed by washing steps. Allele discrimination is performed 
by extension of a common primer which lies upstream of the SNP location, such that 
the 3’-end stops immediately before the SNP. Following allele discrimination, a 
further clean-up step is necessary to remove salt buffers and reaction components 
which can hamper analysis by MALDI-TOF MS. This is achieved by solid-phase 
purification on ion-exchange resins, streptavidin coated magnetic beads (if 
biotinylated primers are extended), or reverse-phase silica (as employed in ZipTip® 
pipette tips, supplied by Millipore), or alternatively by ethanol precipitation. 
Allele discrimination by primer extension can involve a single base extension 
(SBE; Figure 1.13a) with dideoxynucleoside triphosphates (ddNTPs), as used in the 
PinPoint,70 solid-phase capture (SPC)-SBE,71 iPLEX® (Sequenom),72 GenoSNIP™ 73 
and GOOD assays.74, 75 The GOOD assay is notable in that modified extension 
primers are used that possess a modified backbone at the 3’-end with alkylated 
methylphosphonate linkages, or alternatively phosphorothioate linkages which can 
be alkylated with methyl iodide in an additional step. Following extension, the rest of 
the primer can be selectively removed by enzymatic digestion with a 
phosphodiesterase. The remaining alkylated segment carries a charge tag and is 
readily detected by MALDI-TOF MS without further treatment. Furthermore, it has 
been reported that the initial SAP removal of dNTPs can be avoided through the use 
of an enzyme that selectively incorporates ddNTPs over dNTPs.74, 76 
Unless charge-tagged ddNTPs are employed,77 the mass discrimination for 
allele-specific SBE products can be difficult, especially for A/T polymorphisms that 
give rise to a mass difference of just 9 Da. One way to improve mass discrimination 
is through the use of mixtures of ddNTPs and dNTPs. Examples of such systems 
include the MassEXTEND® (Sequenom)78 and very short extension (VSET)79 
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assays. A variation on this theme is the nucleotide depletion genotyping (NUDGE) 
assay that uses just 3 of the 4 dNTPs to obtain allele-specific products varying in 
length by more than one nucleotide.80  
 
Figure 1.13 Approaches to allele discrimination for genotyping by MALDI-TOF MS. (a) 
Single base extension of a primer with ddNTPs generates products differing in mass by 
between 9 and 40 Da. (b) Greater mass discrimination is achieved by multiple base 
extension using a mixture of ddNTPs and dNTPs, giving products differing in mass by 
approximately 300 Da or more. 
 
 
1.2 A Novel Chemical Approach to DNA Sequence Analysis 
The research described in this thesis draws inspiration from the field of dynamic 
(combinatorial) chemistry and applies it to an artificial DNA mimic. These concepts 
will be outlined in this section. 
 
1.2.1 Peptide Nucleic Acid 
Peptide nucleic acid (PNA) is a structural mimic of DNA possessing an acyclic, 
achiral and uncharged pseudopeptide backbone in which the sugar-phosphate groups 
of DNA have been replaced with repeating N-(2-aminoethyl) glycine units.81, 82 
Purine and pyrimidine bases are attached to this backbone through methylene carbon 
linkages. PNA can hybridize efficiently to complementary PNA, DNA and RNA to 
form very stable duplexes according to Watson-Crick base pairing rules (Figure 
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1.14). PNA can hybridize in an antiparallel (the 3’-end of DNA aligned with the N-
terminus of PNA) or parallel (3’-end aligned with the C-terminus) fashion, but the 
antiparallel orientation is strongly preferred. 
 




Under physiological conditions, the binding affinity and selectivity of PNA 
towards DNA, RNA and PNA is higher than for the analogous DNA duplexes. This 
has been attributed to the neutral character of PNA and the resulting lack of 
electrostatic repulsion with a negatively charged sugar-phosphate backbone. 
Furthermore, PNA has better discriminating power than DNA in that a base 
mismatch in a PNA/DNA duplex is more destabilizing than a mismatch in a 
DNA/DNA duplex. PNA oligomers are also resistant to enzymatic degradation by 
proteases and nucleases, which extends their lifetime in vitro and in vivo. 
 The pseudopeptidic nature of PNA means that straightforward solid-phase 
peptide synthesis (SPPS) techniques can be applied to their preparation.83 The 
monomeric building blocks for PNA (Figure 1.15, analogous to the nucleotide 
monomers of DNA) must employ orthogonal protecting groups for the backbone and 
the exocyclic amines of the nucleobases (A, G and C). 













 combinations have been successfully employed in the solid-phase 













 The unique chemical, physical and biological properties of PNA have 
stimulated attention at the interface of chemistry and biology, and a number of 
diagnostic and pharmaceutical applications have been sought such as gene therapy 
and mRNA profiling.81, 88 Forays have even been made into the use of PNA for SNP 
analysis; a PNA mediated PCR clamping technique has been employed to prevent 
amplification of DNA sequences exactly complementary to a PNA probe,89, 90 and 
allele-specific PNA probes have also been used in conjunction with MALDI-TOF 
MS as a tool for SNP genotyping.91-98  
 
1.2.2 Dynamic Combinatorial Chemistry 
Dynamic combinatorial chemistry (DCC) refers to the study of libraries (or ‘dynamic 
combinatorial libraries’, DCLs) of compounds in which all the constituent species 
are in thermodynamic equilibrium.99 Library members are interconvertable through 
the formation of reversible covalent or noncovalent interactions, such that the library 
composition is determined by the thermodynamic stability of each of the library 
members. Those structures possessing the most favourable inter or intramolecular 
interactions will be more stable and will dominate over other library members. It is 
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therefore possible to add a template molecule to a DCL that will bind to a specific 
constituent and remove it from the ‘pool’, with the result that there is an ‘equilibrium 
shift’ to increase or ‘replace’ the concentration of that library member. As DCLs are 
under thermodynamic control, library composition can also be altered through 
variation of other factors such as temperature and pH.100 DCC has found applications 
in areas such as drug discovery, catalyst screening and self-assembly of inorganic 
architectures.101-103  
 Numerous types of reversible reaction have been used to mediate the 
exchange of building blocks and interconversion of DCL members. These reversible 
reactions may involve noncovalent (e.g. hydrogen bonds), coordinative or covalent 
bonds. A pertinent example involving covalent bond formation is the reversible 
formation of imines (or ‘Schiff bases’) and iminium salts through the reaction of 
aldehydes or ketones with amines (Scheme 1.1).99 
 
Scheme 1.1 Reversible formation of imines from primary amines, and iminium salts from 
secondary amines, by reaction with aldehydes or ketones. 
 
1.2.3 A Novel Chemical Approach to SNP Analysis and DNA 
Sequencing 
The strategy underpinning the research described in this thesis applies dynamic 
chemistry to peptide nucleic acid for the development of an entirely novel method of 
DNA sequence analysis. It was hypothesized that Watson-Crick base pairing could 
be harnessed to template a dynamic reaction on a strand of PNA, by creating a 
nucleobase-free position on the PNA (a so-called ‘blank’ position) situated opposite 
to a nucleotide under interrogation on a complementary DNA strand. A reversible 
reaction, between an aldehyde-modified nucleobases (Figure 1.16a) and the free 
secondary amine at the blank position of the PNA probe would generate an iminium 
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intermediate that could be reduced and analyzed (Figure 1.16b). In the presence of all 
four aldehyde modified nucleobases (i.e. adenine, thymine guanine and cytosine 
derivatives) the DNA template would stabilize the iminium species with the correct 
hydrogen-bonding motif (obeying Watson-Crick base-pairing), thereby amplifying it 
over the other possible iminium products. This would be reflected in the final 
product distribution after reduction to the corresponding amine, and would provide a 
means of allele-discrimination for SNP analysis. 
 
Figure 1.16 (a) Aldehyde modified nucleobases. These molecules could conceivably be 
labelled with fluorophores to facilitate fluorescent detection. (b) Sequence specific DNA-
templated reductive amination on a PNA backbone possessing a ‘blank’ position constituting 
a free secondary amine. 
 
 The same principle could conceivably be applied to the DNA-templated 
extension of a PNA oligomer with a free (primary) amine terminus, using aldehyde-
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modified PNA monomers (Figure 1.17a). In this way, SNP analysis could be 
performed by a single base extension (Figure 1.17b). The method could also be 
extended further to full DNA sequencing by cyclic reversible termination, if the free 
secondary amine in the backbone of the extended PNA probe was capped (e.g. with 
an acyl group) to prevent side-reaction, the terminal protecting group was removed to 
reveal a free primary amine, and the process of extension by templated reductive 
amination was repeated. 
 
 
Figure 1.17 (a) General structure of an aldehyde-modified PNA monomer. The protecting 
group, ‘PG’, could contain a fluorophore to enable fluorescent read-out. (b) Sequence 
specific DNA-templated extension of a PNA probe by reductive amination. 
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 The global aim of this thesis was to investigate the scope of templated 
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CHAPTER 2 
DNA-Templated Base-Filling Reactions on a Peptide 
Nucleic Acid Backbone 
 
“DNA analysis by Dynamic Chemistry”, F. R. Bowler, J. J. Diaz-Mochon, M. D. 
Swift and M. Bradley, Angew. Chem., Int. Ed., 2010, 49, 1809-1812. 
 
2.1 Introduction 
The question at the forefront of early investigations related to the degree of 
selectivity that could be obtained by DNA-templated reductive aminations at ‘blank’ 
positions on a PNA backbone. Model studies were designed to probe the scope of 
this dynamic approach, which necessitated the synthesis of aldehyde-modified 
nucleobases and PNA probes containing one or more free secondary amines 
(‘blanks’) at defined locations. 
Mass spectrometry was selected as the detection method which would allow 
direct read-out of the reaction products without the need for additional probe or 
nucleobase labelling. Specifically, it was envisaged that MALDI-TOF MS would be 
used. PNA is well-suited to detection by MALDI-TOF MS, as the neutral backbone 
renders it less prone to adduct formation and its ions (which tend to be singly 
charged) are more stable than those of DNA.92 Indeed, PNA has already been used in 
a number of hybridization-based genotyping assays that employ MALDI-TOF, as 
described previously (see Chapter 1.2.1).  
 
2.2 Synthesis of Aldehyde-Modified Nucleobases 
The four target aldehydes (TCHO, CCHO, ACHO and GCHO; Scheme 2.1) were prepared 
by microwave-assisted acid hydrolysis of the corresponding diethyl acetals. Thymine 
was thus alkylated at the N1 position with bromoacetaldehyde diethyl acetal to afford 
1, which was hydrolyzed by refluxing in aqueous HCl to yield aldehyde TCHO as the 
hydrate according to literature methods.104-106 This route was later accelerated 
through the use of microwave heating. The protocol was extended to the direct 
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alkylation of adenine at N9 to yield acetal 7, which was hydrolyzed in aqueous TFA 
to afford aldehyde ACHO as the hydrate trifluoroacetate. 
To derivatize cytosine, it was necessary to protect the exocyclic amine before 
alkylation at N1. This was achieved through the use of the monomethoxytrityl (Mmt) 
protecting group85 (see intermediates 5 and 6 in Scheme 2.1), allowing a subsequent 
acetal and amine deprotection to be performed in a single step by treatment with 
aqueous TFA. However, the target aldehyde CCHO required purification, and column 
chromatography (eluting with methanol:dichloromethane) afforded a portion of the 
target as the methanolic hemiacetal. An alternative route employed the acyl (Ac) 
protecting group which could be removed with methanolic ammonia after alkylation 
(see intermediates 2, 3 and 4 in Scheme 2.1). Acetal deprotection of 4 then afforded 
CCHO as the hydrate trifluoroacetate without the need for purification.  
In the case of guanine, 2-amino-6-chloropurine was employed as the starting 
material to circumvent the poor solubility of the natural base and difficulty in 
achieving selective alkylation at the N9 position.83 Thus, acetal 8 was obtained by 
direct alkylation of 2-amino-6-chloropurine with bromoacetaldehyde diethyl acetal. 
Nucleophilic aromatic substitution of the chloride and acid hydrolysis of 8 was 
performed in a single step to yield GCHO as the hydrate trifluoroacetate. An 
interesting point to note is that GCHO was occasionally isolated as a blue solid, and 
the 1H NMR complicated by multiple peaks when recorded immediately after 
dissolution in H2O/D2O, possibly due to self-condensation to form (poly)imines or 
hydrogen bonded (e.g. G-quartet) species that were long-lived on the NMR 
timescale.107 However, LCMS analysis always showed the target mass, and upon 
standing overnight at room temperature in H2O or D2O the 
1H NMR showed a single 
species, consistent with the target structure. 
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Scheme 2.1 Synthesis of modified nucleobases: (a) bromoacetaldehyde diethyl acetal, 
K2CO3, DMF, 130 
o
C, 20 h; (b) bromoacetaldehyde diethyl acetal, Cs2CO3, DMF, microwave, 
100 
o
C, 30 min; (c) 1 M HCl aq, reflux, 70 min; (d) 1 M HCl aq, microwave, 30 min; (e) 5:1 v/v 
acetic anhydride:glacial acetic acid, reflux, 17 h; (f) bromoacetaldehyde diethyl acetal, 
K2CO3, DMF, microwave, 130 
o
C, 30 min; (g) 2 M NH3 in MeOH, 92 h; (h) 1:1 v/v TFA:H2O, 
microwave, 100 
o
C, 30 min; (i) 4-methoxytrityl chloride, 40 
o
C, 30 min, then RT, 16 h; (j) 1:2 
v/v TFA:H2O, microwave, 100 
o
C, 30 min. 
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2.3 Design and Synthesis of PNA Oligomers and 
Determination of Duplex Melting Temperatures  
PNA oligomers were prepared by solid-phase synthesis (SPS) using Fmoc/Bhoc 
protected monomers. The free secondary amine (‘blank’) functionality was built into 
the probes through the use of monomer 10 (Scheme 2.2) which enabled the blank to 
be liberated from a tert-butyloxycarbonyl (Boc) protecting group upon acidic 
cleavage from the solid support. 
 
Scheme 2.2 Synthesis of the Dde and Boc protected monomer used to assemble blank 
positions into PNA probes: (a) chloroacetic acid, 11 
o
C → RT, 16 h; (b) SOCl2, MeOH, 0 
o
C 
→ reflux, 15 h; (c) DiPEA, Dde-OH, 1:1 v/v DCM:EtOH, 16h; (d) Boc2O, Et3N, 5 h; (e) 
Cs2CO3, 1:1 v/v MeOH:H2O, RT, 1.5 h. 
 
The 15-mer probe P1 (Table 2.1) was designed to allow optimization of 
reaction conditions for the dynamic incorporation and address the question of 
reaction selectivity (see Chapter 2.4) using DNA 21-mer templates I-IV (Table 2.2) 
The N-terminus of the PNA was protected with an acyl group, but 
triphenylphosphonium charge tags (Figure 2.1) were used as N-terminal caps in later 
probes to enhance the MALDI-TOF detection limit (see Chapter 3.2).97 
 
Table 2.1 PNA ‘blank’ probes for templated base-filling reactions. 




P1 Ac-TAC TAC ATC _CT TCC 3824.6 
P2
b
 Phosphonium-PEG1-GTG GAG _TC AAC GA 4356.8 
P3
b
 Phosphonium-PEG2-GTG GAG _ _C AAC GA 4118.7 
P4
b
 Phosphonium-PEG1-GTG GAG _ _ _ AAC GA 4039.7 
P5
 
Phosphonium-TCG TTG A _C TCC AC 3916.6 
a
’_’ Represents a blank site (see Chapter 1, Figure 1.16b). PNA oligomers were synthesized 
by solid phase synthesis and had a C-terminal primary amide. 
b
See Figure 2.1 for structures 
of Phosphonium and Phosphonium-PEG groups. 
c
Calculated for the most common isotope. 
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PNA probes P2-4 (Table 2.1) were prepared to study the templated 
incorporation of multiple contiguous nucleobases (see Chapter 2.5) by DNA V 
(Table 2.2). These probes were connected to a ‘charge-tag’ through polyethylene 
glycol (PEG) spacers (Figure 2.1). Such spacers improve the aqueous solubility of 
PNA, and would also permit multiplexed analysis of templated reactions by 
differentiating the probe masses to prevent overlap in the mass spectrum. P5 (Table 
2.1) was used to determine the effect that an abasic site in the templating position of 
the complementary DNA strand VI (Table 2.2) would have on the outcome of the 
reductive amination reaction (see Chapter 2.6).  
To investigate whether blank positions in the PNA backbone would prevent 
hybridization with their complementary DNA templates, the duplex melting 
temperatures (Tm) were measured for probes P1-5 (Figure 2.2 and Table 2.3) using 
the hyperchromicty method (i.e. by measuring the increase in absorbance at 260 nm 
when the duplex unzips). Sigmoidal melting curves indicating duplex formation were 
observed for all probes with one exception; a melting temperature could not be 
obtained for P4, suggesting that the presence of three contiguous blanks prevented 
formation of a stable duplex with DNA V. The melting temperature of P2 was 
substantially higher than that for P1, possibly because the triphenylphosphonium 
charge tag provides some stabilization through electrostatic interaction with the 
negatively charged DNA backbone. Surprisingly, the melting temperature for P3 was 
approximately equal (within experimental uncertainty) to that for P2, despite the 
presence of an extra blank position. However, it should be noted that these probes are 
not entirely comparable as the charge tag of P2 is connected via a longer PEG spacer 
than that used for P3. The broader melting transitions observed for probes P2, P3 
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Table 2.2 DNA templates. 
DNA Oligomer Sequence (5’ – 3’)
a 
I TTT TTT GGA AGG GAT GTA GTA 
II TTT TTT GGA AGA GAT GTA GTA 
III TTT TTT GGA AGT GAT GTA GTA 
IV TTT TTT GGA AGC GAT GTA GTA 
V TCG TTG ACC TCC AC 
VI GTG GAG ZTC AAC GA 
a
Nucleobases which lie opposite a blank position on the complementary PNA probe(s) are 
shown in bold . Z = abasic site. 
 
 
Figure 2.1 Structure of the charge tags (with and without PEG linkers) appended to probes 
P2-5. 
 
Table 2.3 Melting temperatures of PNA probes (see Table 2.1 and 2.2 for oligomer 
sequences). 
PNA Oligomer DNA Oligomer
 





P1 I 53 
P2 V 66 
P3 V 68 
P4 V NA 
P5 VI 59 
a
 Determined using CaryWin UV software, from the maximum of the first derivative of a plot 
of T vs A260nm. NA, no sigmoidal melting curve was discernible. Uncertainty based upon the 
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Figure 2.2 Melting curves for probes P1 and P2-4. The absorbance values have been 
normalized to allow direct comparison. 
 
2.4 DNA-Templated Single Base Incorporation 
Early studies involved the development of a robust protocol for the MALDI-TOF 
analysis of DNA-hybridized PNA following templated reductive amination (Scheme 
2.3). Thus, equimolar aqueous solutions of the four nucleobase aldehydes were 
prepared and added in excess to a 1:1 mixture of probe P1 and one of the 
complementary DNA templates I-IV. To allow hybridization and the dynamic 
formation of iminium intermediates, this mixture was heated to 80 oC for 5 minutes 
and then cooled to 40 oC. Reduction was performed using sodium cyanoborohydride 
for 1 hour before Q Sepharose™ (GE Healthcare) was added. This anion exchange 
resin carries quaternary ammonium functionality and binds the negatively charged 
sugar phosphate backbone of the DNA template. In doing so, any hybridized PNA 
probe is also bound, permitting a washing step to remove any inorganic salts (which 
constitute the pH buffer and reducing reagent) that may give rise to adducts in the 
mass spectrum, together with any unbound PNA.97 Finally, the resin beads were 
mixed with a sinapic acid matrix solution and spotted directly onto a stainless steel 
MALDI plate for MS analysis. 
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Scheme 2.3 Steps involved in DNA analysis by dynamic chemistry and MALDI-TOF MS. 
 
 The resulting mass spectra (Figure 2.3) demonstrated selective incorporation 
of the nucleobase complementary to the templating base on the DNA strand. The 
PNA signals suggested complete dehybridization from the DNA template, which 
may occur either upon addition of the acidic matrix or during desorption/ionization 
in the mass spectrometer. In each reaction, some unreacted P1 was observed together 
with a peak of + 14 Da. This is hypothesized to be the result of a borane adduct due 
to the available free amine at the blank position of the probe (i.e. P1 + BH3). 
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Figure 2.3 Representative mass spectra recorded after DNA-templated reductive aminations 
using an equimolar ratio of the four aldehydes. Peaks shown in red are due to products with 
the ‘correct’ base incorporated according to Watson-Crick base-pairing. (a) DNA template I 
directs incorporation of C; (b) II directs incorporation of T; (c) III directs incorporation of A; (d) 
IV directs incorporation of G. Final concentrations in a 20 µL reaction volume: 4 mM pH 6.0 
sodium phosphate buffer; 0.14 mM in each of CCHO, TCHO, ACHO and GCHO; 5 µM in DNA 
template and P1; 100 mM in NaBH3CN. I = relative intensity (as a percentage of the most 
intense peak), m/z = mass-to charge ratio. 
 
Each reaction was performed in duplicate, and five mass spectra were 
obtained for each. Relative peak intensities (of the most common isotope) were 
recorded and averaged across the ten spectra. Based upon these data (Graph 2.1), it 
can be concluded that (under these conditions) guanine and cytosine are incorporated 
in greater yield and more selectively than either adenine or thymine (attributed to the 
greater number of templating hydrogen-bonds). Furthermore, purine bases were 
incorporated with greater yield and selectivity than pyrimidines (A>T, G>C), which 
may be due to greater π-stacking interactions associated with the bicyclic pyrimidine 
rings (Table 2.4). 





































Graph 2.1 Mean peak intensities (of the most common isotope, relative to the most intense 
peak) resulting from the templated reaction of an equimolar mixture of the four nucleobase 
aldehydes with P1. Error bars indicate the standard deviation across ten mass spectra (five 
from each duplicate analysis). 
 












I G 19:1:1:1 4:1 
II A 1:4:1:1 1:1 
III T 1:1:8:1 2:1 
IV C 1:1:1:39 9:1 
a
Based upon the mean relative intensities of the most common isotope and reported to the 
nearest integer. 
b
The value for the nucleobase complementary to the position under 
interrogation on the DNA template is in bold. 
c
Ratio of starting material (sum of the peaks 
associated with P1 and (P1+ BH3)) to base incorporated product.  
 
The reversibility of the nucleobase incorporation (prior to reduction) was 
investigated by analyzing the reaction of PNA/DNA (1/IV). In the absence of GCHO 
small levels of mis-primed incorporation were detected after reduction. However, 
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when GCHO was added to the reaction mixture immediately before reduction, the 
removal of virtually all mis-primed binding resulted, showing the reversibility of the 
selection process (see Figure 2.4). 
 
Figure 2.4 Reaction in the absence of GCHO results in the incorporation of C, T and A 
(resulting mass spectrum shown in black), but the addition of GCHO just before reduction (and 
after reaction with CCHO, TCHO and ACHO for 1h) prevents formation of essentially all of these 
‘incorrect’ products (resulting mass spectrum shown in red). 
 
It was found that altering the starting concentrations of the nucleobase 
aldehydes gave different product ratios (Figure 2.5). Increasing the concentrations of 
those bases that showed poor selectivity and yield under equimolar conditions (such 
that [TCHO] > [ACHO] > [CCHO] > [GCHO]) resulted in improved yields and peak ratios for the 
‘correct’ templated product (Graph 2.2). In particular, an improvement in selectivity 
was observed for T and A at the expense of C and G incorporation (Table 2.5). 
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Figure 2.5 Representative mass spectra recorded after DNA-templated reductive 
aminations using a non-equimolar ratio of the four aldehydes. (a) DNA template I directs 
incorporation of C; (b) II directs incorporation of T; (c) III directs incorporation of A; (d) IV 
directs incorporation of G. Final concentrations in a 20 µL reaction volume: 4 mM pH 6.0 
sodium phosphate buffer; 0.18 mM in CCHO, 0.45 mM in TCHO, 0.26 mM in ACHO and 0.14 
mM in GCHO (ratio ~ 1:3:2:1 CCHO:TCHO:ACHO:GCHO); 5 µM in DNA template and P1; 100 mM 
in NaBH3CN.  
 












I G 20:2:1:1 5:1 
II A 1:8:2:1 2:1 
III T 1:2:10:1 2:1 
IV C 1:1:1:34 9:1 
a
Based upon relative intensities of most common isotope and reported to the nearest integer. 
b
The value for the nucleobase complementary to the position under interrogation on the DNA 
template is in bold. 
c
Ratio of starting material (sum of the peaks associated with P1 and (P1+ 
BH3)) to base incorporated product. 
 





































Graph 2.2 Mean relative peak intensities (of the most common isotope, relative to the most 
intense peak) resulting from the templated reaction of a non-equimolar mixture the four 
nucleobase aldehydes with P1. Error bars indicate the standard deviation across three mass 
spectra recorded for a single analysis. 
 
   
To study the effect of pH on reaction outcome, DNA II was used to template 
reductive aminations on P1 using buffers to vary the pH over the range 5.0-8.5 
(Figure 2.6). As anticipated for iminium ion formation, conversions were better at 
mildly acidic pH; pH 6.0 was optimal, giving the best yields as judged by the relative 
intensities of product and starting material peaks. A mildly acidic pH strikes the 
balance between being high enough to provide sufficient free amine to attack the 
carbonyl group of the aldehyde, but low enough for protonation of the carbonyl 
oxygen prior to nucleophilic attack, and also protonation of the resulting tetrahedral 
intermediate for elimination of water. 
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Figure 2.6 Effect of pH on templated incorporation of T on P1. TAPS was used to buffer pH 
8.5, sodium acetate to buffer pH 5.0, and sodium phosphate to buffer the intermediate pH 
values. Final concentrations in a 20 µL reaction volume: 4 mM buffer; 0.18 mM in CCHO, 0.45 
mM in TCHO, 0.26 mM in ACHO and 0.14 mM in GCHO; 5 µM in DNA template and P1; 100 mM 
in NaBH3CN. 
 
Work next turned to the analysis of mixtures of DNA templates. This was a 
prelude to SNP genotyping, as any method for allele discrimination must permit the 
genotyping of heterozygous individuals who possess two different alleles of a 
particular gene. Heterozygotes present a greater challenge than homozygotes, as the 
ratio of signals due to each allele (or the ‘allelic ratio’) should be close to unity. To 
explore the analysis of ‘heterozygotes’ by dynamic chemistry, DNA oligomers I-IV 
were mixed to generate each of the six possible combinations of templating base 
which may be present for a single biallelic variant. Thus a ratio of 1:3:2:1 
CCHO:TCHO:ACHO:GCHO gave approximately equal ratios of the correct incorporation 
products for the templating combinations A/T and G/C (‘allelic ratios’ of 0.83 and 
0.70 respectively, Figure 2.7b and e). Poorer ‘allelic ratios’ were observed for 
templates G/A and G/T (0.25 and 0.53 respectively, Figure 2.7a and c), whilst 
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selectivity was worse still for T/C and A/C (‘allelic ratios’ of 0.13 and 0.15 
respectively, Figure 2.7d and f; results summarized in Table 2.6). However, by 
further increasing the concentrations of those nucleobase aldehydes (TCHO and ACHO) 
incorporated in lower yield and poorer selectivity, it was possible to bring the ratio of 
peaks representing ‘correct’ products closer to unity. For example, an improvement 
in the ‘allelic ratio’ from 0.13 to 0.86 was observed for T/C templated incorporation 
in this way (Figure 2.8a and last entry in Table 2.6). The mass spectrum for a control 
reaction (with no DNA template, Figure 2.8b) with this unequal ratio of aldehydes 
gave an unselective and low yield of incorporation products, further demonstrating 
the importance of the template in the base-filling reaction. 
 
Table 2.6 MALDI signal ratios observed for mixtures of two DNA templates. 
MALDI Signal Ratios
a








I+II G+A 29:7:1:1 0.25 
I+III G+T 11:2:6:1 0.53 
I+IV G+C 8:1:1:11 0.70 
II+III A+T 1:7:8:1 0.83 
II+IV A+C 1:3:1:20 0.15 
III+IV T+C 1:2:3:20 0.13 
III+IV
d
 T+C 1:5:27:31 0.86 
a
Based upon mean relative intensities of most common isotope. In each case values have 
been averaged between two spectra recorded for a single analysis using a ratio of 1:3:2:1 
CCHO:TCHO:ACHO:GCHO unless noted otherwise. 
b
The values for the nucleobases 
complementary to the position under interrogation on the DNA templates are in bold and are 
reported to the nearest integer. 
c
Calculated by dividing the intensity of the larger ‘correct’ 
peak by that for the smaller ‘correct’ product. 
d
Using a ratio of 1:14:8:1 CCHO:TCHO:ACHO:GCHO. 
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Figure 2.7 Dynamic incorporation templated by a 1:1 mixture of two DNA oligomers. 
Templating bases were: (a) G and A; (b) T and A; (c) G and T; (d) T and C; (e) G and C; (f) A 
and C. Final concentrations in a 20 µL reaction volume: 4 mM pH 6.0 sodium phosphate 
buffer; 0.18 mM in CCHO, 0.45 mM in TCHO, 0.26 mM in ACHO and 0.14 mM in GCHO (ratio 
1:3:2:1 CCHO:TCHO:ACHO:GCHO); 2.5 µM in each of two DNA templates (5.0 µM total [DNA]); 
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Figure 2.8 (a) Selective incorporation of A and G in approximately equal ratio. Final 
concentrations in a 20 µL reaction volume: 4 mM pH 6.0 sodium phosphate buffer; 0.07 mM 
in CCHO, 0.73 mM in TCHO, 0.43 mM in ACHO and 0.05 mM in GCHO (ratio 1:14:8:1 
CCHO:TCHO:ACHO:GCHO); 2.5 µM in each of two DNA templates (5.0 µM total [DNA]); 5.0 µM in 
P1; 100 mM in NaBH3CN. (b) Control reaction in the absence of DNA (using water to 
maintain a constant reaction volume and concentration of other reaction components and 
buffer). The lower signal-to-noise ratio arises because there is no DNA to aid binding of PNA 
to the anion exchange resin prior to the washing step. 
 
2.5 DNA-Templated Incorporation of Multiple Bases 
It was anticipated that probes with two or more contiguous blanks could permit the 
genotyping of mutations involving the insertion or deletion of multiple bases (indels, 
see Chapter 1.1.5). To investigate incorporation at multiple contiguous blank sites 
(Scheme 2.4), DNA V (Table 2.2) was used to template reactions on probes P2, P3 
and P4 which possess one, two and three abasic positions respectively (Table 2.1). 
Full and selective reaction on these probes would yield ‘+G’, ‘+GT’ and ‘+GTC’ 
incorporation products. As expected, the selective addition of GCHO to P2 proceeded 
smoothly (Figure 2.9a). However, although peaks attributed to fully base-filled 
products were observed for P3 and P4 (Figure 2.9b and 2.9c) more intense peaks 
were observed with masses corresponding to incomplete incorporation, and this was 
not improved by increasing the times for either the dynamic selection or reduction 
steps. Furthermore, the mass spectra recorded for P3 and P4 were complicated by the 
presence of multiple adducts attributed to BH3. An explanation for this may be that 
the additional free amine functionality in these probes provides greater scope for 
complexation and adduct formation with borane.  
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Despite the fact that Tm analysis for P4/V did not indicate the formation of a 
stable duplex, the observation of base incorporation products for P4 would suggest 
that some hybridization with V has occurred. Indeed, the dynamic incorporation 














Scheme 2.4 Illustration of the templated incorporation of (a) two and (b) three nucleobases 













Figure 2.9 Templated incorporation of 
(a) one, (b) two and (c) three contiguous 
bases. Final concentrations in a 20 µL 
reaction volume: 4 mM pH 6.0 sodium 
phosphate buffer; 0.07 mM in CCHO, 0.73 
mM in TCHO, 0.43 mM in ACHO and 0.05 
mM in GCHO (ratio 1:14:8:1 CCHO:TCHO: 
ACHO:GCHO); 5.0 µM in DNA template V; 
5.0 µM in PNA probe (P2, P3 and P4 for 
a, b and c respectively); 100 mM in 
NaBH3CN. 
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2.6 Abasic Sites and Templated Incorporation 
Abasic sugars are found naturally in the genome as a result of spontaneous lesions, or 
chemical or physical damage.108, 109 To investigate the effect of an abasic site in the 
templating position of the DNA strand, oligomer VI was obtained which possessed a 
single abasic ribose moiety. It has been reported that pyrene deoxynucleoside 
triphosphate (dPTP) can be enzymatically incorporated opposite a templating abasic 
site in DNA.110 The flat, fused aromatic rings of pyrene mimic the shape of a 
purine/pyrimidine base pair, enabling it to the span space between the backbones in 
the double helix. With this in mind, 1-pyreneacetaldehyde (YCHO) was synthesized 
according to a literature method (Scheme 2.5) by reduction of ethyl ester 11, 
prepared by esterification of commercially available 1-pyreneacetic acid. 
Interrogation of the DNA abasic site with probe P5 and the four nucleobase 
aldehydes resulted in virtually no base-incorporation products (Scheme 2.6a and 
Figure 2.10a), again demonstrating the role of the complementary base of the DNA 
template in promoting selective incorporation. Analysis of VI with P5 was repeated, 
but this time YCHO was included in the reaction mixture. The resulting mass spectrum 




Scheme 2.5 Synthesis of 1-pyreneacetaldehyde: (a) ethanol, H2SO4, reflux, 4 h; (b) DIBAL-
H, toluene, - 78 
o
C, 1.5 h. 
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Scheme 2.6 Dynamic analysis of abasic DNA using the four canonical nucleobase 
aldehydes in the absence (a) and presence (b) of 1-pyreneacetaldehyde, YCHO. 
 
 
Figure 2.10 Mass spectra resulting from the reaction templated by an abasic site in the 
absence (a) and presence (b) of YCHO. Final concentrations in a 20 µL reaction volume: 4 
mM pH 6.0 sodium phosphate buffer; 0.14 mM in each of CCHO, TCHO, ACHO and GCHO; 0.14 
mM in  YCHO (for b only); 5 µM in DNA template VI and P5; 100 mM in NaBH3CN.  
 
2.7 RNA 
PNA/RNA hybridization has been reported widely, and it was therefore hypothesized 
that RNA would also be able to template base-filling reactions on PNA.111 In view of 
this, a 15mer RNA complementary to P1 was obtained (RI; sequence 5’-GGA AGU 
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GAU GUA GUA-3’). The templating base on this RNA oligomer was uracil (U), 
which would be expected to template incorporation of ACHO. Indeed, MALDI-TOF 
analysis of a base-filling reaction in the presence of equimolar amounts of the four 
nucleobase aldehydes showed selective addition of A (Figure 2.11).  
 
 
Figure 2.11 RNA-templated 
incorporation. Final concentrations in a 
20 µL reaction volume: 4 mM pH 6.0 
sodium phosphate buffer; 0.14 mM in 
each of CCHO, TCHO, ACHO and GCHO; 5 




2.8 Discussion and Conclusions 
The work presented in this Chapter has established that DNA can be used to template 
selective base-filling reductive amination reactions on a PNA strand possessing a 
blank position. Four iminium species (one for each base) are created, but the one 
with the correct shape and hydrogen-bonding motif (obeying Watson-Crick base-
pairing) is the most stable and this is reflected in the product ratios measured using 
MALDI-TOF mass spectrometry. Differences in selectivity and yield between the 
four nucleobases have been attributed firstly to differing numbers of templating 
hydrogen bonds, and secondly to differences in π-stacking interactions between the 
purines and pyrimidines. As anticipated for iminium ion formation, reaction yields 
were found to be optimal at a slightly acidic pH (6.0). 
 In accordance with Le Chatelier’s principle for a system in dynamic 
equilibrium, increasing the starting concentrations of the aldehyde-modified 
nucleobases that gave lower reaction selectivities and yields increases the 
representation of those nucleobases in the product distribution. This result has 
implications for the application of the system to the genetic analysis of individuals 
heterozygous for a particular SNP, as approximately equal peak intensities resulting 
from each allele (or an ‘allelic ratio’ close to unity) would permit easier genotyping. 
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The mass spectra obtained for multiple contiguous blanks showed incomplete 
base-filling, and were complicated by multiple adducts (attributed to BH3). The use 
of such probes would therefore seem unlikely to afford a useful means of genotyping 
indels using the conditions described. It is interesting to note that the most intense 
peaks observed for incorporation on the probe (P4) possessing three contiguous 
blanks correspond to base-filling in the N→C direction. The reason for this apparent 
directional preference for base-filling is unclear, but may stem from a greater duplex 
melting temperature for the (6 base) N-terminal stem of P4 relative to the (5 base) C-
terminal stem. 
A reaction in which the templating DNA base was replaced with an abasic 
site, and a control reaction in the absence of DNA, have further demonstrated the 
role of the DNA template in promoting selective nucleobase incorporation.  In both 
cases the absence of template afforded a low and unselective yield of base-filled 
products. However, 1-pyreneacetaldehyde (YCHO) was found to selectively 
incorporate opposite an abasic site on the DNA template, which provides scope for 
the application of this system to the analysis of abasic sites within genomic DNA. 
Finally, an experiment using an RNA template demonstrated the selective 
incorporation of the ‘correct’ base. This result suggests that the approach to allele-
discrimination reported herein could be extended to direct RNA sequence analysis. 
During the course of this work, a similar study undertaken by Heemstra and 
Liu was published in which sequence-selective base-filling reactions on PNA 
oligomers were shown to be templated by complementary PNA strands.112 This 
provides further confirmation of the results presented herein, in particular the relative 
reaction selectivities observed for the four nucleobases. Base-filling reactions were 
performed at the middle and end of a PNA strand, but middle-of-strand incorporation 
was more efficient, emphasizing the role of base-stacking interactions in the reaction. 
Both reductive amination and acylation reactions were reported to give sequence-
selectivity, but better yields and selectivities were obtained by the former method, 
which supports the hypothesis that dynamic iminium formation provides a route to 
reverse the generation of mis-templated products. However, the use of PNA as a 
template limits the utility of this study, and no mention is made of a potential 
application to genetic analysis.       
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The utility of this method of DNA analysis would be greatly enhanced if the 
incorporation could be made to be catalytic, such that selective incorporation on a 
PNA ‘blank’ probe would be driven by a catalytic amount of DNA template. This 
would result in a substantial lowering of the detection limit by this method, and could 
perhaps be achieved if the dynamic incorporation and reduction were performed at, 
or slightly above, the duplex melting temperature (Tm) of the blank PNA/DNA. This 
may be difficult to control, however, given that the base-filled product is likely to be 
more stable than the original blank PNA/DNA duplex.112 Furthermore, the copying 
fidelity observed in the model systems described above is insufficient (particularly in 
the case of thymine incorporation) for the transmission of sequence information 
through repeated rounds of dynamic incorporation and reduction. 
 Although iminium formation has been used as a dynamic reaction requiring 
minimal alteration of the canonical PNA structure, a wealth of alternative strategies 
compatible with aqueous conditions are available for reversible covalent bond 
formation.99 Recently, Ghadiri and co-workers demonstrated the DNA-, RNA- and 
self-templated dynamic self-assembly of thioester-modified nucleobases on oligo-
dipeptide backbones containing alternating cysteine residues (thioester PNA, or 
‘tPNA’).113 This approach employs thioester exchange as the reversible reaction, 
which has an advantage over iminium formation in that an additional reduction step 
is not needed to trap out the final products. However, tPNA hybridizes much less 
strongly than PNA with DNA and RNA, and thioester exchange is possible at all 
positions on the tPNA strand which would make sequence analysis more 
problematic. Nonetheless, this work further demonstrates the utility of dynamic 
chemistry on a pre-formed peptide backbone for the formation of informational 
polymers. Given the initial complexities observed in the 1H NMR spectrum of GCHO 
(see Chapter 2.2 above), it is interesting to note that these workers employed 7-
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CHAPTER 3 
Genotyping Cystic Fibrosis-Linked Mutations by 
Dynamic Chemistry 
 
“Dynamic Chemistry for Enzyme-Free Allele Discrimination in Genotyping by 
MALDI-TOF Mass Spectrometry”, F. R. Bowler, P. A. Reid, C. A. Boyd, J. J. Diaz-
Mochon and M. Bradley, Anal. Methods, accepted for publication. 
 
3.1 Introduction 
Although dynamic chemistry had been validated as an approach to the 
analysis of single-base changes in synthetic DNA (Chapter 2), the question remained 
as to whether dynamic chemistry could be reliably applied as a means of allele 
discrimination for genotyping. To answer this, a study was planned in which 
individuals diagnosed with cystic fibrosis (CF), whose genotypes had been 
previously determined using established methods, would be genotyped for CF-linked 
mutations using dynamic chemistry.  
CF is the most prevalent lethal recessive genetic disease among Caucasians, 
and arises from mutations in the gene coding for the cystic fibrosis transmembrane 
regulator.114 This 1480-amino-acid protein is responsible for the transport of chloride 
ions across epithelial cell membranes. Over 800 disease-associated mutations 
(mostly SNPs) have been found in the CFTR gene, but around two-thirds of CF cases 
are linked to a single mutation, namely ∆F508, which constitutes a 3 base-pair 
deletion.115, 116 This mutation was selected as a suitably challenging target to validate 
the new method, since the loss of 3 bases from the templating DNA necessitates a 
modification of the original probe design. As a more straightforward test, the G551D 
CF-linked SNP was also targeted for analysis. This SNP accounts for around 1-2 % 
of CF cases worldwide, and is one of just four mutations other than ∆F508 which 
account for > 1 % of CF alleles.114 Moreover, G551D is particularly prevalent in the 
Scottish population, accounting for around 5 % of mutant alleles.117 A second SNP, 
W1282X, which accounts for approximately 1-2 % of CF mutant alleles globally, 
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was targeted for model studies using synthetic DNA. W1282X is linked primarily 
with people of Ashkenazi Jewish descent, and as such has a relatively low incidence 
in the Scottish population.117, 118 Clinical samples (sourced from the Western General 
Hospital in Edinburgh) were therefore not tested for this SNP.  
Following initial model studies for ∆F508, W1282X and G551D on synthetic 
DNA, it was envisaged that a protocol for analysis of human genomic DNA could be 
developed using material sourced ‘in-house’ from the author of this thesis and 
another scientist working on the project (both of unknown genotype), and two 
samples from a commercial source (of known genotype). CF patients would then be 
genotyped for G551D and ∆F508 in a blind trial of the technology. 
 
3.2 Design and Synthesis of PNA Oligomers 
PNA probes were designed to ‘clamp’ the region around the target DNA (Table 3.1), 
selected to represent the sense sequence (the PNA probes were thus antisense, such 
that the PNA N-terminus lined up with the 3’ end of the sense DNA). For the chosen 
SNPs (G551D and W1282X), this was straightforward as the sequence either side of 
the point mutation remains constant (see probes P5-6, Table 3.2). However, in the 
case of the indel (∆F508), the removal of 3 bases causes a frameshift, which 
prohibits analysis with a single probe. Given the observation that multiple contiguous 
bases on a PNA blank leads to complicated mass spectra (see Chapter 2.5), the most 
simple way to address this was to employ two PNA probes for the analysis of ∆F508 
which differed in their N-terminal sequence (see probes P7-8, Table 3.2); one to 
clamp the wild-type sequence, and one the mutant (Figure 3.1). To investigate the 
potential for multiplex genotyping, PNA probes were designed to prevent overlap in 
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G551D rs75527207 G → A P5 
W1282X rs77010898 G → A P6 
∆F508 rs113993960 del CTT P7, P8 
a
Numbers refer to the amino acid position in the CFTR protein, and letters to the amino acid 
change (G is glycine, D aspartic acid, W tryptophan, X stop codon, ∆F phenylalanine 
deletion). For example, the W1282X mutation results in premature termination of the protein 
at a position that would normally contain tryptophan. 
b
dbSNP is an open access archive of 
genetic variation hosted by the National Center for Biotechnology Information (NCBI, a US 
government-funded resource). It can be accessed at http://www.ncbi.nlm.nih.gov/projects/SNP/. 
c
Sequence change of the mutation. ‘G → A’ means a replacement of guanine by adenine in 
the mutant allele, ‘del CTT’ refers to a deletion of these three bases from the code. 
 
 
Figure 3.1 Illustration of the different approaches to SNP and indel allele discrimination. 
SNPs (G551D is shown but the principle is the same for W1282X) can be distinguished 
using a single PNA probe; incorporation of C and/or T will indicate the presence of the wild-
type and/or mutant alleles respectively. The frameshift caused by a 3 base-pair deletion 
means that two probes are required to differentiate ∆F508 and wt508 alleles (P7 and P8 
respectively). Incorporation of A into P7 reports ∆F508, whilst incorporation of G into P8 
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Table 3.2 PNA ‘blank’ probes for CF genotyping. 
PNA 
Oligomer 
Length (number of 
nucleotides) 




P5 14 TCG TTG A _C TCC AC 3916.6 
P6 14 CTT TCC T _C ACT GT 3882.6 
P7 14 AAA CAC C_A TGA TA 3966.6 
P8 15 ACA CCA AA_ ATG ATA 4241.8 
a
’_’ Represents a blank site. PNA oligomers synthesized by SPS with a C-terminal primary 
amide and N-terminal triphenylphosphonium charge tag (see Chapter 2, Figure 2.1). 
b
Calculated mass of the most common isotope. 
 
3.3 Model Studies using Synthetic DNA  
Synthetic single-stranded DNA representative of G551D, W1282X and ∆F508 
mutant and wild-type sequences (Table 3.3) was purchased. The standard protocol 
developed previously was applied to the analysis of these synthetic oligomers, using 
concentrations of CCHO, TCHO, ACHO, and GCHO aldehydes that had been shown to 
normalise their differing incorporation selectivities (see Chapter 2.4). Thus, the 
synthetic DNA oligomers were analyzed in reactions designed to model the 
homozygous mutant, homozygous recessive and heterozygous cases for each 
mutation. The resulting MALDI spectra (Figures 3.2 and 3.3) allowed clear calling of 
the homo- and heterozygous cases, demonstrating that PNA oligomers P5-8 were 
suitable for the analysis of the DNA regions of interest. 
 
Table 3.3 DNA oligomers used in model studies for genotyping. 




VII wt551 GTG GAG GTC AAC GA 
VIII G551D GTG GAG ATC AAC GA 
IX wt1282 ACA GTG GAG GAA AG 
X W1282X ACA GTG AAG GAA AG 
XI wt508 TAT CAT CTT TGG TGT 
XII ∆F508 TAT CAT TGG TGT TTC 
a
’wt’ = wild type allele. 
b
Nucleobases that lie opposite a blank position on the complementary 
PNA probe are shown in bold.  
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Figure 3.2 Model systems for genotyping G551D and W1282X. For both SNP models 
(G551D and W1282X), templated incorporation of C and/or T indicates the presence of 
the wild-type and/or mutant allele respectively. Final concentrations in a 20 µL reaction 
volume: 4 mM pH 6.0 sodium phosphate buffer; 0.07 mM in CCHO, 0.73 mM in TCHO, 0.43 
mM in ACHO and 0.05 mM in GCHO (ratio 1:14:8:1 CCHO:TCHO:ACHO:GCHO); 5.0 µM in DNA 
(for the heterozygous models, 2.5 µM in each of two templates); 5.0 µM in the PNA probe; 
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Figure 3.3 Model systems for genotyping ∆F508. Selective incorporation of A into P7 shows 
the presence of the mutant allele, and G into P8 the presence of the wild-type allele. Final 
concentrations in a 20 µL reaction volume: 2.8 mM pH 6.0 sodium phosphate buffer; 0.07 
mM in CCHO, 0.73 mM in TCHO, 0.43 mM in ACHO and 0.05 mM in GCHO (ratio 1:14:8:1 
CCHO:TCHO:ACHO:GCHO); 5.0 µM in DNA (for the heterozygous models, 2.5 µM in each of two 
templates); 5.0 µM in each PNA probe; 100 mM in NaBH3CN. 
 
 To model a duplex genotyping of an individual heterozygous for G551D and 
W1282X, DNA oligomers VII-X were mixed in equal ratio and analyzed as before 
using an equimolar ratio of P5 and P6. The resulting mass spectrum showed the 
selective incorporation of the expected nucleobases, although the signals for G551D 
analysis were stronger than for W1282X (Figure 3.4a). These could be normalized 
by lowering the amount of P5 (used for G551D analysis) relative to P6, although 
importantly the concentrations of the four DNA templates were kept the same 
(Figure 3.4b). 
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Figure 3.4 Model duplex analyses for G551D and W1282X. (a) Using an equimolar ratio of 
the two PNA probes, signals arising from P6 are lower than those for P5. (b) Signal strengths 
were normalized by using a 5:3 molar ratio of P6:P5. 
 
 Dynamic chemistry was thus successfully applied to the analysis of mixtures 
of synthetic DNA. However, three features of the protocol developed in these studies 
presented potential hurdles to the analysis of genomic DNA: 
1. The PNA probe concentration must always be approximately equal to or less 
than that of the DNA template. If a large excess of PNA was used, then any (now 
small) signals for the templated products were masked by the nonspecific 
incorporation products observed in the absence of template (see Chapter 2, 
Figure 2.8b). Poor yield and no selectivity were observed for reactions in which 
the PNA was in a 102-103 fold excess relative to DNA template (Figure 3.5). The 
sensitivity of this method of DNA analysis is therefore limited by the detection 
limit for the PNA probe(s). 
2. The detection limit for the PNA following dynamic incorporation was 
established to be on the order of 100 femtomoles (using the 
triphenylphosphonium charge-tagged P5 and DNA VII, by serial dilutions of the 
PNA/DNA and maintaining all other reaction components and conditions as per 
the model study outlined in Figure 3.2). In the absence of a charge tag the limit 
of detection was 1 pmole (established using acyl-capped P1 and DNA II, see 
Chapter 2.3). The ultimate goal of the work presented in this Chapter was the 
analysis (by dynamic chemistry) of human genomic DNA which had been 
isolated from buccal (cheek) swabs using a commercial kit (Isohelix). According 
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to the manufacturer’s instructions, 2 - 10 µg of DNA is typically obtained from a 
swab which (neglecting any contribution from mitochondrial and bacterial DNA) 
equates to approximately 1 - 5 attomoles (10-18 moles) of template sequence (see 
Appendix 1 for the derivation of this value). Given point ‘1’ above and the 
detection limit established for the PNA probes of around 100 femtomoles (10-13 
moles), then the amount of DNA obtainable from buccal swabs is a factor of 105 
too low for direct analysis. 
3. Only single stranded DNA was analyzed in model studies, because canonical 
PNA (containing all four bases) is unable to invade linear (B-form) double-
stranded (ds)DNA.119 However, genomic DNA is double stranded, which 
provides a further barrier to direct analysis. 
 
 
Figure 3.5 Analysis of DNA VII with an excess of P5. Conditions as per Figure 3.2, but with 
final concentrations of (a) 0.5 µM DNA and 50 µM PNA (a 10
2
 fold excess of PNA), and (b) 
0.05 µM DNA and 50 µM PNA (a 10
3
 fold excess of PNA). 
 
 To analyze genomic DNA, it was therefore concluded that an amplification 
step would be required. PCR would be used to amplify double-stranded DNA around 
the region of interest, and a second asymmetric PCR step would then generate 
sufficient single-stranded (ss)DNA for analysis. Asymmetric PCR would be achieved 
by amplifying a sample of the original (symmetric) PCR mixture in a second round 
using just one primer, thereby generating an excess of a single strand which would 
serve as the template for analysis. 
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3.4 Analysis of ‘In-House’ and Commercial Genomic DNA 
Samples for G551D 
DNA was isolated from the two scientists working on this project (samples ‘FB’ and 
‘JJ’) using commercially available buccal swabs and isolation kits (Isohelix). This 
involved treatment of the swabs consecutively with three proprietary solutions; one 
to disrupt the phospholipid membranes of the cells (such solutions often contain 
detergent and guanidinium hydrochloride), a second containing an enzyme (protease) 
to break-down cellular proteins, and a third (alcohol-based) solution to precipitate the 
genomic DNA. The final, isolated precipitates were resuspended in a (proprietary, 
though possibly tris-EDTA) basic storage buffer ready for amplification. 
 PCR primers were chosen from a previous publication and used in a 
symmetric PCR to amplify a 92 bp section of double-stranded DNA in the region 
around the G551D mutation.55 Gel electrophoresis of the PCR products for samples 
FB and JJ confirmed the presence of an amplicon of the correct length (Figure 3.6). 
An aliquot of each sample was then subjected to asymmetric PCR with a single 
primer. Attempted analysis of this PCR mix directly by dynamic chemistry was 
unsuccessful, probably because the mixture contains components and buffer which 
could hamper the reductive amination (for example if they contained amines). The 
products of this second PCR were therefore purified using commercially available 
spin-columns (Qiagen). These silica-based columns require an initial acidification of 
the crude PCR mix with high-salt buffer before it is applied to the column and 
bound. A washing step is then performed to remove enzymes, buffer, nucleotides and 
primers (< 40 bp in length) before the purified DNA amplicon is eluted with a buffer 
of 7.0 ≥ pH ≤ 8.5. These columns are supplied with a pH 8.5 elution buffer, but this 
was substituted with pH 7.4 phosphate buffered saline (PBS) owing to the previous 
observation that the reductive amination is not efficient at pH 8.5 (see also Chapter 
2.4, Figure 2.6). Although not optimal for reductive amination, pH 7.4 PBS allowed 
elution of the amplified DNA whilst still permitting analysis by dynamic chemistry 
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Figure 3.6 Agarose gel showing PCR amplification 
of 92 bp double-stranded DNA in the region around 





An aliquot of both eluted samples was used to estimate the final DNA 
concentrations by UV absorbance (Table 3.4). Based upon these values, it was 
calculated that each contained approximately 40-50 picomoles of target DNA (see 
Appendix 2). Subsequent analyses of these DNA samples by dynamic chemistry 
were performed with 40 picomoles of probe P5. Only TCHO and CCHO (using 
concentrations reflective of the relative incorporation selectivities of these bases) 
were used in order to simplify the analyses, given that only C or T incorporation 
would be expected for the wt551 or G551D alleles respectively. For both samples 
(i.e. for FB and JJ) selective incorporation of C only was observed (Figure 3.7). This 
was consistent with both individuals being homozygous for the wt551 allele. It 
should also be recorded that spin-column purification and analysis was performed 
directly after the initial (symmetric) PCR stage but without success, thereby 
supporting the assertion that single-stranded DNA is required for this method of 
DNA analysis. 
Although the results for samples FB and JJ had been expected on the basis 
that neither individual has a family history of cystic fibrosis, these genotypes were 
not validated by established technologies, and so samples of known genotype for the 
G551D mutation were sought. Thus, two isolated genomic DNA samples were 
purchased (Coriell Cell Repositories) that had been extracted from cell cultures 
sourced from individuals genotyped for CF-linked mutations (Table 3.4). Both 
samples (‘Cor1’ and ‘Cor2’) were from individuals heterozygous for the G551D 
allele. Analyses of these commercial samples were performed after a single 
asymmetric PCR step using an unequal ratio of forward and reverse primers (i.e. 
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skipping the preliminary symmetric PCR step). The resulting MALDI-TOF spectra 
showed selective incorporation of both C and T, consistent with the known 
genotypes (Figure 3.8).  
 





















Buccal swab 58 97 N/N n/a 
JJ
d
 Buccal swab 144 108 N/N n/a 
Cor1
e 
Cell culture 371 44 G551D/N Yes 
Cor2
e
 Cell culture 360 46 G551D/N Yes 
a
Determined from the UV absorbance.
 b
’N/N’ = homozygous wt551, ‘G551D/N’ = 
heterozygous for the G551D mutation. 
c
’n/a’ = genotype unknown.
 d
Analysis performed after 
two step PCR (symmetric then asymmetric). 
e
Analysis performed after one step 
(asymmetric) PCR. 
  
It was even possible to analyze (with probes P5, P7, P8 and all four 
nucleobase aldehydes) for both G551D and ∆F508 (the Coriell samples were 
homozygous wild-type for ∆F508) after a single duplexed asymmetric PCR in one 
reaction (Figure 3.9). Amplification of a 173 bp region around the ∆F508 mutation 
was achieved using primers again selected from the literature.55 However, this single-
step asymmetric amplification gave weaker signals than were observed using the two 
step procedure employed for the ‘in-house’ samples and in later work (see Chapter 
3.5 and 3.6). Furthermore, it could not be reliably reproduced using samples sourced 
from buccal swabs, most likely due to differences in the purity and concentration of 
the input genomic DNA.    
Gel electrophoresis after the duplexed asymmetric PCR for the Coriell 
samples confirmed the presence of the double-stranded ∆F508 and G551D 
amplicons. Other faint bands were observed, but they could not be unambiguously 
assigned to single-stranded (ss)DNA (Figure 3.10). However, this may be due to the 
relatively low affinity of ethidium bromide for single-stranded DNA versus double-
stranded DNA. 







Figure 3.7 Genotpying of (a) JJ and (b) 
FB, using dynamic chemistry for allele-
discrimination. Both samples gave 
peaks attributed to C incorporation, 
consistent with homozygous wild-type 
551 genotypes.  A control reaction (c) 
resulted in mainly starting material. 
Unidentified peaks of lower intensity 
were present in each case but did not 
impede genotyping. 
Figure 3.8 Genotpying of commercial 
genomic samples (a) Cor1 and (b) Cor2, 
for G551D. Both samples gave peaks 
attributed to C and T incorporation, 
consistent with heterozygous G551D 
genotypes. A control reaction (c) 
resulted in a weak signal for unreacted 
PNA blank. 






Figure 3.10 Agarose gel after duplex asymmetric PCR for commercial samples Cor1 and 
Cor2. 92 bp and 173 bp double-stranded DNA in the regions around the G551D and ∆F508 
mutations respectively are observed, but single-stranded DNA cannot be readily 
distinguished. 
Figure 3.9 Duplex genotyping of 
commercial genomic samples (a) Cor1 
and (b) Cor2, for G551D and ∆F508. 
Both samples gave signals consistent 
with both individuals being heterozygous 
for the G551D mutation and 
homozygous wt508. A control reaction 
(c) resulted in weak signals for 
unreacted PNA blank.    = BH3 adduct. 
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3.5 ‘Singleplex’ Analysis of Clinical Genomic DNA Samples 
for G551D and ∆F508 
Genomic DNA was obtained from twelve individuals with cystic fibrosis who had 
been genotyped for CF-linked mutations using established methods. The technology 
currently used by the South East Scotland Genetic Service (Western General 
Hospital, Edinburgh) to test for CF mutations is an enzymatic amplification-
refractory mutation system (ARMS, supplied by Gen-Probe as the Elucigene™ CF-
EU2 kit; see Chapter 1.1.6 for a description of the ARMS method as applied to 
Scorpion primers) that uses capillary electrophoresis and fluorescence detection (on 
an Applied Biosystems Genetic Analyzer) for read-out. The CF patients provided 
buccal (cheek) swabs from which the genomic DNA was isolated as before. Regions 
surrounding the G551D and ∆F508 mutations were then amplified in separate 
(‘singleplex’) PCR reactions using the two-step protocol (i.e. symmetric then 
asymmetric, Figure 3.11). PCR primers were as above for amplification of the 
G551D and ∆F508 templates (Chapter 3.4). For one of the samples, gel-shift 
electrophoretic analysis using P5 after the asymmetric PCR stage for G551D also 
suggested the presence of the target single-stranded DNA, together with some 
unidentified amplicons possibly formed as a result of primer-dimer formation or 
other nonspecific amplification (Figure 3.12). 
 
 
Figure 3.11 PCR steps used to generate single-stranded DNA for analysis of clinical CF 
samples by dynamic chemistry. 
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Figure 3.12 Gel electrophoresis of PCR products during the analysis of sample CF2 for 
G551D: Lane 1 = P5; 2 = P5 + product of second, asymmetric PCR; 3 = product of second 
asymmetric PCR; 4 = product of first, symmetric PCR (dsDNA); 5 = control for second, 
asymmetric PCR; 6 = control for first, symmetric PCR. The addition of P5 to the product of 
the asymmetric PCR results in a shift in two of the bands, suggesting that these may be 
represent single-stranded DNA amplicons. 
 
In a blind trial (such that only the clinician who collected the samples was 
aware of the previously determined genotypes), analysis for the G551D and ∆F508 
mutations were performed in singleplex fashion (Figure 3.11) following the two-step 
asymmetric PCR protocol. Of the twelve samples analyzed, five were found to be 
∆F508 homozygotes, four were G551D/∆F508 heterozygotes, two were G551D 
heterozygotes who did not possess the ∆F508 allele, and one was a G551D 
homozygote (see Table 3.5 and Figure 3.13a-c, e-g). The results were in complete 
agreement with the known genotypes determined using established technologies. 
Peaks were always observed for unreacted PNA probes which could be used as 
internal calibrants. For control reactions in the absence of any DNA template (Figure 
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Table 3.5 Analysis of clinical samples for G551D and ∆F508 CF-linked mutations. 
CF Sample 
Extract  DNA Conc. 
(ng/µL)
a 
Result of G551D 
Genotyping
b 







1 112.0 G551D/N ∆F508/N ∆F508/G551D 
2 18.5 G551D/N ∆F508/N ∆F508/G551D 
3 6.4 G551D/N ∆F508/N ∆F508/G551D 
4 5.5 N/N ∆F508/∆F508 ∆F508/∆F508 
5 17.0 G551D/G551D N/N G551D/G551D 
6 19.0 G551D/N N/N P67L/G551D 
7 142.0 G551D/N ∆F508/N ∆F508/G551D 
8 110.5 G551D/N N/N G542X/G551D 
9 157.5 N/N ∆F508/ ∆F508 ∆F508/∆F508 
10 377.5 N/N ∆F508/ ∆F508 ∆F508/∆F508 
11 145.5 N/N ∆F508/ ∆F508 ∆F508/∆F508 
12 107.0 N/N ∆F508/ ∆F508 ∆F508/∆F508 
a
Determined from the UV absorbance.
 b
’N/N’ = homozygous wt551, ‘G551D/N’ = 
heterozygous for the G551D mutation, ‘G551D/G551D’ = homozygous for the G551D 
mutation. 
c
N/N’ = homozygous wt508, ‘∆F508/N’ = heterozygous for the ∆F508 mutation, 
‘∆F508/ ∆F508’ = heterozygous for the ∆F508 mutation.
 d
Mutations P67L and G542X 
(present in samples CF6 and CF8) were not tested for in this study.  
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Figure 3.13 Representative MALDI-TOF spectra for genotyping: (a) C incorporation into P5 
showing an individual homozygous for the wild-type 551 allele (wt551); (b) P5+T showing an 
individual homozygous for the G551D mutant allele; (c) P5+C and P5+T together showing an 
individual heterozygous for the G551D mutation; (d) a control reaction for G551D analysis 
showing unreacted P5 only; (e) P7+G showing an individual homozygous for the wt508 
allele; (f) P8+A showing a genotype of homozygous ∆F508; (g) P7+A and P8+G together 
showing an individual heterozygous for the ∆F508 mutation; (h) a control reaction for ∆F508 
analysis showing unreacted P7 and P8.  
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Mean allelic ratios for heterozygotes (averaged across the 5 spectra recorded 
for each singleplex analysis) were 0.46 (SD = 0.12; n = 30) for G551D (A/G) and 
0.79 (SD = 0.25; n = 20) for ∆F508 (C/T) analysis. Peaks resulting from DNA-
templated incorporation were always > 5 % relative intensity. No peaks 
corresponding to nucleobase incorporation were observed with lower intensities, 
with one exception. In this case, when analyzing a sample for ∆F508, a peak of mass 
corresponding to ‘2 + A’ (indicating presence of the ∆F508 mutant allele) was 
observed at < 5 % relative intensity in 3 of the 5 recorded spectra. However, given 
the low signal strength, the peak was disregarded and the genotype was called as 
homozygous wild-type. Furthermore, repeat analysis of this sample for ∆F508 firmly 
corroborated this assertion (see Figure 3.13e) 
The genomic DNA used in this study was isolated from buccal swabs with 
Isohelix kits, but no further purification was performed, and the concentration of 
DNA was not normalized prior to input into the first PCR cycle. However, this made 
no discernable difference to the quality of the final mass spectra, despite the 
concentration of genomic DNA ranging from 5.5 ng/ µL to 377 ng/ µL across the 
samples (Table 3.5). 
 
3.6 Duplex Analysis of Clinical Genomic DNA Samples for 
G551D and ∆F508 
The duplex analysis of one of the G551D/∆F508 heterozygous samples was 
performed by repeating the singleplex amplification of ssDNA for G551D and 
∆F508, then combining the final crude PCR mixtures and purifying them into a 
single batch for analysis with all three PNA probes. The resulting mass spectrum 
permitted clear determination of the genotype for both mutations (Figure 3.14a). 
Allelic ratios for this duplex analysis (averaging peak intensities across the 5 spectra) 
were 0.28 (SD = 0.03; n = 5) for G551D (G/A) and 0.86 (SD = 0.09; n = 5) for 
∆F508 (C/T). Again, a control reaction showed no incorporation in the absence of 
DNA template (Figure 3.14b).  
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Figure 3.14 (a) Representative MALDI-TOF spectrum for duplex genotyping of G551D and 
∆F508 showing an individual heterozygous for both mutations. Peaks are observed for all 
four possible incorporation products (P5+C and P5+T report wt551 and G551D alleles 
respectively; P7+A and P8+G report ∆F508 and wt508 alleles respectively). (b) A control 
duplex analysis showing unreacted P5, P7 and P8.  
 
3.7 Discussion and Conclusions 
Dynamic chemistry can now be added to the lexicon of methods to generate 
allele-specific products for genotyping (outlined in Chapter 1.1.5-7). Twelve 
individuals were successfully genotyped for the G551D and ∆F508 CF-linked 
mutations in a blind trial of this approach with no false negatives or positives. 
Dynamic chemistry was thus shown to be applicable to the genotyping of SNPs and 
indels, both in a singleplex and duplex format. This distinct method holds several 
advantages over the established allele discrimination assays. Specifically, there is no 
need for the stringent optimization and control of conditions associated with the 
hybridization of ASO probes and subsequent washing steps,120 because the PNA 
‘blank’ probes clamp either side of the polymorphic nucleotide position irrespective 
of the allele present. When compared to methods that rely upon enzymatic extension 
for allele-discrimination, dynamic chemistry removes the need for an enzyme. This is 
of particular advantage in assays that use ddNTPs, as these unnatural triphosphates 
are not incorporated as selectively as dNTPs by natural enzymes, and modified 
enzymes are often required to overcome this.121 Furthermore, assays like iPLEX72 
and SPC-SBE71 require an additional enzymatic step with shrimp alkaline 
phosphatase (SAP) and exonuclease I to degrade dNTPs and primers before a final 
extension with a mixture of ddNTPs; dynamic chemistry obviates these enzymatic 
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reactions, with concomitant advantages in terms of cost and analysis time. The 
ARMS technology used currently by the NHS in Edinburgh for genotyping CF-
linked mutations relies upon the enzymatic extension of allele-specific primers.57  
When compared to other methods relying upon MALDI-TOF for read-out, 
dynamic chemical allele-discrimination with PNA has an additional advantage over 
DNA-based assays, in that PNA is particularly well suited to detection by MALDI 
using matrices suitable for peptide analysis.122 DNA and RNA are more difficult to 
analyze; indeed, the GOOD assay uses an additional alkylation step and a permanent 
charge tag to address this. The application of PNA to genotyping by MALDI-TOF 
MS has been reported by others, but these assays use ASO probes for discrimination, 
with the associated disadvantages touched on above.97 
The American College of Medical Genetics recommends testing for a panel 
of 23 mutations for CF carrier screening, which between them account for the 
majority of cases.123 The assay reported herein analyzes for two of the more 
important mutations, which is evidently insufficient for full CF carrier screening. 
Indeed, a recent test was reported which screened for 108 CF-linked mutations, using 
enzymatic primer extension and MALDI-TOF MS.124 It is not proposed therefore 
that this assay per se be utilized for this purpose. Instead, it has been demonstrated 
that dynamic chemistry can be applied to the generation of allele-specific products 
for genotyping, which argues that the scope of this method of allele discrimination 
merits further investigation.  
Given a successful duplex analysis, then it is reasonable to expect that the 
multiplex analysis of several mutations would be possible with probes designed to 
prevent overlap in the mass spectrum. In this respect, peaks due to the presence of 
unreacted PNA probes can be regarded as an advantage in the sense that they serve 
as useful internal calibrants. However, they also ‘clutter’ the spectrum, which would 
limit the number of mutations which could be multiplexed. It is interesting that 
analysis of the clinical DNA samples by dynamic chemistry generated MALDI 
spectra containing virtually no borane adducts (Figure 3.13) which had complicated 
spectra during model studies with synthetic DNA. The reason for this is unclear, 
although perhaps it is related to differences in PNA/DNA concentration or the 
lengths of the templating DNA strands. It should also be noted however that borane 
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adducts were still observed during the fully duplexed analysis of the commercial 
genomic DNA samples (Figure 3.9). 
It has been shown that indels can be analyzed by dynamic chemistry if two 
PNA probes are used. This is a disadvantage when compared to primer extension 
assays which could achieve this with a single probe. However, indels are much rarer 
than SNPs in the genome, and the use of an additional probe for each is unlikely to 
limit the utility of dynamic chemistry for allele-discrimination. Furthermore, it may 
be that indel analysis would be possible with the use of a single probe if universal 
bases (e.g. hypoxanthine) were built in to the N-terminal side of the ‘blank’ position 
of the PNA.125 A second alternative could involve incorporation of the ‘blank’ site 
directly at the N-terminus, but this has been shown to give poorer dynamic selection 
by others investigating dynamic chemistry on PNA/PNA duplexes.112 
The mean allelic peak ratios for the heterozygous individuals genotyped in 
this study differed substantially from unity. However, the detection of an 
incorporation product clearly signified the presence of the associated allele, so there 
was no urgent need to address this. It has been shown previously in model systems, 
however, that the peak ratios for ‘heterozygotes’ can be brought closer to unity by 
varying the initial concentrations of the aldehyde-modified nucleobases (see Chapter 
2.4). Differences in allelic ratio between the model and clinical studies may have 
arisen as a result of differences in the reaction conditions (e.g. pH and PNA/DNA 
concentration). The allelic ratio showed greater variation for ∆F508 analysis than for 
G551D. This is to be expected given the additional probe needed for indel detection, 
and it is likely to be more difficult to improve the peak ratios by altering aldehyde 
concentrations in this case. 
MALDI-TOF allows direct read-out of allele-specific products for multiplex 
genotyping. However, there is no reason why dynamic chemistry would not also be 
amenable to indirect fluorescence detection using labelled nucleobase aldehydes, so 
long as the hydrogen bonding motif is still available for selection through Watson-
Crick base-pairing. Furthermore, it may be hypothesized that the method for allele-
discrimination reported herein could be readily extended to direct RNA analysis, 
without the need for reverse transcription into cDNA libraries. RNA provides a 
source of single stranded nucleic acid for analysis by PNA probes, and PNA/RNA 
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hybridization has been reported widely.111 Indeed, RNA-templated incorporation has 
already been demonstrated using a synthetic RNA template (see Chapter 2.7). 
The assay described here relies upon polymerase chain reaction, with all of its 
inherent problems, for DNA amplification126. Since nucleobase incorporation will 
only occur in the presence of templating DNA, any false positives or negatives will 
arise from the enzymatic amplification stage. However, this dependence on PCR is 
shared by virtually all genotyping technologies currently available. A notable 
exception is the INVADER assay,64 although it is important to note that this method 
requires the input of an often prohibitively large amount of genomic DNA.127 The 
requisite of ssDNA necessitates an additional step, although one which is also a 
drawback for other assays. An example is the solid-phase capture-single base 
extension (SPC-SBE) method, which overcomes this through the use of biotinylated 
primers and expensive streptavidin-functionalized solid supports. Asymmetric PCR 
may be performed in a single step as opposed to the two reported here,128 although 
multiplex asymmetric PCR is harder to achieve (as found in this study, necessitating 
the use of separate PCR steps to reliably generate double- and single-stranded DNA 
for analysis of each mutation). Direct analysis of dsDNA may be possible through 
the use of conditions which favour PNA/DNA over DNA/DNA hybridization (such 
as low salt concentrations),129 or modifications to the PNA backbone which have 
been shown to result in helical pre-organization of the PNA to favour duplex 
invasion.119  
 The need for a PCR step in genotyping by dynamic chemistry is dependent 
on the sensitivity of the detection method and the concentration of the templating 
nucleic acid. It is reasonable to predict, for example, that a realistic lowering of the 
detection limit to the 10-15 mol (1 femtomole) level would allow direct profiling of 
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CHAPTER 4 




The genetic ‘alphabet’ of A-T/U and G-C Watson-Crick base-pairs is universally 
conserved in nature. Increasingly, efforts are aimed at expanding this genetic 
alphabet through the use of non-natural nucleobases.131-133 A long-term goal of such 
research is the development of non-natural base-pairs which can be faithfully 
replicated, transcribed and translated in vivo.134 Semi-synthetic organisms could thus 
be generated possessing novel functionality for biotechnological applications. In the 
more immediate future, however, non-natural nucleobases hold great potential for in 
vitro applications, such as molecular diagnostics, and antisense gene therapy.   
Early work in this field by Benner and co-workers focused on the rational 
design of new base-pairs through alternative hydrogen-bonding motifs.135-137 A so-
called ‘artificially expanded genetic information system’ (AEGIS) was introduced 
which has already found applications in molecular diagnostics. For example, the 
isoG-isoC base-pair (Figure 4.1a) was used successfully to improve sensitivity in a 
diagnostic assay for the human immunodeficiency virus (HIV), which led to an 
FDA-approved AEGIS-based assay for monitoring HIV and hepatitis viral loads.138, 
139 This non-natural base-pair has also been used for real-time PCR and genotyping 
(including CF genotyping).140, 141 One problem associated with the ‘first-generation’ 
AEGIS base-pairs such as isoG-isoC is their propensity to tautomerize, which results 
in reduced binding selectivity (e.g. isoG can form an enolic tautomer with the correct 
hydrogen-bonding pattern for T/U recognition).142 However, a more recent non-
natural base-pair (P-Z, Figure 4.1b) has been reported that does not suffer from this 
limitation. This P-Z base-pair has been found to contribute more to duplex stability 
than G-C base-pairs and exhibits greater mismatch discrimination versus natural 
nucleobases.143-145 P-Z can be replicated by polymerase enzymes, and primers 
incorporating these nucleobases have been shown to give improved performance 
versus natural nucleobases when used as tags during nested PCR.146 Benner and co-
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workers have also recently reported a ‘self-avoiding molecular-recognition system’ 
(SAMRS), employing non-natural bases that do not recognize one-another, but bind 
selectively to natural nucleobases.147 This provides a means to avoid primer 
interactions during PCR, and was found to give improved results during multiplexed 
PCR. 
 Other approaches to the design of non-natural base-pairs have been described, 
including expanded hydrogen-bonded motifs (i.e. with four hydrogen-bond 
recognition sites, Figure 4.1c)148 and size-expanded nucleobases (so-called 
‘expanded’ (x)DNA and ‘wide’ (y)DNA, Figure 4.1d and 4.1e).149 However, a more 
radical approach to expanding the genetic alphabet dispensed with hydrogen-bonding 
altogether and instead focused on the development of hydrophobic base-pair 
analogues.  This builds on pioneering work by Kool and co-workers, who 
demonstrated that hydrogen-bonds are not essential for DNA replication or 
hybridization.150-152 Nucleobase analogues of this type rely upon hydrophobic effects 
and shape complementarity for duplex stabilization and selective base recognition. 
Eliminating the need for templating hydrogen-bonds has greatly widened the scope 
for design of novel base-pair analogues, and has inspired many further developments 
in this direction, most notably by Romesberg, Schultz, Hirao and co-workers.153-157 
Examples of hydrophobic nucleobase analogues include a propynyl-substituted 
derivative (PICS, Figure 4.1f) which can self-pair and increase duplex stability even 
over a G-C pair,158 and a methoxynaphthyl (NaM)-5-methylthioisocarbostyril 
(5SICS) base-pair which can be replicated in DNA (Figure 4.1g) and was developed 
following an initial screen of 3600 candidate molecules.134  
 
Chapter 4: Non-Natural Nucleobases 
 78 
 
Figure 4.1 (a) AEGIS nucleobases introduced by Benner and co-workers, possessing a 
DDA-AAD pattern of hydrogen-bonding not found in natural nucleic acids (D = hydrogen-
bond donor, A = hydrogen-bond acceptor). (b) A more recent AEGIS base-pair developed to 
remove the tautomerization observed in isoG-isoC. (c) A base-pair analogue displaying a 




 refers to ‘(amin-oxo)-(oxo-amino)’, a 
description of the hydrogen-bonding donor/acceptor at each end of the pattern. (d) An xDNA 
nucleobase (xA, shown paired with natural T) wherein the Watson-Crick hydrogen-bonding 
edge is distanced from the backbone by benzo fusion. (e) Benzo fusion with a different 
geometry generates yDNA. (f) A hydrophobic, propynylisocarbostyril (PICS) base-pair which 
lacks hydrogen-bonds for recognition. (g) A predominantly hydrophobic base-pair which can 
be enzymatically replicated. The ortho substituents are hydrogen-bond acceptors which aid 
enzymatic DNA extension following incorporation of one of these unnatural bases. 
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 In the context of PNA, a number of nucleobase analogues have been reported 
that increase duplex melting temperatures with potential for improved recognition of 
target strands in molecular diagnostics and antisense technologies. Examples include 
2,6-diaminopurine (D, Figure 4.2a) which has an extra hydrogen-bond donor 
(relative to adenine) with which to bind thymine,159 7-chloro-1,8-naphthyridin-2-
(1H)-one (‘bicyclic T’ or bT, Figure 4.2b) which increases duplex stability (relative 
to thymine) through additional hydrophobic interactions,160, 161 and 9-(2-
guanidinoethoxy)phenoxazine (G-clamp, Figure 4.2c), which can form five 
hydrogen-bonds with guanine.162 
 Encouraged by the observation that templated base-filling reactions give 
selective incorporation of the natural nucleobases (Chapters 2 and 3), it was 
hypothesized that this chemistry could serve as a tool for the rapid screening and 
discovery of nucleobase analogues with improved binding to and selectivity for the 
natural bases. In this way, novel nucleobases could be screened without the need for 
their incorporation into full-length PNA (or DNA) oligomers. It was envisaged that 
the aldehydes required for this method of screening would be more easily 
synthesized than the Fmoc/Bhoc protected PNA monomers or DNA 
phosphoramidites necessary for oligomer synthesis. It might even be possible to 
identify novel base-pairs through the use of two PNA ‘blank’ oligomers if they were 
designed such that the ‘blank’ positions lay opposite one another in a PNA/PNA 
duplex. In relation to earlier work on genotyping (Chapters 2 and 3), it would also be 
desirable to find a replacement aldehyde for TCHO and ACHO to improve on the lower 
incorporation selectivity associated with these bases. 
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Figure 4.2 (a) 2,6-diaminopurine hybridizes more strongly with thymine as a result of an 
additional hydrogen-bond. (b) Increased duplex stability can also be affected through 
additional base-stacking interactions, as exemplified by a bicyclic thymine (bT) analogue. (c) 
The G-clamp base possesses guanidinium functionality which can form two additional 
hydrogen-bonds with G, whilst imparting a positive charge which provides additional 
stabilization through electrostatic interactions with the negatively charged sugar-phosphate 
backbone of DNA.  
 
 The protocol developed previously for templated incorporation could thus be 
applied to the discovery of new nucleobase analogues, again using mass 
spectrometry as a read-out tool. Two approaches were planned: firstly, a library of 
aldehydes available in-house would be screened for selective recognition of the 
natural nucleobases; secondly, a more targeted set of aldehyde-modified nucleobases 
would be synthesized and compared to the canonical nucleobases for incorporation 
selectivity. Any nucleobase found to strongly and/or selectively incorporate opposite 
a natural nucleobase could then be built into a full-length PNA oligomer for 
PNA/DNA duplex melting temperature (Tm) measurements, to determine whether or 
not this dynamic chemical approach gave a reliable estimate of base-pair stability 
and discrimination.  
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4.2 Library Screening for Nucleobase Analogues 
A small library of eighteen aldehydes available in-house (Figure 4.3) was screened 
for template-selective incorporation using the protocol developed previously 
(Chapter 2.4). The aldehydes were chosen based upon in-house availability, the 
presence of aromaticity (to allow base-stacking), and ease of discrimination of the 
possible incorporation products in a mass spectrum (i.e. masses were chosen to avoid 
overlap). The aldehydes were screened for selective incorporation into PNA P1 
(Chapter 2.3, Table 2.1) using DNA templates I-IV (Chapter 2.3, Table 2.2). 
 The resulting mass spectra showed peaks associated with incorporation only 
of aldehydes 27 and 28 (Figure 4.4). However, the molecular ion associated with the 
incorporation of cinnamaldehyde 28 was always 2 Da greater in mass than the 
calculated value, although the isotopic distribution was poorly resolved. The reason 
for this was undetermined, but it is likely that the alkene functionality in 28 has also 
been reduced in the presence of excess cyanoborohydride. 1,4-addition of hydride to 
the conjugated iminium species generated by 28 would give an enamine which could 
be protonated under the acidic conditions of the experiment (at the carbon β to the 
aromatic ring) to afford a second iminium intermediate, reduction of which would 
generate a peak with the observed mass.163 The mass was too low to result from 
incorporation of aldehyde 22 which has the next highest mass (6 Da greater than that 
of 28), but the increase in 2 Da brings this peak close enough to overlap with that 
calculated for incorporation of 22. Although the isotope resolution was not good 
enough to eliminate the possibility of a small amount of 22 incorporation, this seems 
unlikely in view of the lack of incorporation of similar aldehydes 26 and 29. 
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Figure 4.3 Aldehyde mixture screened for incorporation. Compounds 12-17, 22, 26, and 29 
had been previously synthesized as part of a separate medicinal chemistry project. All other 
aldehydes were commercially available. 
 
 
Figure 4.4 Representative mass spectrum obtained after dynamic incorporation of a library 
of aldehydes, showing peaks attributable to 27 and 28 incorporation (DNA III represents the 
T template). Although the peak attributed to 28 incorporation had a mass 2 Da higher than 
the calculated value, this is probably due to reduction of the alkene functionality proceeding 
via an enamine intermediate. Final concentrations in a 20 µL reaction volume: 4 mM pH 6.0 
sodium phosphate buffer; 0.48 mM in each of the eighteen aldehdyes; 5.0 µM in DNA 
template; 5.0 µM in P1; 100 mM in NaBH3CN.   
  



































Graph 4.1 Mean peak intensities (of the most common isotope, relative to the most intense 
peak) resulting from the templated incorporation of aldehydes 27 and 28 from an equimolar 
library. Error bars indicate the standard deviation across ten mass spectra (five from each 
duplicate analysis). 
 
No additional incorporation products were distinguishable above the 
background noise in the MALDI spectra. This is remarkable, given that each of the 
eighteen aldehydes screened could potentially react with the secondary amine on the 
PNA probe in a reductive amination. Both 27 and 28 (a propionaldehyde and 
cinnamaldehyde derivative respectively) possess an aromatic ring connected to the 
aldehyde functionality by a two-carbon linkage. For each of the other compounds 
screened, the aldehyde functionality was attached directly to an aromatic ring, which 
may have been disfavourable for base-stacking and hence templated incorporation.  
Aside from a slightly lower incorporation of 28 in the case of DNA IV (T 
template), equal selectivity (within standard deviation) was observed for 27 and 28 
between the four templates (Graph 4.1), so these compounds are evidently unsuitable 
for sequence-specific recognition of DNA. However, bases which allow sequence-
independent duplex formation can usefully serve as ‘universal’ bases, for example in 
PCR primers which span sections of genomic DNA of variable sequence (i.e. a 
Chapter 4: Non-Natural Nucleobases 
 84 
universal base could be integrated into the primer at a position opposite a site of 
ambiguous sequence, such as a SNP location).125 
 
4.3 Targeted Synthesis and Screening of Nucleobase 
Analogues 
A smaller set of four aldehydes was targeted for screening. Firstly, aldehyde-
modified 2,6-diaminopurine (DCHO; Scheme 4.1a) was designed to allow an initial 
comparison with ACHO (Chapters 2 and 3). This would provide a good indication of 
the suitability of templated dynamic incorporation as a means for the discovery of 
nucleobase analogues, given that D has already been reported to improve PNA/DNA 
duplex stability.159 For further comparison, thiouracil aldehyde (SCHO; Scheme 4.1b) 
was targeted as an analogue of TCHO, since S-A is known to give melting 
temperatures similar to a T-A base pair.164 Other aldehydes would be synthesized 
with a view to improving on the relatively poor selectivity observed for TCHO 
incorporation. Thus, the N9-alkylated xanthine aldehyde was initially targeted for 
synthesis in light of the improved selectivity observed for purine versus pyrimidine 
incorporation (Chapter 2.4), although the N7-alkylated isomer (XCHO; Scheme 4.1c) 
was eventually isolated. Building on the observation that increased hydrogen 
bonding also gives improved selectivity (Chapter 2.4), pyridone aldehyde (T*CHO; 
Scheme 4.1d) was prepared, as a recent publication calculated an increased 
hydrogen-bond strength for a T*-A base-pair relative to T-A.165  
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Scheme 4.1 Synthesis of a targeted set of aldehydes. (a) NH3 in methanol, microwave, 65 
→ 90 
o
C, 150 min; (b) 1:1 v/v TFA:H2O, microwave, 100 
o
C, 30 min; (c) N,O-
bis(trimethylsilyl) acetamide, bromoacetaldehyde diethyl acetal, KI, DiPEA, RT → 100 
o
C 
(microwave); (d) bromoacetaldehyde diethyl acetal, Cs2CO3, DMF, microwave, 100 → 130 
o
C, 60 min, then RT, 40 h; (e) 10 M KOH aq, microwave, 205 
o
C, 25 min; (f) EtOH, cat. HCl, 
microwave, 85 
o
C, 30 min; (g) DIBAL-H, n-hexane/DCM, -78 
o
C → RT. 
 
2,6-diaminopurine aldehyde (DCHO) was prepared via 2-amino-6-chloropurine 
acetal (8; Chapter 2.2) by nucleophilic aromatic substitution with methanolic 
ammonia in a microwave-assisted reaction to afford intermediate acetal 30. 
Microwave-assisted hydrolysis of 30 in aqueous TFA then afforded DCHO as the 
hydrate trifluoroacetate.  
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Although thiouracil could be successfully alkylated with bromoacetaldehyde 
diethyl acetal to afford 31, attempted hydrolysis of 31 to the target aldehyde in 
aqueous acid was fruitless. Instead, several products were present (as judged by 1H 
NMR), and ES-MS showed the presence of a compound with mass corresponding to 
the bicyclic derivative resulting from nucleophilic attack of sulfur on the liberated 
aldehyde. Thiouracil is able to tautomerize more readily than uracil owing to the 
greater polarizability of the larger sulfur atom as compared to the analogous oxygen 
in uracil. The target SCHO was therefore dismissed as being inherently unstable to 
cyclization, and serves as an example to show that these ‘simple’ aldehyde-modified 
nucleobases may not always be synthetically accessible, owing to the reactivity of 
the aldehyde functionality with any nucleophilic groups present in the target 
molecule. An attempted incorporation on P1 (Chapter 2.3, Table 2.1) templated by A 
(DNA II; Chapter 2.3, Table 2.2) using the crude hydrolysis product of 31 returned 
the starting PNA only, suggesting the absence of any reactive aldehydic functionality 
and the stability of any cyclic thioacetal to ring-opening. 
Xanthine derivative XCHO was synthesized via 32, which was prepared by 
direct alkylation of xanthine with bromoacetaldehyde diethyl acetal. Although the N9 
isomer was originally targeted for synthesis and analysis, only products resulting 
from alkylation at the N3 and N7 positions were obtained as a mixture in vanishingly 
low yield after column chromatography. These isomers were distinguished by 2D 
(HMBC) NMR spectroscopy. The N7 derivative was isolated and taken forward for 
testing in dynamic incorporation experiments. Thus, microwave-assisted hydrolysis 
of 32 in aqueous TFA afforded XCHO as the hydrate trifluoroacetate. 
In order to synthesize the pyridone derivative, commercially available 2-
chloro-3-pyridylacetic acid was subjected to nucleophilic aromatic substitution in a 
high-pressure microwave-assisted reaction in concentrated aqueous potassium 
hydroxide. The resulting carboxylic acid was not isolated in this instance but 
converted directly to the corresponding ethyl ester 33 in a further microwave-assisted 
step, then reduced with DIBAL-H to afford a separable mixture of the alcohol and 
target aldehyde T*CHO. 
 The three synthesized aldehydes were tested in a series of competition 
experiments with their analogous natural nucleobases. Thus, DCHO and ACHO were 
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mixed in equimolar ratio and the resulting solution used in a dynamic incorporation 
reaction templated by T (DNA III; Chapter 2.2, Table 2.2). As anticipated given the 
additional stabilization imparted by its extra hydrogen-bond, only D incorporation 
was observed in the resulting mass spectrum (Figure 4.5a; no A incorporation was 
discernible above the background noise). 
 
 
Figure 4.5 Mass spectra obtained by dynamic incorporation of the non-natural nucleobase 
aldehydes in competition with their natural analogues. (a) Incorporation of only D was 
observed in the presence of A, with T as the templating base; (b) X was incorporated to a 
lesser extent than T in a reaction templated by A; (d) T* was incorporated to a greater extent 
than T in a reaction templated by A. Final concentrations in a 20 µL reaction volume: 4 mM 
pH 6.0 sodium phosphate buffer; 0.27 mM in each of the two competing aldehdyes; 5.0 µM 
in DNA template; 5.0 µM in P1; 100 mM in NaBH3CN.   
 
 Templated incorporation of an equimolar mixture of XCHO and TCHO resulted 
in a mass spectrum showing a slightly larger peak height associated with T 
incorporation (Figure 4.5b), suggesting that duplex stability is greater for adenine 
paired with the natural base than with the N7-xanthine derivative. X:T peak ratios 
were 0.6:1, averaged over ten spectra (five for each of two duplicate experiments). 
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However, repeating the experiment with T*CHO in place of XCHO resulted in a peak 
indicating greater incorporation of pyridone (T*) relative to thymine (Figure 4.5c). 
T*:T peak ratios were 3:1, again averaged over ten spectra (five for each of two 
duplicate experiments).  Thus, T* was selected as a potential candidate nucleobase 
analogue that may impart greater duplex stability than T when paired with A.  
Further dynamic chemical incorporation experiments using T*CHO, CCHO, 
ACHO and GCHO and the four DNA templates I-IV (Figure 4.6) were performed to 
investigate the selectivity for T* against mis-incorporation.  
 
 
Figure 4.6 Representative mass spectra recorded after DNA-templated reductive aminations 
using an equimolar ratio of aldehydes CCHO, T*CHO, ACHO and GCHO. Peaks shown in red are 
due to products with the ‘correct’ base incorporated according to Watson-Crick base-pairing. 
(a) DNA template I directs incorporation of C; (b) II directs incorporation of T*; (c) III directs 
incorporation of A; (d) IV directs incorporation of G. Final concentrations in a 20 µL reaction 
volume: 4 mM pH 6.0 sodium phosphate buffer; 0.14 mM in each of CCHO, T*CHO, ACHO and 




Chapter 4: Non-Natural Nucleobases 
 89 
Thus, in the presence of the A template, T* was incorporated more 
selectively than T in the presence of the other three natural nucleobase aldehydes 
(Graph 4.2 and Table 4.1), again suggesting that replacement of T-A with T*-A 
base-pairs would increase duplex melting temperatures. However, mis-templated 
incorporation of T* in the presence of the C and G templates was slightly higher than 
for T, and in the presence of the T template mis-templated incorporation of T* was 
much higher (the selectivity for A versus T was only 2:1). On the basis of these 
results, it was predicted that the duplex melting temperatures for T* would be 
slightly higher for single-base T*-C and T*-G mismatches, and substantially higher 




































Graph 4.2 Mean peak intensities (of the most common isotope, relative to the most intense 
peak) resulting from the templated reaction of an equimolar mixture of CCHO, T*CHO, ACHO and 
GCHO with P1. Error bars indicate the standard deviation across ten mass spectra (five from 
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Table 4.1 MALDI signal ratios resulting from an equimolar mixture of CCHO, T*CHO, ACHO and 










I G 21:2:1:1 19:1:1:1 
II A 1:5:1:1 1:4:1:1 
III T 1:4:8:2 1:1:8:1 
IV C 1:2:1:30 1:1:1:39 
a
Based upon the mean relative intensities of the most common isotope and reported to the 
nearest integer. The value for the nucleobase complementary to the position under 
interrogation on the DNA template is in bold. 
b
See Chapter 2.4. 
 
4.4 Comparison of Dynamic Incorporation Results and 
Duplex Melting Temperatures 
To determine whether or not the results for dynamic chemical incorporation of the 
pyridone aldehyde T*CHO provided a reliable estimate of the duplex stability and 
selectivity conferred by this nucleobase mimic, PNA oligomers P9-12 containing 
zero, one, two and three pyridone (T*) nucleobases respectively were synthesized, 
complementary to DNA oligomers XII-XVI which represented a fully matched and 
T, G and C single-base mismatched sequences respectively (Table 4.2). 
Incorporation of pyridone into oligomers P9-12 was achieved using monomer 36, 
which was synthesized as shown (Figure 4.7).  
 
Table 4.2 PNA and DNA sequences used for Tm measurements. 
Oligomer Sequence
a 
P9 N-AGT GAT CTA C Lys-C 
P10 N-AGT GAT* CTA C Lys-C 
P11 N-AGT GAT* C T*A C Lys-C 
P12 N-AGT* GAT* CT*A C Lys-C 
XIII 5’-GTA GAT CAC T-3’ 
XIV 5’-GTA GTT CAC T-3’ 
XV 5’-GTA GGT CAC T-3’ 
XVI 5’-GTA GCT CAC T-3’ 
a
All PNA oligomers possessed a C-terminal lysine residue. 





Figure 4.7 (a) 10 M KOH aq, microwave, 205 
o
C, 25 min; (b) Fmoc-aeg-O
t
Bu.HCl, DCC, 
oxyma, DiPEA, DMF, microwave, 60 
o
C, 30 min; (c) 1:1 v/v TFA:DCM, 8 h. 
 
 The melting temperatures for PNA/DNA duplexes containing T* in the PNA 
strand (Table 4.3) did not agree with the predictions made on the basis of the 
dynamic incorporation experiments performed with T*CHO. Specifically, the 
replacement of T with T* at one position lowered the Tm by 13 
oC. No substantial 
difference was observed between Tm values of duplexes containing one and two T*-
A base-pairs, but a further decrease in Tm of 14 
oC resulted from a third T*-A pair. 
However, comparison of the duplex Tm values for P10 with DNA oligomers XIV-
XVI showed poor mismatch discrimination for T* as expected, although with greater 
stability observed for the T*-G ‘mismatched’ base-pair than the predicted T*-T 
‘mismatch’. The stability recorded for the T*-G ‘mismatch’ was even higher than for 
the supposed T*-A match, and is indicative of the tautomerization of pyridone to 
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P9 XIII T/A 49
c 
(0) 
P10 XIII T*/A 36 -13 
P11 XIII T*/A (× 2) 36 -13 
P12 XIII T*/A (× 3) 22 -27 
P10 XIV T*/T 36
d 
-13 
P10 XV T*/G 42 -7 
P10 XVI T*/C 33 -16 
a
Determined using CaryWin UV software, from the maximum of the first derivative of a plot of 
T vs A260nm. Measurements were performed at 1 
o
C intervals. Uncertainty is based on the 
standard deviation across four measurements. 
b
Change in Tm relative to fully matched 
canonical PNA/DNA duplex P9/XIII.  
c




Uncertainty in this reading is ± 6 
o
C due to poorly defined melting curves.  
 
4.5 Discussion and Conclusions 
Dynamic chemical incorporation of aldehydes DCHO and ACHO in the presence of T 
template (DNA III) showed clear incorporation of the 2,6-diaminopurine (D) only. 
This is entirely consistent with the hypothesis that the additional hydrogen-bond of D 
provides extra stability to the iminium species generated from DCHO and the 
secondary amine at the PNA blank position. This iminium species is therefore the 
more concentrated (relative to that formed from ACHO and the PNA blank) at 
equilibrium, which is reflected in the product distribution after reduction and mass-
spectrometric detection. This ties in well with reported studies on the effect of D on 
the Tm of PNA/DNA melting temperatures, wherein D was shown to increase duplex 
melting temperatures.159  
 Of the T analogues investigated, the aldehyde derived from xanthine, XCHO, 
was incorporated slightly less selectively than TCHO. This was predicted, as xanthine 
can be thought of as a size-expanded version of T, and as such will destabilize a 
duplex in which all of the other bases are natural (i.e. not size-expanded). In addition, 
alkylation at N7 may present a sub-optimal hydrogen-bonding motif for recognition 
by an adenine template. The pyridone aldehyde, T*CHO, on the other hand, was 
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incorporated slightly more selectively than TCHO. This was also expected, given the 
additional hydrogen-bond strength calculated for this base analogue. 
 However, for T*, the dynamic chemical incorporation results were not 
predictive of the Tm measurements made for PNA/DNA duplexes in which the PNA 
oligomer contained T*. While this work was in progress, Benner and co-workers 
reported the use of 3-methyl-2-pyridone as a potential nucleobase mimic, but it was 
found to cause duplex destabilization and poor mismatch discrimination in 
DNA/DNA duplexes.147 This has been attributed to the absence of a minor-groove 
hydrogen-bond donor in the pyrimidine ring (which is present in thymine), resulting 
in duplex stabilization, as this is necessary for hydrogen-bonding with water in the 
minor grove of the duplex (Figure 4.8).166  
 
 
Figure 4.8 (a) Hydrogen-bond donors in the minor groove stabilize a B-form DNA double-
helix through hydration. (b) Pyridone lacks a hydrogen-bond donor in this position. 
 
 Based upon the discrepancy between the greater dynamic chemical 
incorporation for T* versus T and the duplex destabilization caused by the presence 
of T*-A in place of T-A base-pairs, it can be concluded that the method of dynamic 
chemical incorporation reported herein does not always provide a true estimate of 
duplex stability, and therefore is not a reliable means of screening for nucleobase 
analogues with improved properties for diagnostic and antisense applications.  The 
reason for this discrepancy has yet to be fully investigated and determined, but 
potential reasons may be offered. Firstly, the dynamic chemistry employed selects 
for the most stable iminium species at equilibrium. In some instances (e.g. for the 
templated incorporation of the natural nucleobases or D), this may correspond to the 
relative stabilities of PNA/DNA duplexes in which the nucleobase is connected to 
the PNA backbone by the canonical amide linkage, but this may not always be the 
case. Secondly, although it has been supposed that a single base change in the PNA 
Chapter 4: Non-Natural Nucleobases 
 94 
sequence does not substantially affect the ionizability of the PNA oligomer and 
hence mass spectrometric signal strengths, this cannot be ruled out because a 
calibration curve to determine peak heights at, for example, different relative 
concentrations of PNA oligomers P9 and P10 (to measure the effect of T*/T 
substitution on peak heights) was not performed. 
 In spite of the failure of dynamic chemistry to reliably predict Tm values by 
the method described, it has been demonstrated that novel aldehydes can be screened 
to identify those which are more selectively incorporated, as exemplified by the 
experiment using DCHO. Such aldehydes may serve to improve the method of genetic 
analysis developed previously, by reducing the possibility of mis-primed 
incorporation. DCHO could thus replace ACHO for SNP and indel genotyping by 
dynamic chemistry (see Chapter 3), although this may require derivatization with a 
mass tag to prevent overlap with peaks associated with G incorporation (since D has 
a mass only 1 Da less than that of G).  
In a recent development, Leumann and co-workers reported a very similar 
approach to that described herein for the rapid screening of a parallel library of 
aromatic heterocyclic amines for the discovery of novel artificial nucleobases.167 In 
this study, reversible hemiaminal formation was employed at an abasic site on a 
fluorophore-labelled dodecameric DNA oligomer. The nucleobase candidates were 
screened in parallel for sequence selective incorporation opposite a templating DNA 
strand which was labelled with a fluorescence quencher to facilitate direct Tm 
determination by fluorescence measurements. One drawback of this hemiaminal 
approach, however, was that both anomers may have been produced, and so 
carbocyclic derivatives had to be synthesized representing the α and β derivatives to 
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CHAPTER 5 




Several examples of non-enzymatic, nucleic acid templated extension of 
informational polymers have been reported. One strategy involves the irreversible 
chemical ligation of activated building blocks, notable examples of which have been 
described by Szostak and co-workers in studies focused on the development of an 
alternative genetic system. The reaction between an amine and an imidazole-
activated phosphate group facilitated the template-directed synthesis of both 
N2’→P3’ glycerol nucleic acid (npGNA) and N2’→P5’ DNA.168, 169 Template-
directed ligation of DNA has also been achieved by Kool and co-workers, who 
employed an SN2 reaction of a phosphorothioate with an alkyl iodide to ligate 
oligomers for DNA and RNA sequence analysis.170 More recently, Brown and 
colleagues used the a Diels-Alder reaction to perform the simultaneous DNA-
templated ligation of three oligonucleotides.171 Examples of templated oligomer 
ligation chemistries applied to mutation detection include the native chemical 
ligation of PNA reported by Seitz and colleagues,172 and the reaction between an 
amine and an azaoxybenzotriazolide activated phosphate reported by Richert and co-
workers in the ligation of both DNA and RNA.173, 174 
 As an alternative to these irreversible chemical ligation strategies, reversible 
reactions have been employed in a number of dynamic chemical approaches to the 
template-directed extension of oligomers. Such reactions permit the reversal of any 
mis-incorporation and subsequent insertion of the ‘correct’ building block to improve 
fidelity in the daughter strand. This is more akin to biological systems, in which mis-
incorporated nucleotides can be removed by the hydrolytic domains of polymerase 
enzymes. For example, reversible imine formation for DNA template-directed 
ligation has been reported by Lynn and colleagues, who joined modified DNA 
trimers and also polymerized amino-aldehyde DNA dimers by reductive 
amination.175-177 In a strategy similar to that described herein, Liu and colleagues 
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have performed the DNA-templated polymerization of PNA aldehyde tetramers and 
pentamers by reductive amination.178-180 Sequence-selective single-base extension 
has also been reported by Micklefield and colleagues, using DNA to template a 
reductive animation between a hybridized strand of PNA and di-aldehyde 
morpholino precursors to generate a morpholino-PNA chimera for analysis by 
MALDI-TOF mass spectrometry.181 
 To facilitate the method of genotyping and sequencing by terminal extension 
outlined in Chapter 1.2.3, a set of four N-terminal protected PNA aldehydes was 
required (Figure 5.1). The aim of the work presented in this Chapter was to 
synthesize such aldehydes and test them for DNA-templated dynamic extension of a 
PNA probe. Early work targeted a set of unlabelled monomers for direct read-out of 
the extended PNA products by MALDI-TOF MS analysis as described in previous 
Chapters.  
 
Figure 5.1 General structure of targeted PNA aldehydes for terminal extension. B = 
nucleobase (A, G, C or T); PG = protecting group. 
 
5.2 Synthesis of a Thymine PNA Aldehyde  
The initial phase of this work concerned the synthesis of a Dde-protected PNA-
aldehyde thymine monomer (44, Scheme 5.1) from the analogous carboxylic acid 
(43). This route was chosen because 43 was readily prepared via a well-established 
synthetic route.83 The Dde (1-(4,4-dimethyl-2,6-dioxacyclohexylidene)ethyl) 
protecting group is classically removed with hydrazine, and is orthogonal to the acid 
labile groups (Bhoc and Mmt) that are  routinely used for the protection of the 
exocyclic amine functionality of adenine, guanine and cytosine.182 A compound very 
similar to the target aldehyde 44 but bearing a Boc protecting group in place of Dde 
had been reported by Liu.178 However, the preparation of this poorly characterized 
PNA-aldehyde thymine monomer involved a low-yielding synthesis culminating in 
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an OsO4-catalyzed cleavage of an allylic intermediate, and an alternative route to 44 




Scheme 5.1 Synthesis of carboxylic acid 43 as a precursor to thymine aldehyde 44: (a) 10 
o
C → RT, 16 h; (b) SOCl2, MeOH, 0 
o
C → reflux, 20 h; (c) DiPEA, DCM, 16 h; (d) K2CO3, 
DMF, 16 h; (e) NaOH aq, reflux, 3h; (f) DCC, HOBt.H2O, DMF, 16 h; (g) Cs2CO3, 1:1 v/v 
MeOH:H2O, 4.5 h. 
 
The synthesis of peptide aldehydes has been widely investigated as they have 
many applications. For example, they are potent inhibitors of serine and cysteine 
proteases, as they react with these enzymes to yield, respectively, hemiacetals and 
hemithioacetals which resemble the transition state of amide hydrolysis and are 
bound tightly in the active site.183 One of the most widely reported methods of 
synthesising N-protected peptide aldehydes involves the reduction of Weinreb 
amides, often with lithium aluminium hydride or DIBAL-H.184, 185 Thus 43 was 
converted into Weinreb amide 45 (Scheme 5.2), then reduced to the target aldehyde. 
To prevent over-reduction of 44, the milder reducing agent lithium tri-tert-
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Scheme 5.2 Synthesis of target aldehyde via reduction of a Weinreb amide: (a) 
MeONHMe.HCl, EDC.HCl, HOBt.H2O, Et3N, DMF, 20 h; (b) LiAlH(O-t-Bu)3, THF, 95 min. 
 
However, reduction of 45 and isolation of the resulting aldehyde is not facile. 
The use of three equivalents of LiAlH(O-t-Bu)3 affords 44 with approximately 63 % 
conversion as judged by HPLC. The use of fewer equivalents of the hydride gives a 
lower conversion of the amide, whilst greater equivalents result in over-reduction to 
the corresponding alcohol and unidentified impurities. Attempts to purify the 
aldehyde by column chromatography on silica gel were unsuccessful, and resulted in 
decomposition of the target. A small, analytically pure sample of 44 was finally 
isolated for partial characterization after purification by preparative HPLC, although 
this compound degraded over time in solution (vide infra). 
As an alternative route to aldehyde 44, the S-benzyl thioester 46 was prepared 
and reduced (Scheme 5.3).   
 
 
Scheme 5.3 Synthesis of target aldehyde via reduction of an S-benzyl thioester: (a) benzyl 
mercaptan, DMAP, DCC, DMF, 22 h; (b) triethylsilane, Pd/C, THF, 2 h. 
 
HPLC of the reaction mixture for reduction of 45 suggested approximately 83 % 
conversion of the thioester to the aldehyde 44. However, it was not possible to drive 
the reaction to completion through the addition of extra catalyst or triethylsilane. 
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Furthermore, work-up of the reaction mixture was less straightforward than for 
reduction of the Weinreb amide as the crude product was contaminated with catalyst 
and unreacted triethylsilane.  
A ‘cleaner’ catalytic hydrogenation reaction of 46 was attempted with 10 % 
Pd/C using the HC-Tutor™. This is an educational version of the H-Cube™ 
developed by ThalesNano, which is a bench-top continuous-flow reactor capable of 
heterogeneous catalytic reductions.187 The instrument generates hydrogen by the 
electrolysis of water, and mixes it with a solution of the starting material before it is 
pumped through a heated column containing a solid-supported catalyst. 
Unfortunately, the HC-Tutor™ generated only a trace of 44 even after repeated flows 
through the catalyst column. This may be because the catalyst is poisoned by the 
sulfur-containing starting material or by-products. 
The difficulties (moderate yields and problematic purifications) experienced 
in the conversion of carboxylic acid 43 to 44 stimulated the investigation of faster 
and cleaner routes to the aldehyde. It was envisaged that methyl ester 42, which is a 
precursor in the synthesis of the acid (Scheme 5.1) could be reduced to the 
corresponding alcohol. Test reactions with LiAlH(O-t-Bu)3 showed this to be 
possible. The alcohol might then be oxidized to aldehyde 44, thereby removing two 
steps from the overall synthesis. However, a faster route to the alcohol (48, Scheme 




Scheme 5.4 Synthesis of target aldehyde via oxidation of a primary alcohol: (a) Dde-OH 
(39), DCM, 16 h; (b) 41, PyBOP, DiPEA, DCM, 0 
o
C → RT, 2 h. 
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Thus 48 was rapidly prepared by a coupling of acid 41 with the Dde protected 
intermediate 47. The low yield of this reaction was attributable to the formation of 
the ester by coupling of the terminal hydroxyl group with 41. Trial oxidations of 48 
using Dess-Martin periodinane188 and sulphur trioxide-pyridine complex189 afforded 
crude aldehyde (judged by TLC and 1H NMR of the crude material) although it was 
not isolated or purified. With some reaction optimization this synthesis of aldehyde 
44 offers a much faster and more economical route than that proceeding via 
carboxylic acid 43. However, focus was shifted from this synthetic route by the 
development of an alternative methodology (vide infra). 
A more straightforward route to aldehyde 44 was envisaged in which the 
aldehyde functionality was incorporated through a diethyl acetal. Thus, acetal 50 
prepared in a microwave assisted synthesis starting from 1,2-diaminoethane and 
bromoacetaldehyde diethyl acetal (Scheme 5.5).  
 
Scheme 5.5 Synthesis of target aldehyde via acetal hydrolysis: (a) bromoacetaldehyde 
diethyl acetal, K2CO3, MeCN, microwave at 130 
o
C, 30 min; (b) DdeOH (39), DCM, 16 h; (c) 
41, DCC, HOBt.H2O, DMF, microwave at 60 
o
C, 30 min; (d) 90 % TFA aq, -10 → 0 
o
C, 1 h. 
 
Several attempts were made to hydrolyze this acetal to the target aldehyde: refluxing 
in aqueous HCl; pTsOH in acetone/water;190 iodine in acetone/DCM.191 However, 
the best result was obtained by stirring with aqueous trifluoroacetic acid at between 0 
and -10 oC.192 This gave the target aldehyde in approximately 90 % yield as judged 
by HPLC. The synthesis and deprotection of acetal 50 appears to offer the fastest and 
most economical route to aldehyde 44.  
 Mention should be made of the instability of the target aldehyde 44. As noted 
above, the final target is difficult to purify, and tends to degrade rapidly in solution 
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(aqueous or organic) to a mixture of products. Although a thorough investigation of 
the degradation products was not undertaken, it may be speculated that one possible 
cause is an intramolecular cyclization via a favourable 6-exo-trig ring-closure. 
Intramolecular cyclization in this way has been reported previously, wherein cyclic 
enamides were synthesized via intramolcular attack of the amide nitrogen of N-
carboxybenzyl (Cbz) protected amines on Nα-acetals in aqueous TFA.193-196 
Furthermore, the relatively mild conditions (aqueous acid at between -10 and 0 oC) 
used to hydrolyze acetal 50 are in stark contrast to those needed in the hydrolysis of 
the nucleobase acetals described in previous chapters (e.g. microwave heating in 
aqueous acid at 100 oC, used in the hydrolysis of diethyl acetals 4 and 7 to yield 
aldehydes CCHO and ACHO respectively; see Chapter 2, Scheme 2.1), which is 
consistent with neighbouring-group participation in the hydrolysis of 50. 
 
5.3 Resin Capture of a Thymine PNA Aldehyde 
It was anticipated that aldehyde 44 could be resin-captured using a threonyl 
scavenging resin, as reported by Liu (Scheme 5.6).178, 180 This would allow 
purification of 44, and also enable Dde deprotection on the resin for alternative 
derivatization of the N-terminus of the aldehyde (e.g. by attachment of fluorophores, 
with or without cleavable linkers for sequencing by cyclic reversible termination). 
Cleavage from the resin would then afford the pure PNA aldehyde monomer for 
templated terminal extension of a PNA strand.  
 
Scheme 5.6 Condensation of an impure aldehyde with a threonine modified resin yields a 
supported oxazolidine. After washing, cleavage affords the pure aldehyde.  
 
Thus, a threonyl scavenging resin was prepared from a commercially available 
aminomethyl functionalized PEG-PS (i.e. polyethylene glycol/ polystyrene 
composite) resin, namely NovaGel HL, by coupling with Fmoc-Thr(t-Bu)-OH and 
removal of the Fmoc and t-Bu protecting groups (Scheme 5.7) according to a 
literature method.188 A model study was then performed in which the scavenger was 
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used to purify 3-phenylpropionaldehyde from an equimolar mixture with 3-
phenylpropan-1-ol by capture/release in the microwave (Figure 5.2).  
 
Scheme 5.7 Preparation of an aldehyde-scavenging resin: (a) TBTU, DiPEA, DMF; (b) 20 % 
v/v piperidine/DMF; (c) 80 % v/v TFA/DCM. 
 
 
Figure 5.2 HPLC traces of: (a) an equimolar mixture of 3-phenylpropan-1-ol and 3-
phenylpropionaldehyde in MeOH + DiPEA; (b) the supernatant after resin capture in the 
microwave at 60 
o
C for 60 min; (c) the cleavage cocktail obtained after heating in the 
microwave at 60 
o
C for 30 min with 60:40:1 MeCN:H2O:TFA. 
 
Initial studies towards capturing 44 using the threonyl scavenging resin were met 
with some success. Following capture, washing and release of the crude aldehyde 
obtained by reduction of Weinreb amide 45, HPLC analysis of the cleavage cocktail 
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showed the presence of aldehyde 44 and a slight reduction in the amount of 45 
present (Figure 5.3). 
 
 
Figure 5.3 Capture/release of 44 using a threonyl scavenging resin. HPLC traces of: (a) 
crude product; (b) cleavage cocktail. Capture performed from 86:9:6:1 
MeOH:DCM:DMF:AcOH at room temperature, 1 h. Release with 80:10:5:5 
MeOH:AcOH:DCM:H2O at room temperature, 80 min. Milder conditions than for the model 
system were employed during capture/release owing to the poorer stability of 44. 
 
5.4 Templated Terminal Extension of a PNA Oligomer 
A DNA-templated extension was planned using PNA oligomer P13, which was 
synthesized with a free N-terminus (Table 5.1). DNA oligomer XVII was purchased, 
with A as the templating base for terminal extension. 
 
Table 5.1 PNA and DNA sequences used for terminal extension. 
Oligomer Sequence
a 
P13 N-CAT TCT TCC TCT-C 
XVII 5’-AGA GGA AGA ATG AAA CAT AGA C-3’ 
a
P13 has a free N-terminus. The section of DNA XVII to which P13 is complementary is 
underlined; as the N-terminus of PNA aligns with the 3’-end of DNA, XVII presents A as the 
templating base for extension of P13 by reductive amination. 
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Owing to the problems associated with the stability of aldehyde 44, it was envisaged 
that the easiest way to obtain DNA-templated extension of a PNA oligomer would be 
to hydrolyze the PNA acetal immediately prior to the extension reaction. Thus acetal 
50 was treated with aqueous TFA and the resulting aldehyde was dissolved in water 
and used directly in extension reactions of P13 templated by DNA XVII using the 
protocol described previously (see Chapter 2.4). A control reaction was performed in 
the absence of DNA template. The resulting mass spectra (Figure 5.4) showed 
incorporation of the thymine aldehyde 44 in the presence of DNA only, 
demonstrating the templated extension of a PNA oligomer by reductive amination. A 
significant signal for the extended product was only observed when the freshly 
prepared aldehyde solution was added after the initial PNA/DNA hybridization at 80 
oC. If the aldehyde was present from the start, only very weak signals were observed 
for extension, which provides further evidence for the instability of 44 in solution.  
 
 
Figure 5.4 Extension of P13 by reductive amination: (a) in the presence of DNA template 
XVII, with the aldehyde added at 40 
o
C immediately before reduction; (b) in the presence of 
DNA XVII, with the aldehyde added at the start prior to hybridization at 80 
o
C; (c) control 
reaction in the absence of DNA XVII, with the aldehyde added after the initial hybridization 
(as for (a)). Final concentrations in a 20 µL reaction volume: 4 mM pH 6.0 sodium phosphate 
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buffer; 3.2 mM in crude, freshly prepared 44; 5 µM in DNA template (for (a) and (b) only) and 
P13; 100 mM in NaBH3CN. 
 
5.5 Discussion and Conclusions 
A PNA aldehyde thymine monomer 44 was successfully synthesized by a number of 
routes, but the fastest involved the microwave assisted synthesis and mild 
deprotection of a diethyl acetal derivative, 50. The aldehyde was used in a DNA-
templated extension of a PNA strand by reductive amination, although sequence-
selective templated extension has yet to be demonstrated by this approach as the 
cytosine, guanine and adenine analogues remain to be synthesized. However, the 
chemistry employed in the synthesis of the thymine PNA aldehyde monomer is 
readily applicable to the preparation of these analogues, as the exocyclic amines of 
these bases are routinely protected with the acid-labile Mmt or Bhoc groups, which 
could be removed in the same step as the deprotection of the acetal to the target 
aldehyde. Difficulties encountered in the isolation of 44 stimulated investigation of 
purifying the aldehyde by capture with a threonine modified resin, and a trial 
reaction met with some success. This could allow the Dde deprotection of resin-
bound aldehyde for attachment of alternative protecting groups or fluorophores.  
Problems during the synthesis of aldehyde 44 related to its instability in 
solution. Although the mechanism of degradation of 44 remains to be investigated, it 
is noteworthy that similar issues have been encountered by others when preparing 
monomers for the terminal extension of informational polymers. For example, 
Szostak and co-workers resorted to the use of dimers during the templated extension 
of N2’→P3’ GNA, as the monomers were prone to cyclization.168 It would be 
interesting to learn whether PNA aldehyde dimers would be less refractory and more 
useful for sequencing studies. Such dimers could be prepared after resin capture of 
those aldehydes reported herein and extension by solid-phase synthesis, as described 
by Liu and colleagues during the synthesis of PNA aldehyde tetramers.178 It would 
also be interesting to test aromatic intercalating molecules (or ‘molecular midwives’) 
of the type described by Hud and co-workers in these extension reactions, as such 
molecules have been shown to hinder the cyclization of oligonucleotides and 
promote strand extension reactions.197-199 





6.1 General Information 
The commercially available reagents were used without further purification. All 
DNA and RNA oligomers were purchased in desalted form from Microsynth AG, 
Switzerland. Dry solvents were obtained using a Pure Solv Solvent Purification 
System (Innovate Technology, USA) or from commercial sources. 1H NMR spectra 
were recorded on Bruker AVA600, DMX500, AVA500, DPX360, or ARX250 
spectrometers and 13C NMR on Bruker AVA600, DMX500, AVA500 or DPX360 
spectrometers in the solvents indicated at 298 K (300 K for spectra recorded on the 
Bruker ARX250). Chemical shifts are reported on the δ scale in parts per million and 
are referenced via residual non-deuterated solvent resonances.200 13C chemical shifts 
in D2O or 10 % D2O:H2O were referenced via internal 1,4-dioxane (67.19 ppm) 
unless otherwise stated. Low resolution electrospray (ES) mass spectra were 
recorded on an Agilent Technologies LC/MSD 1100 Quadrupole Mass Spectrometer 
(QMS) with an electrospray ion source. Electron impact (EI) ionization and high 
resolution electrospray mass spectra were recorded by the MS Section of the 
University of Edinburgh on a Finnigan MAT 900 XLP high resolution, double-
focussing mass spectrometer. Microwave reactions were performed using a Biotage 
Initiator instrument. MALDI-TOF mass spectra were recorded on an Applied 
Biosystems Voyager-DE™ STR instrument in positive ionization reflector mode 
(delay 175 ns, 20 kV accelerating voltage, variable laser intensity, typically 200 shots 
or fewer). Sinapic acid matrix consisted of 10 mg/mL sinapic acid in 50 % v/v 
acetonitrile in water with 0.1 % v/v TFA. Melting points were determined using a 
Gallenkamp melting point apparatus. IR spectra were recorded neat using a Bruker 
Tensor 27 FT-IR spectrometer. TLC was performed on aluminium-backed silica gel 
60 plates using the eluents described. Aldehyde and acetal products were 
visualized on TLC plates using a 2,4-dinitrophenylhydrazine dip, which was 
prepared by dissolving 12 g of 2,4-dinitrophenylhydrazine in a mixture of conc. H-
2SO4 (60 mL), H2O (80 mL) and 95 % EtOH (200 mL). Flash column 
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chromatography was carried out on silica gel 60 (40-63 µm particle size). Unless 
stated otherwise, compounds for purification were loaded directly onto the column as 
a solution in a small volume of eluting solvent. Alternatively (when stated), 
compounds were loaded onto the column by dissolving in a greater volume of 
solvent and ‘pre-adsorbing’ (with evaporation of the solvent) onto a small amount of 
silica which was then layered onto the silica column. Automated flash column 
chromatography was performed on a Biotage Isolera One instrument using pre-
packed columns of the size specified. Prior to use, Q Sepharose® Fast Flow (GE 
Healthcare; 1 mL of a suspension in ethanol) was centrifuged and the supernatant 
removed. The resin was subsequently washed centrifugally with H2O (1 mL) and 10 
mM phosphate buffer, pH 7 (2 × 1 mL), before resuspending in the same buffer (0.5 
mL). Immediately before use, the pre-equilibrated Q Sepharose® was agitated to 
resuspend the resin beads. 
HPLC analyses were performed on an Agilent 1100 analytical system with a 
Supelco Discovery® C18, 5 µm, 50 × 4.6 mm column unless otherwise stated. 
Detection was by UV absorbance at 254 nm. The following eluents were used: (A) 
H2O + 0.1 % TFA; (B) MeCN + 0.04 % TFA; (C) MeOH + 0.1 % FA; (D) H2O + 
0.1 % FA; (E) MeCN + 0.1 % FA; (F) MeOH; (G) H2O; (H) MeCN + 0.1 % TFA. 
HPLC grade eluents were employed, at a flow rate of 1 mL/min with samples 
prepared to a concentration of approximately 1 mg/mL and filtered prior to injection. 
The following HPLC methods were used:  
Method 1 (A and B): 10 % to 90 % B over 3 min, then 90 % B over 1 min. 
Method 2 (C and D): 5 % to 95 % C over 6 min, then 95 % C over 3 min. 
Method 3 (C and D): 5 % to 95 % C over 3 min, then 95 % C over 1 min. 
Method 4 (F and G): 5 % to 95 % F over 3 min, then 95 % F over 1 min.  
Method 5 (D and E): 5 % to 95 % E over 3 min, then 95 % E over 1 min. 
Method 6 (A and H): 5 % to 95 % H over 10 min, then 95 % H over 4 min. 
Method 7 (A and H; Phenomenex Jupiter® Proteo 4 µm, 90 Å, 250 × 4.6 mm 
column): 0 % to 18 % H over 13 min. 
 Preparative HPLC was performed on an Agilent 1100 preparative system. 
HPLC grade eluents were employed, at a flow rate of 3 mL/min with samples 
prepared to a concentration of approximately 10-20 mg/mL and filtered prior to 
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injection of a volume containing up to 10 mg. The following eluents were used: (A) 
H2O + 0.1 % TFA; (B) MeCN + 0.1 % TFA. The following methods were used: 
Method 1 (A and B, Phenomenex® Prodigy ODS (3), 5 µm, 100Å, 250 × 10 mm 
column): 30 % B over 1 min, then 30 to 90 % B over 20 min, then 90 % B over 5 
min. 
Method 2 (A and B, Hichrom C18, 5 µm, 100Å, 250 × 21.2 mm column): 5 % B 
over 1 min, then 5 to 50 % B over 20 min, then 50 % B over 14 min. 
Method 3 (A and B, Hichrom C18, 5 µm, 100Å, 250 × 21.2 mm column): 0 % B 
over 1 min, then 0 to 65 % B over 30 min, then 65 to 100 % B over 4 min. 
 
6.2 General Solid-Phase Synthesis (SPS) Procedures and 
Information 
The PNA oligomers reported herein were prepared by standard solid-phase synthesis 
techniques on polymer supports by repeated rounds of coupling of activated (amino-
protected) PNA monomers followed by deprotection of the terminal amino group, 
with washing steps after each stage.201 Unless stated otherwise, all reactions were 
performed at room temperature in Supelco Solid-Phase Extraction (SPE) tubes fitted 
with frits and Teflon taps (Sigma-Aldrich, UK) which allowed washing steps to be 
carried out using a vacuum manifold. Resin agitation during reactions was by gentle 
rotation of the capped SPE tubes on a blood tube rotator (Stuart Scientific, UK). 
 
6.2.1 Calculation of Theoretical Loading 
The theoretical loading of a resin after a reaction can be calculated using the 
following equation: 
NL = SL / [1 + (SL × ∆M × 10
-3)]  
 Where:  NL is the ‘new’ theoretical loading (mmol/g); 
 SL is the original, ‘starting’ loading (mmol/g); 
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6.2.2 Qualitative Ninhydrin Test 
A qualitative ninhydrin test was used to monitor amine deprotection and coupling 
steps. To a few resin beads was added three drops of reagent A and one drop of 
reagent B (see below), and the resulting mixture was heated at 100 oC for 10 min. A 
blue colour indicated the presence of free amine, whilst a yellow colour showed no 
free amine. 
Reagent A:  
Solution 1: Phenol (40 g) was dissolved in ethanol (10 mL) with gentle warming and 
stirred over Amberlite mixed-bed MB-3 resin (4 g) for 45 min. The resulting solution 
was obtained by filtration. 
Solution 2: Potassium cyanide (65 mg) was dissolved in water (100 mL) and an 
aliquot (2 mL) was diluted with pyridine (38 mL, freshly distilled from ninhydrin) 
and stirred over Amberlite mixed-bed MB-3 resin (4 g). The solution was collected 
by filtration and added to ‘solution 1’ to give ‘reagent A’. 
Reagent B: 
Ninhydrin (2.5 g) was dissolved in ethanol (50 mL) to give ‘reagent B’. 
 
6.2.3 Quantitative Fmoc Test201 
A quantitative Fmoc test was used to determine the new loading of 
(aminomethyl)polystyrene resin after functionalization with the Fmoc-Rink amide 
linker. In duplicate, a small sample (approximately 3 mg) of dried resin was weighed 
accurately and transferred to a 10 mm quartz UV cuvette. 20 % piperidine in DMF 
(3.00 mL) was measured accurately and added to the cuvette which was capped and 
shaken gently for 2 h. The resin beads were allowed to settle before the absorbance at 
290 nm (A290) was measured and the new loading was calculated using the following 
equation (based upon an extinction coefficient, ε290 of 5253 M
-1cm-1 for the 
piperidyl-fulvene adduct), averaging over the duplicate measurements: 
Loading (mmol/g) = A290 / (mg of resin used × 1.75) 
 
6.2.4 Cleavage of Final PNA Oligomers from Solid-Support 
Final cleavages of full length PNAs with concomitant Bhoc and Boc deprotection 
were carried out using a TFA:TIS:DCM (90:5:5 v/v) cocktail for 2.5 h. The resulting 
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cleavage mixtures were evaporated to a small volume (< 0.1 mL) under a stream of 
nitrogen then the PNA oligomers were obtained by precipitation with Et2O. The 
precipitates were collected by centrifugation and removal of the supernatant before 
being dried in vacuo. Aqueous solutions were prepared and PNA concentrations 
determined by measuring the absorbance at 260 nm (A260) on an Agilent 8453 
spectrophotometer using ε260 values of 6.6, 8.6, 13.7, 11.7 and 2.5 mLµmol
-1cm-1 for 
C, T, A, G and the triphenylphosphonium tag respectively.202, 203 PNA oligomers 
were characterized by MALDI-TOF mass spectrometry and HPLC. 
 
6.3 Chapter 2 Experimental 
6.3.1 Synthesis of Aldehydes and ‘Blank’ PNA Monomer 
1-(2,2-Diethoxyethyl)-thymine (1) 
 
Route (a):104-106 To a stirred suspension of thymine (1.60 g, 13 mmol) and dry K2CO3 
(1.75 g, 13 mmol, 1 eq) in dry DMF (40 mL) under N2 (g) was added 
bromoacetaldehyde diethyl acetal (1.97 mL, 13 mmol, 1 eq) and the resulting 
suspension was heated to 130 oC for 20 h. The reaction mixture was then cooled to 
room temperature and stirred for an additional 10 h before the solvent was removed 
in vacuo to afford a sticky brown solid. The crude product was dissolved in H2O (65 
mL) and extracted with EtOAc (3 × 100 mL). The combined organics were then 
washed with brine (65 mL), dried (MgSO4), filtered and concentrated in vacuo to 
afford a brown oil. Purification by column chromatography (3.5 × 15 cm silica, 
eluting with 5 % MeOH:DCM) afforded 1 as an oil which solidified to an off-white 
solid on standing (864 mg, 3.6 mmol, 27 %). 
Route (b): A mixture of thymine (800 mg, 6.3 mmol), bromoacetaldehyde diethyl 
acetal (984 µL, 6.3 mmol, 1 eq) and Cs2CO3 (4.1 g, 12.6 mmol, 2 eq) in DMF (20 
mL) was heated at 100 oC (microwave) for 30 min. This reaction was repeated in a 
second vial, and both batches were combined and concentrated in vacuo to give a 
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brown solid. This was resuspended in H2O (65 mL) and extracted with EtOAc (3 × 
100 mL). The combined organics were then washed with brine (65 mL), dried 
(Na2SO4), filtered and concentrated in vacuo to afford a yellow solid. This crude 
product was dissolved in 50 % MeOH:DCM and pre-adsorbed by evaporation onto 
silica, then purified by automated column chromatography (50 g column size, 3 CV 
DCM, 24 CV 0 → 5 % MeOH:DCM, 3 CV 5 % MeOH:DCM) to afford 1 as a 
yellow oil which solidified to an off-white solid on standing (333 mg, 1.4 mmol, 11 
%). Rf = 0.33 (5 % MeOH:DCM); IR νmax/ cm
-1 (neat) 3212 (w), 2975 (w), 1668 (s), 
1351 (m), 1034 (s); mp 101-102 oC, lit.106 106-109 oC; 1H NMR (600 MHz, CDCl3) 
δH 8.04 (br s, 1H, NH), 7.09 (q, 1H, 
4
J = 1.2 Hz, C=CH), 4.63 (t, 1H, 3J = 5.4 Hz, 
CH(OEt)2), 3.76 (dq, A of an ABX3 spin system, 2H, 
2
JAB = 9.6 Hz, 
3
JAX = 7.2 Hz, 
OCH2), 3.76 (d, 2H, 
3
J = 5.4 Hz, NCH2), 3.54 (dq, B of an ABX3 spin system, 2H, 
2
JAB = 9.6 Hz, 
3
JAX = 7.2 Hz, OCH2), 1.91 (d, 3H, 
4
J = 1.2 Hz, C=CCH3), 1.20 (t, X3 
of an ABX3 spin system, 6H, 
3
JAX = 7.2 Hz, 2 × CH3);
 13
C NMR (150.9 MHz, 
CDCl3) δC 164.6 (CO), 151.3 (CO), 142.0 (CH), 109.8 (C), 100.3 (CH), 64.2 (CH2), 
50.8 (CH2), 15.2 (CH3), 12.1 (CH3); m/z (ES
+
) 243 (M+H)+, 265 (M+Na)+; HRMS 
(ES
+
) for C11H19O4N2 (M+H)
+: calcd 243.13486, found 243.13503; HPLC tR = 3.56 
min (method 2). 
 
2-(2,4-Dihydroxy-5-methylpyrimidin-1-yl)-ethanal hydrate (TCHO) 
 
Route (c):105, 106 A stirred suspension of 1 (157 mg, 0.65 mmol) in 1 M HCl aq (30 
mL) was heated to reflux for 70 min, then cooled to room temperature and 
concentrated in vacuo to afford an oil which solidified to yield crude TCHO as a 
colourless solid (164 mg). 
Route (d): A suspension of 1 (111 mg, 0.46 mmol) in 1 M HCl aq (20 mL) was 
heated at 105 oC (microwave) for 30 min, then concentrated in vacuo to a yellow oil 
which solidified on standing. This was triturated with DCM to yield TCHO as an off-
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white solid which was collected by suction filtration (46 mg, 0.25 mmol, 54 %). Rf = 
0.32 (5 % MeOH:DCM); IR νmax/ cm
-1 (neat) 3305 (m), 3164 (m), 3048 (m), 1672 
(s), 1020 (s); mp decomp. > 164 oC, lit.106 200-210 oC; 1H NMR (250 MHz, D2O) δH 
7.44 (s, 1H, C=CH), 5.24 (t, 1H, 3J = 5.2 Hz, CH(OH)2), 3.80 (d, 2H, 
3
J = 5.2 Hz, 
CH2), 1.85 (s, 3H, C=CCH3); 
13
C NMR (150.9 MHz, D2O referenced to internal 
MeOH at δC 49.5) δC 167.7 (CO), 153.1 (CO), 144.5 (CH), 111.1 (C), 88.0 (CH), 
53.7 (CH2), 11.9 (CH3); m/z (ES
+
) 169 (M+H)+, 187 (M+H3O)
+; HRMS (ES+) for 
C7H9O3N2 (M+H)







A stirred suspension of cytosine (1 g, 9 mmol) in acetic anhydride (10 mL) and 
glacial acetic acid (2 mL) was refluxed overnight (17 h) under N2 (g). The reaction 
mixture was then cooled to room temperature and the insoluble material was 
collected by filtration, washed with cold EtOH (10 mL), then Et2O (10 mL), and 
dried to afford 2 as an off-white solid (1.2 g, 7.8 mmol, 87 %). Rf = 0.33 (10 % 
MeOH:DCM);  1H NMR (500 MHz, d6-DMSO) δH 11.50 (s, 1H, H-1), 10.74 (s, 1H, 
NHAc), 7.80 (d, 1H, 3J = 7 Hz, H-6), 7.09 (d, 1H, 3J = 7 Hz, H-5), 2.08 (s, 1H, CH3); 
13
C NMR (125.7 MHz, CD3OD) δC 170.8 (CO), 163.1 (CO), 156.1 (C), 147.1 (CH), 
94.4 (CH), 24.2 (CH3);  m/z (ES
+













A mixture of 2 (250 mg, 1.6 mmol), dry K2CO3 (226 mg, 1.6 mmol, 1 eq) and 
bromoacetaldehyde diethyl acetal (253 µL, 1.6 mmol, 1 eq) in dry DMF (4.5 mL) 
was heated at 130 oC in the microwave for 30 min. The resulting dark brown/black 
reaction mixture was concentrated to a dark brown oil in vacuo then resuspended in 
H2O (10 mL) and extracted with EtOAc (3 × 15 mL). The combined organics were 
washed with brine (10 mL), dried (Na2SO4), filtered and concentrated in vacuo to 
afford a yellow solid. Purification by column chromatography (1.5 × 16 cm silica, 
eluting with 5 % MeOH:DCM) afforded 3 as an off-white solid (103 mg, 0.38 mmol, 
24 %). Rf = 0.46 (5 % MeOH:DCM); IR νmax/ cm
-1 (neat) 2974 (w), 2931 (w), 1712 
(m), 1655 (s), 1051 (s); mp 131-132 oC; 1H NMR (500 MHz, d6-DMSO) δH 10.83 
(s, 1H, NH), 7.96 (d, 1H, 3J = 7 Hz, H-6), 7.14 (d, 1H, 3J = 7 Hz, H-5), 4.71 (t, 1H, 3J 
= 5.5 Hz, CH(OEt)2), 3.84 (d, 2H, 
3
J = 5.5 Hz, CH2), 3.65 (dq, A of an ABX3 spin 
system, 2H, 2JAB = 9 Hz, 
3
JAX = 7 Hz, OCH2), 3.44 (dq, B of an ABX3 spin system, 
2H, 2JAB = 9 Hz, 
3
JAX = 7 Hz, OCH2), 2.09 (s, 3H, NH(CO)CH3), 1.06 (t, X3 of an 
ABX3 spin system, 6H, 
3
JAX = 7 Hz, 2 × OCH2CH3); 
13
C NMR (125.7 MHz, 
CD3OD) δC 172.9 (CO), 164.4 (CO), 158.7 (C), 152.4 (CH), 100.8 (CH), 97.5 (CH), 
64.8 (CH2), 54.1 (CH2), 24.6 (CH3), 15.7 (CH3); m/z (ES
+
) 270 (M+H)+, 292 
(M+Na)+; HRMS (ES+) for C12H20O4N3 (M+H)
+: calcd 270.14483, found 













A solution of 3 (303 mg, 1.1 mmol) in methanolic ammonia (2M NH3, 10 mL) was 
stirred at room temperature for 92 h, then the reaction mixture was concentrated in 
vacuo to a white solid and purified by column chromatography (2 × 16 cm silica, 
eluting with 5 % MeOH:DCM, with the crude sample dissolved in MeOH and pre-
adsorbed on silica by evaporation) to afford 4 as a white solid (148 mg, 0.65 mmol, 
58 %). Rf = 0.20 (10 % MeOH:DCM); IR νmax/ cm
-1 (neat) 3349 (m), 2975 (m), 
1660 (s), 1616 (s), 1058 (s); mp 232-234oC, lit.105 232-234 oC;  1H NMR (500 MHz, 
CD3OD) δH 7.49 (d, 1H, 
3
J = 7.5 Hz, H-6), 5.82 (d, 1H, 3J = 7.5 Hz, H-5), 4.73 (t, 
1H, 3J = 5 Hz, CH(OEt)2), 3.81 (d, 2H, 
3
J = 5 Hz, CH2), 3.74 (dq, A of an ABX3 spin 
system, 2H, 2JAB = 9.5 Hz, 
3
JAX = 7 Hz, OCH2), 3.53 (dq, B of an ABX3 spin system, 
2H, 2JAB = 9.5 Hz, 
3
JAX = 7 Hz, OCH2), 1.16 (t, X3 of an ABX3 spin system, 6H, 
3
JAX 
= 7 Hz, 2 × OCH2CH3); 
13
C NMR (125.7 MHz, CD3OD) δC 168.2 (CO), 159.2 (C), 
148.8 (CH), 101.5 (CH), 95.3 (CH), 65.0 (CH2), 53.6 (CH2), 15.7 (CH3); m/z (ES
+
) 
228 (M+H)+; HRMS (EI) for C10H17O3N3 M
+: calcd 227.12644, found 227.12631; 






To a stirred suspension of cytosine (5 g, 45 mmol) and 4-methoxytrityl chloride (20.8 
g, 67.5 mmol, 1.5 eq) in pyridine (225 mL) under N2 (g) was added N-
ethylmorpholine (5.7 mL, 45 mmol, 1 eq). The reaction mixture was heated to 40 oC 
for 30 min then stirred at room temperature for 16 h before the solvent was removed 
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in vacuo. The residue was resuspended in EtOAc (800 mL) and the insoluble 
material was collected by suction filtration, washed with EtOAc then Et2O and dried 
in a vacuum oven at 40 oC overnight to afford crude 5 as a white solid (26.7 g). This 
was used directly without further purification. Rf = 0.63 (10 % MeOH:DCM); 
1
H 
NMR (500 MHz, d6-DMSO) δH 10.25 (br s, 1H, NH), 8.25 (br s, 1H, NH), 7.37-6.78 
(m, 16H, Ar-H), 3.72 (s, 1H, CH3); m/z (ES
+




A suspension of crude 5 (2 g, 5.2 mmol), Cs2CO3 (3.4 g) and bromoacetaldehyde 
diethyl acetal (810 µL, 5.2 mmol, 1 eq) in DMF (15 mL) was heated at 100 oC in the 
microwave for 30 min. The solvent was then removed in vacuo and the residue was 
resuspended in H2O (50 mL) and collected by filtration to afford an off-white solid 
which was washed further with H2O (10 mL). This crude product was then dissolved 
in DCM (150 mL) and washed with 1M KHSO4 aq (50 mL), 1M NaHCO3 aq (2 × 50 
mL), brine (50 mL) then dried (Na2SO4), filtered and concentrated in vacuo to yield 
1.1 g of a white solid. Purification by column chromatography (4.5 × 16 cm silica, 
eluting with 5 % MeOH:DCM, with the crude product applied to the column as a 
suspension in 5 % MeOH:DCM) afforded 6 as a white solid (431 mg, 0.86 mmol, 17 
%). Rf = 0.33 (5 % MeOH:DCM); IR νmax/ cm
-1 (neat) 2974 (w), 1653 (m), 1624 (s), 
1489 (m), 1058 (s); mp 196-197 oC; 1H NMR (250 MHz, CDCl3) δH 7.40-7.10 (m, 
12H, Ar-H), 6.99 (d, 1H, 3J = 7.5 Hz, H-6), 6.92-6.73 (m, 2H, Ar-H), 4.99 (d, 1H, 3J 
= 7.5 Hz, H-5), 4.71 (t, 1H, 3J = 5.5 Hz, CH(OEt)2), 3.93-3.57 (m, 7H, OCH3 and 
NCH2 and OCH2), 3.46 (dq, B of an ABX3 spin system, 2H, 
2
JAB = 9.2 Hz, 
3
JAX = 7 
Hz, OCH2), 1.11 (t, X3 of an ABX3 spin system, 6H, 
3
JAX = 7 Hz, 2 × OCH2CH3); 
13
C NMR (62.9 MHz, CDCl3) δC 165.7 (CO), 158.6 (C), 156.0 (C), 146.7 (CH), 
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144.1 (C), 135.9 (C), 129.9 (CH), 128.5 (CH), 128.2 (CH), 127.4 (CH), 113.4 (CH), 
100.4 (CH), 93.9 (CH), 70.3 (C), 64.6 (CH2), 55.1 (CH3), 52.7 (CH2), 15.2 (CH3); 
m/z (ES
+
) 500 (M+H)+, 522 (M+Na)+, 538 (M+K)+; HRMS (ES+) for C30H34O4N3 
(M+H)+: calcd 500.25438, found 500.25468; HPLC tR = 3.54 min (method 1). 
 
2-(Cytosin-1-yl)-ethanal hydrate trifluoroacetate (CCHO)  
 
From 6: A solution of 6 (263 mg, 0.53 mmol) in 1:1 v/v TFA:H2O (10 mL) was 
heated at 100 oC in the microwave for 30 min then concentrated in vacuo to a viscous 
orange oil. Purification by column chromatography (2 × 15 cm silica, eluting with 25 
% MeOH:DCM) afforded a straw-coloured oil which was redissolved in H2O and 
lyophilized to give CCHO as a white solid (137 mg,  mmol, 91 %). NMR and LCMS 
suggest that some of the target is present as the methanolic hemiacetal. 
From 4: A solution of 4 (10 mg, 44 µmol) in 1:1 v/v TFA:H2O (0.5 mL) was heated 
at 100 oC in the microwave for 30 min then concentrated in vacuo to a viscous 
yellow oil which was lyophilized to give CCHO as an off-white hygroscopic solid (13 
mg, quantitative). Rf = 0.50 (25 % MeOH:DCM); IR νmax/ cm
-1 (neat) 3205 (m), 
16389 (s), 1610 (s), 1491(s), 1198 (s); mp decomp. > 110 oC;  1H NMR (360 MHz, 
D2O) δH 7.83 (d, 
3
J = 7.7 Hz, 1H, H-6), 6.17 (d, 3J = 7.7 Hz, 1H, H-5), 5.30 (t, 3J = 
5.1 Hz, 1H, CH(OH)2), 3.93 (d, 
3
J = 5.1 Hz, 2H, CH2); 
13
C NMR (125.7 MHz, 10 % 
D2O:H2O) δC 163.3 (q, 
2
J = 36.4 Hz, C(O)CF3), 160.4 (CO), 150.9 (CH), 149.9 (C), 




+, 176 (M+Na)+; HRMS (ES+) for aldehyde, C6H8O2N3 











A mixture of adenine (500 mg, 3.7 mmol), K2CO3 (512 mg, 3.7 mmol, 1 eq) and 
bromoacetaldehyde diethyl acetal (574 µL, 3.7 mmol, 1 eq) in DMF (9 mL) was 
heated at 130 oC in the microwave for 30 min. This reaction was repeated twice and 
all three batches were combined and concentrated to dryness in vacuo. The resulting 
brown solid was resuspended in H2O (20 mL), extracted with EtOAc (3 × 30 mL) 
and the combined organics were washed with brine (20 mL), dried (Na2SO4), filtered 
and concentrated in vacuo to afford an off-white solid. Purification by column 
chromatography (4.5 × 24 cm silica, eluting with 5 % MeOH:DCM, sample 
dissolved in MeOH and pre-adsorbed on silica by evaporation) afforded 7 as an off-
white solid (730 mg, 2.9 mmol, 26 %). Rf = 0.51 (10 % MeOH:DCM); IR νmax/ cm
-1 
(neat) 3278 (w), 3112 (m), 1673 (s), 1602 (m), 1056 (s);  mp 206-208 oC, lit.85, 105 
212 oC; 1H NMR (500 MHz, d6-DMSO) δH 8.14 (s, 1H, H-8), 8.05 (s, 1H, H-2), 7.20 
(s, 2H, NH2), 4.84 (t, 1H, 
3
J = 5.5 Hz, CH(OEt)2), 4.21 (d, 2H, 
3
J = 5.5 Hz, NCH2), 
3.64 (dq, A of an ABX3 spin system, 2H, 
2
JAB = 9.5 Hz, 
3
JAX = 7 Hz, OCH2), 3.42 
(dq, B of an ABX3 spin system, 2H, 
2
JAB = 9.5 Hz, 
3
JAX = 7 Hz, OCH2), 1.02 (t, X3 
of an ABX3 spin system, 6H, 
3
JAX = 7 Hz, 2 × OCH2CH3); 
13
C NMR (62.9 MHz, 
CDCl3) δC 155.8 (C), 152.4 (CH), 149.6 (C), 141.2 (CH), 118.3 (C), 99.4 (CH), 62.2 
(CH2), 45.2 (CH2), 15.0 (CH3); m/z (ES
+
) 252 (M+H)+, 274 (M+Na)+; HRMS (ES+) 
for C11H18O2N5 (M+H)
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2-(Adenin-9-yl)-ethanal hydrate trifluoroacetate (ACHO) 
 
9-(2,2-diethoxyethyl)-adenine, 7 (300 mg, 1.2 mmol) in 1:1 v/v TFA:H2O (10 mL) 
was heated at 100 oC in the microwave for 30 min then concentrated in vacuo to give 
a viscous yellow oil which was triturated with Et2O (2 × 20 mL) and dried in vacuo 
to give ACHO as an off-white solid (376 mg, quantitative). Rf = 0.07 (10 % 
MeOH:DCM); IR νmax/ cm
-1 (neat) 3216 (w), 2970 (w), 1698 (s), 1622 (m), 1045 (s); 
mp decomp. > 120 oC;  1H NMR (360 MHz, D2O) δH 8.42 (s, 1H, H-8), 8.35 (s, 1H, 
H-2), 5.44 (t, 3J = 4.7 Hz, 1H, CH(OH)2), 4.41 (d, 
3
J = 4.7 Hz, 2H, CH2);
 13
C NMR 
(125.7 MHz, 10 % D2O:H2O) δC 163.5 (q, 
3
J = 35.2 Hz, C(O)CF3), 150.7 (C), 149.4 
(C), 145.9 (CH), 145.3 (CH), 118.5 (C), 116.9 (q, 2J = 291.6 Hz, CF3), 88.2 (CH), 
49.9 (CH2); m/z (ES
+
) 178 (M+H)+; HRMS (ES+) for aldehyde, C7H8O1N5 (M+H)
+: 
calcd 178.07234, found 178.07234; HPLC tR = 0.71 min (method 3); Anal. calc. for 






A suspension of 2-amino-6-chloropurine (500 mg, 2.9 mmol), Cs2CO3 (1.92 g, 5.9 
mmol, 2 eq) and bromoacetaldehyde diethyl acetal (460 µL, 3.0 mmol, 1 eq) was 
heated at 100 oC in the microwave for 30 min. The reaction mixture was then 
concentrated in vacuo to a brown solid which was resuspended in H2O (20 mL) and 
washed with EtOAc (3 × 30 mL). The combined organics were washed with brine 
(20 mL), dried (Na2SO4), filtered and concentrated in vacuo to give a yellow oil. 
Purification by column chromatography (3.5 × 16 cm silica, eluting with 5 % 
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MeOH:DCM, crude product dissolved in EtOAc/DCM/MeOH and pre-adsorbed on 
silica by evaporation) afforded 8 as a white solid (201 mg, 0.7 mmol, 24 %). Rf = 
0.37 (5 % MeOH:DCM); IR νmax/ cm
-1 (neat) 3300 (w), 3183 (m), 1613 (s), 1558 (s), 
1051 (s); mp 132-133 oC; 1H NMR (250 MHz, CD3OD) δH 8.02 (s, 1H, H-8), 4.82 
(t, 1H, 3J = 5.1 Hz, CH(OEt)2), 4.22 (d, 2H, 
3
J = 5.1 Hz, NCH2), 3.72 (dq, A of an 
ABX3 spin system, 2H, 
2
JAB = 9.2 Hz, 
3
JAX = 7.1 Hz, OCH2), 3.52 (dq, B of an 
ABX3 spin system, 2H, 
2
JAB = 9.2 Hz, 
3
JAX = 7.1 Hz, OCH2), 1.12 (t, X3 of an ABX3 
spin system, 6H, 3JAX = 7.1 Hz, 2 × OCH2CH3); 
13
C NMR (62.9 MHz, CD3OD) δC 
161.7 (C), 155.5 (C), 151.4 (C), 145.4 (CH), 124.5 (C), 101.2 (CH), 64.6 (CH2), 46.9 
(CH2), 15.6 (CH3); m/z (ES
+
) 286 (M+H)+, 308 (M+Na)+; HRMS (ES+) for 
C11H17O2N5Cl (M+H)
+: calcd 286.10653, found 286.10679; HPLC tR = 2.58 min 
(method 1). 
 
2-(Guanin-9-yl)-ethanal hydrate trifluoroacetate (GCHO)  
 
2-Amino-6-chloro-9-(2,2-diethoxyethyl)-purine, 8 (10 mg, 35 mmol) in 1:2 v/v 
TFA:H2O (0.5 mL) was heated at 100 
oC (microwave) for 30 min then concentrated 
in vacuo to give a viscous yellow oil which was lyophilized to give GCHO as an off-
white solid (11 mg, quantitative). The 1H and 13C NMR spectra of this compound 
were very complicated when acquired immediately after dissolution in D2O/H2O, 
possibly due to the presence of multiple hydrogen bonded or imine species which 
were long-lived on the NMR timescale. However, upon standing overnight at room 
temperature, the NMR spectra became much simpler and consistent with the 
structure of the target hydrate trifluoroacetate. Rf = 0.07 (10 % MeOH:DCM); IR 
νmax/ cm
-1 (neat) 3120 (m), 1673 (s), 1598 (s), 1191 (s), 1048 (s); mp decomp. > 290 
oC;  1H NMR (360 MHz, D2O) δH 8.76 (s, 1H, H-8), 5.43 (t, 
3
J = 4.7 Hz, 1H, 
CH(OH)2), 4.31 (d, 
3
J = 4.7 Hz, 2H, CH2); 
13
C NMR (125.7 MHz, 10 % D2O:H2O) 
δC 163.2 (q, 
2
J = 36.4 Hz, C(O)CF3), 156.2 (C), 155.7 (C), 150.8 (C), 138.8 (CH), 
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+, 216 (M+Na)+; HRMS (ES+) for aldehyde, C7H8O2N5 





To a solution of methyl N-(2-[1-(4,4-Dimethyl-2,6-dioxocyclohexylidene)-
ethylamino]-ethyl)-glycinate (9; for the synthesis of 9, see compound 40, Chapter 
6.6.1)83  (300 mg, 1.0 mmol) in THF (10 mL) was added di-tert-butyl dicarbonate 
(250 µL, 1.1 mmol) and triethylamine (150 µL, 1.1 mmol) and the reaction mixture 
was stirred for 5 hours at room temperature. After removal of the solvent in vacuo, 
the crude product was dissolved in DCM (200 mL) and washed with 1 M NaHCO3 
aq (2 × 50 mL), 1 M KHSO4 aq (2 × 50 mL) and brine (50 mL). The organic phase 
was dried over Na2SO4, filtered and concentrated in vacuo to give a yellow solid. 
Without any further purification the crude was dissolved in MeOH (100 mL) and a 2 
M solution of Cs2CO3 in water (100 mL) was added. After stirring at room 
temperature for 1.5 h, the reaction was acidified to pH 3 with sat. KHSO4 aq and the 
precipitate was collected by filtration, washed with water (20 mL) and dried in vacuo 
to afford 10 as a white solid (279 mg, 0.7 mmol, 73 %). Rf = 0.09 (5 % 
MeOH:DCM); IR νmax/ cm
-1 (neat) 2935 (w), 1731 (m), 1683 (s), 1587 (s), 1139 (s); 
mp 117-118 oC; 1H NMR (360 MHz, CDCl3) two rotamers: δH 4.03 and 3.95 (s, 2H, 
CH2COO), 3.66 (m, 2H, CH2), 3.53 (m, 4H, CH2), 2.57 (s, 3H, CCH3), 2.35 (s, 4H, 
Dde-CH2), 1.41 and 1.44 (s, 9H, Boc-CH3), 1.01 (s, 6H, Dde-CH3) ppm; 
13
C NMR 
(90.6 MHz, CDCl3) two rotamers: δC 198.2 (CO), 174.8 (CO), 172.6  and 172.4 (C), 
155.3 and 155.2 (CO), 108.1 (C), 81.5 and 81.1 (C), 52.5 (CH2), 50.8 (CH2), 48.4 
and 48.2 (CH2), 42.1 and 42.0 (CH2), 30.1 (CH3), 28.3 and 28.1 (C), 28.2 (CH3),  
18.0 (CH3); m/z (ES
-
) 381 (M-H)-, 763 (2M-H)-; HRMS (EI) for C19H30O6N2 (M)
+: 
calcd 382.20984, found 382.20990; HPLC tR = 3.88  min (method 3). 





1-Pyreneacetic acid (500 mg, 1.9 mmol) was suspended in a mixture of EtOH (2 mL) 
toluene (10 mL) and conc. H2SO4 and heated to reflux (oil bath at 120 
oC) under N2 
(g) with a Dean-Stark water trap for 4 h. The black solution was then cooled to room 
temperature and washed with 5 % NaHCO3 aq (2 × 10 mL) and brine (10 mL), dried 
(Na2SO4), filtered (washing the residue with toluene) and concentrated to a brown oil 
in vacuo. Purification by column chromatography (2.2 × 5.7 cm silica, eluting with 
toluene) afforded a yellow oil which was recrystallized from n-hexane to yield 11 as 
a pale yellow solid (410 mg, 1.4 mmol, 74 %). Rf = 0.36 (toluene); IR νmax/ cm
-1 
(neat) 2982 (w), 1725 (s), 1602 (m), 1368 (m), 1029 (s); mp 63-65 oC, lit.206 66.5-
67.5 oC; 1H NMR (250 MHz, CDCl3) δH 8.29-7.93 (m, 9H, ArH), 4.35 (s, 2H, 
ArCH2), 4.16 (q, 2H, 
3
J = 7.5 Hz, OCH2), 1.22 (t, 6H, 
3
J = 7.5 Hz, CH3); 
13
C NMR 
(125.7 MHz, CDCl3) δC 171.6 (CO), 131.3 (C), 130.8 (C), 130.8 (C), 129.5 (C), 
128.4 (CH), 128.3 (C), 127.9 (CH), 127.4 (CH), 127.3 (CH), 126.0 (CH), 125.2 
(CH), 125.1 (CH), 125.0 (C), 124.9 (CH), 124.8 (C), 123.3 (CH), 61.0 (CH2), 39.6 









A stirred solution of ethyl 1-pyreneacetate, 11 (200 mg, 0.69 mmol) in anhydrous 
toluene (6.9 mL) under N2 (g) was cooled to -78 
oC before 1 M DIBAL-H in n-
hexane  (0.69 mL) was added dropwise and stirring was continued at -78 oC for 2 h. 
The reaction mixture was then quenched carefully (i.e. keeping the temperature 
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below -74 oC) with a solution of 37 % w/w HCl (0.17 mL) in THF (1.55 mL) and 
stirring was continued at -78 oC for 5 min. The reaction mixture was warmed to room 
temperature, decanted from white insoluble precipitate and washed with H2O (2 × 7 
mL) and brine (7 mL), dried (MgSO4), decanted and concentrated in vacuo to afford 
a yellow oil which was recrystallized from n-hexane to afford crude YCHO (154 mg, 
of approximately 85 % purity as judged by HPLC) as a yellow solid. An analytical 
sample (16 mg) of YCHO was obtained by preparative HPLC (method 1) of a portion 
(23 mg) of this crude material. IR νmax/ cm
-1 (neat) 2828 (w), 2726 (w), 1709 (m), 
1379 (m), 1058 (m); mp 109-110 oC, lit.206 111.5-112.5 oC; 1H NMR (360 MHz, 
CDCl3) δH 9.90 (t, 1H, 
3
J = 2.5 Hz, CHO), 8.23-7.96 (m, 9H, ArH), 4.40 (d, 2H,  3J = 
2.5 Hz, ArCH2); 
13
C NMR (125.7 MHz, CDCl3) δC 199.3 (CO), 131.3 (C), 131.1 
(C), 130.8 (C), 129.8 (C), 128.6 (CH), 128.4 (CH), 127.6 (CH), 127.4 (CH), 12.2 
(CH), 125.6 (C), 125.5 (CH), 125.4 (CH), 125.2 (C), 125.1 (CH), 124.7 (C), 122.8 




) 267 (M+Na)+, 299 (M+MeOH+Na)+; HPLC tR = 4.47 
min (method 3). 
 
6.3.2 Synthesis of PNA Oligomers and Tm Measurements 
PNA oligomers P1-5 (Table 2.1) were synthesized* on a solid support using a Rink 
amide linker attached to PEGA resin (Polymer Labs, UK)207 according to a literature 
method.83 Fmoc/Bhoc protected PNA monomers (Link Technologies, UK) were 
employed alongside 10, which was used as the monomer to insert ‘blank’ positions. 
Couplings were carried out using PyBOP/NEM (for 3 h) as described elsewhere.83, 
208 Fmoc deprotections were carried out using 20% piperidine in DMF  for (2 × 6) 
min while Dde deprotection was achieved using a solution of NH2OH.HCl/imidazole 
(1.25g and 0.9 g respectively) in NMP (5 mL) and DMF (1 mL) for (2 × 1.5 h).208 
Phosphonium tags (PNA 2-5) were added using (4-carboxybutyl)triphenyl-
phosphonium bromide (Sigma-Aldrich, UK) while N-Fmoc protected PEG units, 
PEG1 (PNA 2 and 4) and PEG2 (PNA 3) were commercially available (Sigma-
Aldrich, UK and Polypeptide Labs, France respectively). 
                                                 
* P1-5 and P6 (Chapter 6.4) were synthesised by Dr Juan Jose Diaz-Mochon. Characterization was 
carried out by the author. 
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P1: m/z (MALDI-TOF MS); for C154H201N74O46 (M+H)
+: calcd 3824.57, found 
3824.36; HPLC tR = 5.40 min (method 6). 
P2: m/z (MALDI-TOF MS); for C182H230N86O44P
+ (M)+: calcd 4356.82, found 
4356.64; HPLC tR = 7.57 min (method 6). 
P3: m/z (MALDI-TOF MS); for C171H216N84O40P
+ (M)+: calcd 4118.72, found 
4118.77; HPLC tR = 7.28 min (method 6). 
P4: m/z (MALDI-TOF MS); for C169H219N81O39P
+ (M)+: calcd 4039.74, found 
4039.42; HPLC tR = 7.42 min (method 6). 
P5: m/z (MALDI-TOF MS); for C165H206N72O43P
+ (M)+: calcd 3916.59, found 
3916.22; HPLC tR = 6.99 min (method 6). 
 
The Tm values (Table 2.3) for P1-5 and complementary DNA oligomers I-VI 
(Table 2.2) were determined using a Varian Cary 300 Bio UV/Vis spectrometer. An 
initial heating cooling cycle was performed over the range 20-80 oC to permit 
hybridization of a 1:1 mixture of the PNA and DNA strands (2 µM) in 4.5 mM pH 6 
phosphate buffer (500 µL final volume). The change in A260nm was then recorded 
over this range at 1 oC intervals, heating at a rate of 1 oC/min, and the Tm was 
determined from the maximum of the first derivative of the resulting curve. 
 
 6.3.3 Base-Filling Reactions 
General 
Aqueous solutions of each aldehyde were prepared and concentrations confirmed by 
1H NMR in 10 % D2O:H2O. For TCHO, a solution of thymine of known concentration 
was used as an internal standard, and the concentration confirmed by the relative 
integral peak areas for the CH3 protons. This solution of TCHO of known 
concentration was used as an internal standard to confirm the concentrations of the 
other aldehydes by comparing the relative integral peak areas for the CH2 protons. 
 For MALDI-TOF analysis, +BH3, +C, +T, +A, +G and +Y incorporation 
result in mass increases of +14, +137, +152, +161, +177 and +228 Da respectively. 
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(i) Reactions at equimolar aldehyde concentrations (Chapter 2.4: Figure 2.3, 
Graph 2.1, and Table 2.4) 
A PNA blank (2.5 µL, 40 µM aq), DNA template (1 µL, 100 µM aq), aldehydes 
ACHO, GCHO, CCHO, and TCHO (1.6 µL of each, 1.7 mM aq), and pH 6 phosphate 
buffer (8.1 µL, 10 mM aq) were combined in a 1.5 mL Eppendorf tube (Eppendorf 
AG) and placed in an Eppendorf Thermomixer comfort (Eppendorf AG) at 80 oC and 
1200 rpm for 5 min. The reaction mixture was then cooled to 40 oC (3 oC/min) before 
NaBH3CN (2 µL, 1 M aq) was added and shaking continued for 1 h. Pre-treated Q 
Sepharose® Fast Flow (5 µL; see above) was then added before the reaction mixture 
was agitated at room temperature for 20 min. The reaction tube was centrifuged and 
the supernatant removed, then the resin was washed centrifugally with 3% MeCN in 
water (3 × 200 mL). Sinapic acid matrix (10 µL) was added to the resin, and this 
mixture was spotted (1 µL in duplicate) onto a stainless steel MALDI plate (Applied 
Biosystems). Reactions were performed in duplicate, and five MALDI spectra 
acquired for each reaction. Spectra are presented unprocessed. Relative peak 
intensities were determined for the most common isotopes of the PNA-incorporation 
products. Product signal ratios were determined by averaging over the ten spectra.  
 
(ii) Test of reversibility (Chapter 2.4: Figure 2.4) 
To test the reversibility of iminium formation, a reaction was performed as above (i) 
but without GCHO (water was added to maintain the final reaction volume and 
component concentrations). The reaction was then repeated, but this time ACHO, 
CCHO and TCHO were allowed to react for 1 h at 40 
oC, before GCHO was added 
followed by 2 µL of 1 M NaBH3CN, and the reaction left for 1 h at 40 
oC. Treatment 
with Q Sepharose® and MALDI-TOF analysis were performed as above. 
 
(iii) Reactions at non-equimolar aldehyde concentrations (Chapter 2.4: Figure 
2.5, Graph 2.2, and Table 2.5) 
Conditions as reported above (i) with the following amounts of nucleobase 
aldehydes: 1.6 µL of CCHO (2.2 mM), 1.6 µL of TCHO (5.6 mM), 1.6 µL of ACHO (3.3 
mM) and 1.6 µL of GCHO (1.7 mM). A single reaction was run under each set of 
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conditions, and three MALDI spectra acquired for each. Product signal ratios were 
determined by averaging over the three spectra.  
 
(iv) Effect of pH (Chapter 2.4: Figure 2.6) 
For investigation of the pH dependence of the incorporation reaction, conditions 
were as above (iii), using PNA P1 (Table 2.1) and DNA II (Table 2.2) but 
employing the relevant buffer (8.1 µL of a 10 mM aqueous buffer solution). pH 8.5 
was buffered with N-tris(hydroxymethyl)methyl-3-aminopropanesulfonic acid 
(TAPS), pH 5.0 with sodium acetate, and intermediate pH values with sodium 
phosphate. 
 
(v) Analysis of mixtures of DNA templates (Chapter 2.4: Figure 2.7 and 2.8, and 
Table 2.6) 
For initial investigations (Figure 2.7), conditions as above (iii) but using 0.5 µL of 
each of two DNA templates (100 µΜ). Improved results (Figure 2.8) were obtained 
using different amounts of the four aldehydes, specifically 0.6 µL of CCHO (2.2 mM), 
2.6 µL of TCHO (5.6 mM), 2.6 µL of ACHO (3.3 mM) and 0.6 µL of GCHO (1.7 mM). 
A control reaction was performed with the same aldehyde ratio but with water (1 µL) 
in place of DNA. 
 
(vi) Templated reaction at multiple contiguous blanks (Chapter 2.5) 
Conditions as above (iii) using PNA oligomers P2-4 (Table 2.1), DNA V (Table 2.2) 
and the following amounts of the four aldehydes:  0.6 µL of CCHO (2.2 mM), 2.6 µL 
of TCHO (5.6 mM), 2.6 µL of ACHO (3.3 mM) and 0.6 µL of GCHO (1.7 mM). 
 
(vii) Abasic site analysis (Chapter 2.6) 
For abasic site-templated base-filling in the absence of YCHO, conditions were as 
above (iii) using PNA P5 (Table 2.1) and DNA VI (Table 2.2). For abasic site 
analysis with YCHO, conditions were as for (i), but with the addition of 1.6 µL of 
YCHO (1.7 mM) and less buffer (6.5 µL) to maintain a constant reaction volume. 
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(viii) Analysis of RNA (Chapter 2.7) 
Conditions as above (i) with PNA P1, but with RNA RI in place of DNA.  
 
6.4 Chapter 3 Experimental 
6.4.1 Synthesis of PNA Oligomers 
Probes P5-6 were synthesized as described above (Chapter 6.2.2).  
 
P5: (See Chapter 6.3.2 for characterization data). 
P6: m/z (MALDI-TOF MS); for C165H208N66O46P
+ (M)+: calcd 3882.58, found 
3882.60; HPLC tR = 7.09 min (method 6). 
 
Fmoc-Rink amide PS Resin 
 
Low-loading aminomethylpolystyrene resin (1.0 g, ~ 0.5 mmol/g) was swollen in 
DCM for 1 h. Meanwhile, Fmoc-Rink linker (809 mg, 1.5 mmol) was dissolved in 
DMF (15 mL) and activated with DIC (189 mg, 1.5 mmol) and HOBt.H2O (203 mg, 
1.5 mmol) for 15 min. The resin was filtered and the solution of activated Rink linker 
was added. After agitating for 3 h, the resin was filtered, washed with DMF (3 × 3 
mL) then DCM (3 × 3 mL), and a small sample of resin was analyzed by qualitative 
ninhydrin test to confirm the absence of free amines. The resin was washed with 
MeOH (3 × 3 mL) then Et2O (3 × 3 mL) and dried in vacuo. Loading = 0.20 mmol/g 
(theoretical loading = 0.40 mmol/g, yield = 50 %). Prior to use, Fmoc-Rink PS resin 
was pre-swollen in DCM and deprotected using 20 % piperidine in DMF (2 × 6 min) 
and washed with DMF (3 ×) and DCM (3 ×) to afford Rink amide PS. 
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Probes P7-8 were synthesized on Rink amide PS (37.5 mg each, 7.5 µmol) as 
follows, using monomers as per Chapter 6.3.2 (yields are based upon UV 
determination of the concentration of a solution of the total PNA dissolved in water). 
General procedure for PNA monomer couplings 
PNA monomer (3 eq) was dissolved in DMF (to 0.1 M concentration) and activated 
with DIC (3 eq) and oxyma (3 eq) for 5 min, then added to the pre-swollen resin in 
an SPE tube. The resulting mixture was then transferred to a glass microwave vial (5 
mL size, Biotage AB, Sweden) using a plastic Pasteur pipette. A small magnetic 
stirrer was added to the vial, which was then sealed and transferred to a heating block 
(aluminium, containing holes of 17 mm diameter and 30 mm depth to hold 
microwave vials, prepared by the mechanical workshop of the School of Chemistry, 
University of Edinburgh) on a hot plate at 60 oC. The reaction mixture was stirred 
very slowly at 60 oC for 30 min, then transferred back to the SPE tube (again with a 
plastic Pasteur pipette) for washing with DMF (3 ×) and DCM (3 ×). 
Fmoc and Dde deprotection steps 
As per Chapter 6.3.2, which were always followed by DMF (3 ×) and DCM (3 ×) 
washings before the next coupling or capping step. 
 
P7: m/z (MALDI-TOF MS); for C167H204N82O36P
+ (M)+: calcd 3966.64, found 
3966.63; HPLC tR =  5.33 min (method 6); Yield = 50 % (95 % per monomer). 
P8: m/z (MALDI-TOF MS); for C178H217N89O38P
+ (M)+: calcd 4241.76, found 
4241.82; HPLC tR =  5.21 min (method 6); Yield = 46 % (95 % per monomer). 
 
6.4.2 Model Studies using Synthetic DNA 
(i) G551D and W1282X (Chapter 3.3: Figure 3.2 and 3.4) 
Conditions for the homo- and heterozygous SNP (G551D and W1282X) analyses 
were as per Chapter 6.3.3(i), using the optimized ratios of the four nucleobase 
aldehydes described in Chapter 6.3.3(v). Homozygous models employed 1 µL of the 
relevant DNA template (100 µM), whilst heterozygous studies used 0.5 µL of both 
templates (100 µM). The experiment that modelled duplex analysis of both SNPs 
(Figure 3.4a) employed 0.5 µL of each DNA template (100 µΜ), 2.5 µL of PNA 5 
(40 µΜ) , 2.5 of µL of PNA 6 (40 µΜ) and 5.6 µL pH 6 10mM phosphate buffer 
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(final reaction volume of 20 µL after addition of aldehydes and NaBH3CN solution). 
A substoichiometric amount of PNA 6 was used to normalize the product ratios 
(Figure 3.4b) using 2.5 µL of PNA 5 (40 µΜ) , 1.5 of µL of PNA 6 (40 µΜ) and 6.6 
µL pH 6 10mM phosphate buffer (to maintain a final reaction volume of 20 µL). 
  
(ii) ∆F508 (Chapter 3.3: Figure 3.3) 
Model analyses for the ∆F508 mutation were performed as above (i) but this time 2.5 
µL of each of two probes (P7 and P8; 40 µM) was used along with 5.6 µL of pH 6 
10mM phosphate buffer (to maintain a final reaction volume of 20 µL). 
 
(iii) Investigation of the effect of [PNA] >> [DNA] (Chapter 3.3: Figure 3.5) 
Conditions were as above (i) but 6 µL of P5 (167 µM) and 4.6 µL of pH 6 10 mM 
phosphate buffer (final reaction volume 20 µL) were used along with 1 µL of 10 µM 
DNA VII (Figure 3.5a) or 1 µM DNA VII (Figure 3.5b) to give PNA:DNA ratios of 
100:1 and 1000:1 respectively. 
 
(iv) Detection limit for PNA following dynamic incorporation 
To determine the detection limit for the charge-tagged PNA, varying amounts of 
DNA template VI (10 pmol, 1 pmol and 100 fmol) were used in three templated 
incorporation reactions (conditions as per (i), using 1 µL of DNA solutions of 
concentration 10 µM, 1 µM and 0.1 µM respectively) with a parallel decrease in the 
amount of PNA 6 blank to maintain a 1:1 stoichiometry (i.e. by using 2.5 µL of PNA 
solutions of concentration 4 µM, 0.4 µM and 0.04 µM respectively). In each case the 
desired incorporation product was observable in unprocessed spectra, although for 
100 fmol the product was only weakly detectable at ‘sweet spots’ on the MALDI 
plate. However, given that only 1/10th of the reaction product (i.e. 1 µL of a 10 µl 
dilution with sinapic acid matrix) was spotted onto the plate, then it can be concluded 
that a reliable detection limit of 100 fmol of DNA is possible with the charge tagged 
PNA (although detection at the 10 fmol level was possible in some cases). 
Investigation of base-filling on acyl-capped P1 using DNA III (Chapter 2.3) in the 
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same way showed a detection limit of 1 pmol, which supports the use of the 
triphenylphosphonium charge tag to improve detection limits. 
 
6.4.3 Human Genomic DNA samples 
For ‘in-house’ and clinical samples, DNA was isolated from buccal (cheek) swabs 
(Isohelix for in-house samples, medical wire (MWE) Dryswab for clinical samples) 
using a commercial (Isohleix) DNA isolation kit and kept at -20 oC in the storage 
buffer provided until analysis. The concentrations of DNA in the samples were 
determined by UV absorbance using a GE Healthcare NanoVue. 
To obtain clinical samples (Chapter 3.5 and 3.6), subjects were identified 
from the Western General Hospital Adult Cystic Fibrosis Unit database. This 
database consists of 159 adults with CF; 147 have fully identified genotypes, of 
whom 17 possess the G551D mutation and 63 are ∆F508 homozygotes. Inclusion 
criteria included ability to provide written informed consent. Ethical approval was 
granted by Lothian Regional Ethics Committee.  13 Patients were approached to 
participate in the study on attendance at CF outpatient clinic with an invitation letter 
and patient information sheet. 12 (6 male) agreed to provide a sample. 7 of these 
were homozygous or heterozygous for G551D and 5 were ∆F508 homozygotes. The 
genotyping reported herein was performed by individuals who were blind to the 
previously determined patient genotypes. All participants provided written consent 
before a buccal swab was provided by each. All swabs were taken by the same CF 
clinical research fellow (Dr Philip Andrew Reid) and stored at -20 oC until isolation.  
Commercial DNA samples (Coriell Cell Repositories, USA) were supplied as 
solutions of known concentration in 10 mM Tris, 1 mM EDTA buffer at pH 8.0. The 
repository numbers for samples ‘Cor1’ and Cor2’ were NA08338 and NA12785 
respectively. More information on these samples (including genotypic and 
phenotypic data) is available at http://ccr.coriell.org/. 
 
6.4.4 PCR Amplification 
General 
PCR primers were selected from a previous publication55 and purchased from 
Microsynth. For the G551D SNP, primer sequences were:  




For the ∆F508 indel, primer sequences were:  
Forward 5’-AGTTTTCCTGGATTATGCCT-3’;  
Reverse 5’-TTGGGTAGTGTGAAGGGTTC-3’.  
PCR amplifications were performed on a Techne TC-312 Thermocycler and all water 
was nuclease free. Cycling conditions were an initial denaturation at 95 oC for 3 min, 
40 cycles of 95 oC for 30 s, annealing at 47 oC for 45 s, and extension at 72 oC for 45 
s, a final extension at 78 oC for 5 min, and a final hold at 4 oC.  
 
(i) Two-stage asymmetric PCR (Chapter 3.4 (‘in-house’ samples), 3.5 and 3.6 
(clinical samples)) 
For the first symmetric PCR step (final volume, 50 µL), 2 µL of isolated genomic 
DNA solution was amplified (for DNA concentrations see Table 3.4 and 3.5; these 
were not normalized) and reagent concentrations were: 1X PCR mastermix 
(Promega), 0.4 µM forward and reverse primers. The genomic DNA was replaced 
with water for negative controls.  
For the subsequent asymmetric PCR (final volume, 50 µL), 3 µL of the first 
crude PCR mixture was used. Reagent concentrations were:  1X PCR mastermix 
(Promega), 1 µM forward primer. Negative controls were performed with 3 µL of the 
negative controls from the first PCR stage. For individual mutation analysis, crude 
PCR products were purified individually into 28 µL of 10 mM pH 7.4 PBS using a 
QIAGEN® QIAquick® PCR purification kit. For duplex analysis, the ssDNA PCR 
products for both G551D and ∆F508 were combined and purified together into 28 µL 
of 10 mM pH 7.4 PBS as above. 
 
(ii) One-stage asymmetric PCR (Chapter 3.4 (commercial samples)) 
For amplification (singleplex and duplex, Figure 3.8 and 3.9 respectively), 2 µL of 
isolated genomic DNA solution was amplified (for DNA concentrations see Table 
3.4; these were not normalized) and reagent concentrations were: 1X PCR mastermix 
(Promega), 1.0 µM forward and 0.2 µM reverse primers. The genomic DNA was 
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replaced with water for negative controls. Crude PCR products were purified into 28 
µL of 10 mM pH 7.4 PBS using a QIAGEN® QIAquick® PCR purification kit. 
 
6.4.5 Allele Discrimination by Dynamic Chemistry 
Depending upon the analysis (i.e. G551D, ∆F508 or duplex), the following were 
added to the purified, amplified DNA (28 µL):  
G551D analysis - 1 µL of PNA P5 (40 µM), 1.8 µL CCHO (2.2 mM), 7.8 µL TCHO 
(5.6 mM), and 15.4 µL water.  
∆F508 analysis - 1 µL of PNA probes P7 and P8 (40 µM), 1.8 µL GCHO (1.7 mM), 
7.8 µL ACHO (3.3 mM), and 14.4 µL water. 
Duplex G551D and ∆F508 analysis - 1 µL of PNA probes P5, P7 and P8 (40 µM), 
1.8 µL GCHO (1.7 mM), 1.8 µL CCHO (2.2 mM), 7.8 µL TCHO (5.6 mM),  7.8 µL ACHO 
(3.3 mM), and 3.8 µL water.  
The resulting mixtures were heated (in a Techne TC-312 Thermocycler) at 95 oC for 
5 min, then cooled to 40 oC at ~ 3 oC/min. 6 µL of freshly prepared 1 M aqueous 
sodium cyanoborohydride was added (final volume 60 µL) and the mixture left at 40 
oC for 1 h, then 10 µL of pre-treated Q sepharose® Fast Flow was added and the 
mixture left to shake at 20 oC for 20 min. The resin was then centrifuged, the 
supernatant removed, and the resin washed centrifugally (for 30 sec at 13,000 rpm) 
with 3 % aqueous acetonitrile (3 × 200 µL). Finally, 10 µL of sinapic acid matrix was 
added to the resin, and 1 µL of the resulting mixture spotted in duplicate directly onto 
a stainless steel MALDI-TOF plate for MS analysis. The unreacted PNA probe of 
lowest mass was used as an internal calibrant. Genotypes were determined by visual 
inspection of the unprocessed MALDI spectra. For the clinical samples, genotypes 
were also established by input of the MS peak table data into a Microsoft Excel file 
(briefly, raw data for peaks above a certain intensity threshold obtained from the 
MALDI spectra were analyzed using Excel formulae, which converted numerical 
peak m/z values within a set range into an output genotype; see Appendix 3 for 
representative examples of the resulting Excel spreadsheets for each clinical sample). 
Peaks of relative intensity < 5 % of the most intense peak were disregarded. 
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6.4.6 Agarose Gel Electrophoresis 
Agarose gels were prepared using 1.8-2.0 % w/v Type XI agarose (Sigma-Aldrich) 
and 0.5 µg/mL ethidium bromide (Sigma-Aldrich, UK) in 1 X TBE buffer (Fischer 
Scientific, UK). Gels were run for 45-60 min at 90 V on a Bio-Rad Power PAC 300 
instrument and imaged using UV light (Uvitec transilluminator). Size markers were 
low molecular weight DNA ladders (0.5 µg/lane, New England Biolabs, USA). PCR 
products (20 µL from 50 µL reactions) and ladders were loaded using blue/orange 
loading dye (Promega, UK). For the gel-shift assay of single-stranded DNA (lane 2, 
Figure 3.12), PCR product (20 µL) was pre-hybridized with PNA P5 (0.4 µL of a 40 
µM solution) by heating to 95 oC for 2 min and cooling to 4 oC in a PCR 
thermocycler. As a control for the gel-shift assay (lane 1, Figure 3.12), P5 (0.4 µL of 
a 40 µM solution) was loaded directly with blue/orange loading dye. 
 
6.5 Chapter 4 Experimental 
6.5.1 Library Screening for Nucleobase Analogues (Chapter 4.3) 
(i) Library compounds (Figure 4.3) 
Compounds 18-21, 23-25 and 27-28 were commercially available (from Sigma-
Aldrich, with the exception of 24 from Acros Organics). Compounds 12-17, 22, 26 
and 29 were synthesized as part of a separate project by Dr Jeff Walton and Dr 
Sunay Chankeshwara, who supplied small (< 4 mg) quantities of each together with 




Beige solid. 1H NMR (360 MHz, CDCl3) δH 9.66 (s, 1H, CHO), 7.75 (d, 2H, 
3
J = 8.6 
Hz, Ar-H), 7.42 (d, 2H, 3J = 8.6 Hz, Ar-H), 7.32 (d, 1H, 3J = 3.7 Hz, Ar-H), 6.83 (d, 
1H, 3J = 3.7 Hz, Ar-H); m/z (ES+) 207 (M+H)+.  
 
 




Colourless oil. 1H NMR (360 MHz, CDCl3) δH 9.66 (s, 1H, CHO), 7.82 (dd, 2H, 
3
J = 
8.4, 4J = 2.0 Hz, Ar-H), 7.47-7.38 (3H, m, Ar-H), 7.32 (d, 1H, 3J = 3.7 Hz, Ar-H), 
6.85 (d, 1H, 3J = 3.7 Hz, Ar-H); m/z (ES+) 173 (M+H)+. 
 
3-(5-Formylfuran-2-yl)benzoic acid (14) 
 
Brown solid. 1H NMR (360 MHz, d6-DMSO) δH 9.64 (s, 1H, CHO), 8.38 (s, 1H, Ar-
H), 8.13 (d, 1H, 3J  = 7.5 Hz, Ar-H), 8.00 (d, 1H, 3J = 7.4 Hz, Ar-H), 7.68-7.64 (m, 
2H, Ar-H), 7.64 (1H, d, 3J = 7.7 Hz, Ar-H), 7.43 (d, 1H, J = 3.8 Hz, Ar-H); m/z 
(ES
+




Off-white solid. 1H NMR (360 MHz, CDCl3) δH 9.80 (s, 1H, CHO), 7.65 (d, 1H, 
3
J 
= 4.0 Hz, Ar-H), 7.49 (d, 2H, 3J = 8.3 Hz, Ar-H), 7.29 (d, 1H, 3J = 4.0 Hz, Ar-H), 
7.16 (d, 2H, 3J = 8.4 Hz, Ar-H), 2.32 (s, 3H, CH3); m/z (ES
+
) 203 (M+H)+. 
 
3-(5-Formylthiophen-2-yl)benzoic acid (16) 
 
Yellow solid. 1H NMR (360 MHz, CDCl3) δH 13.34-13.11 (br s, 1H, OH), 9.93 (s, 
1H, CHO), 8.26 (t, 1H, 4J =1.7 Hz, Ar-H), 8.08-8.05 (m, 2H, Ar-H), 8.00-7.97 (m, 
1H, Ar-H), 7.85 (1H, d, 3J = 4.0 Hz, Ar-H), 7.63 (1H, t, 3J = 7.8 Hz, Ar-H); m/z   
(ES
-
) 231 (M-H)-. 




Pale yellow solid. 1H NMR (360 MHz, CDCl3) δH 9.97 (d, 1H,
 4
J =1.4 Hz, CHO), 
8.04 (s, 1H, 4J =1.4 Hz, Ar-H), 7.86 (s, 1H, Ar-H), 7.81-7.56 (m, 2H, Ar-H), 7.47-
7.34 (m, 3H, Ar-H); m/z (ES+) 189 (M+H)+. 
 
3'-Formylbiphenyl-3-carboxylic acid (22) 
 
Beige solid. 1H NMR (360 MHz, d6-DMSO) δH 13.29-13.01 (br s, 1H, OH), 10.12 
(s, 1H, CHO), 8.26-8.25 (m, 2H, Ar-H), 8.07 (d, 1H, 3J = 7.9 Hz, Ar-H), 8.03-7.98 
(m, 2H, Ar-H), 7.94 (d, 1H, 3J = 7.6 Hz, Ar-H), 7.72 (t, 1H, 3J = 7.6 Hz, Ar-H), 7.65 




White solid. 1H NMR (360 MHz, CDCl3) δH 10.08 (s, 1H, CHO), 8.06 (s, 1H, Ar-
H), 7.83-7.80 (m, 2H, Ar-H), 7.61-7.56 (m, 3H, Ar-H), 7.01 (d, 2H, 3J = 8.7 Hz, Ar-
H), 3.87 (s, 3H, CH3); m/z (ES
+









Colourless oil. 1H NMR (250 MHz, CDCl3) δH 10.10 (s, 1H, CHO), 8.11 (t, 1H, 
4
J = 
1.6 Hz, Ar-H), 7.87 (dd, 2H, 4J = 1.6 Hz, 3J = 7.6 Hz, Ar-H), 7.66-7.62 (m, 3H, Ar-
H), 7.52-7.40 (m, 3H, Ar-H); m/z (ES+) 183 (M+H)+. 
 
(ii) Screening by dynamic chemistry (Figure 4.4 and Graph 4.1) 
The library of eighteen aldehydes (Chapter 4, Figure 4.3) was dissolved in 5:5:1 v/v 
H2O:MeOH:MeCN to a concentration of 1.5 mM in each aldehyde. The organic 
solvents were necessary to allow complete dissolution. Dynamic incorporation of this 
library was then investigated in four separate experiments using PNA P1 (Chapter 2, 
Table 2.1) and one of the four DNA templates I-IV (Chapter 2, Table 2.2; templating 
bases are G, A, T and C respectively). The standard protocol described above was 
followed (Chapter 6.3.3(i)) but the aldehyde library solution (6.4 µL) was used in 
place of the natural nucleobase aldehydes. For MALDI-TOF analysis, mass increases 
expected for aldehydes 12-29 are given below (Table 6.1). 
 
Table 6.1 Mass increases calculated for incorporation of library members. 























6.5.2 Targeted Synthesis and Screening of Nucleobase Analogues 
(Chapter 4.3) 
 
(i) Aldehyde synthesis (Scheme 4.1) 
2,6-Diamino-9-(2,2-diethoxyethyl)-purine (30) 
 
A solution of 8 (101 mg, 0.35 mmol) in 7 M NH3 in MeOH (2 mL) was heated at 65 
oC in the microwave for 30 min. TLC (10 % MeOH:DCM) showed the presence of 
mainly unreacted starting material, so the reaction mixture was saturated with NH3 
by bubbling NH3 (g) through the solution for 15 min before heating at 90 
oC in the 
microwave for 1 h (pressure = 4-5 bar). The reaction mixture was concentrated to 
dryness in vacuo and purified by automated column chromatography (10 g column 
size, 3 CV 5 % MeOH:DCM, 24 CV 5 → 10 % MeOH:DCM, 9 CV 10 % 
MeOH:DCM, sample dissolved in MeOH and pre-adsorbed on silica by evaporation) 
to afford 30 as a white solid (18 mg, 0.07 mmol, 19 %). Rf = 0.51 (10 % 
MeOH:DCM); IR νmax/ cm
-1 (neat) 3446 (w), 3306 (m), 3119 (m), 1656 (s), 1055 
(s); mp 169-170 oC; 1H NMR (250 MHz, CD3OD) δH 7.73 (s, 1H, H-8), 4.79 (t, 1H, 
3
J = 5.4 Hz, CH(OEt)2), 4.14 (d, 2H, 
3
J = 5.4 Hz, NCH2), 3.73 (dq, A of an ABX3 
spin system, 2H, 2JAB = 9.4 Hz, 
3
JAX = 7.0 Hz, OCH2), 3.50 (dq, B of an ABX3 spin 
system, 2H, 2JAB = 9.2 Hz, 
3
JAX = 7.0 Hz, OCH2), 1.12 (t, X3 of an ABX3 spin 
system, 6H, 3JAX = 7.0 Hz, 2 × OCH2CH3); 
13
C NMR (125.7 MHz, CD3OD) δC 
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161.9 (C), 157.5 (C), 153.0 (C), 140.7 (CH), 113.8 (C), 101.5 (CH), 64.6 (CH2), 46.8 
(CH2), 15.6 (CH3); m/z (ES
+
) 267 (M+H)+, 289 (M+Na)+; HRMS (ES+) for 
C11H19O2N6 (M+H)
+: calcd 267.15640, found 267.15607; HPLC tR =  2.59 min 
(method 3). 
 
2-(2,6-Diaminopurin-9-yl)-ethanal hydrate trifluoroacetate (DCHO) 
 
A suspension of 30 (5.5 mg, 21 µmol) in 1:1 v/v TFA:H2O (250 µL) was heated at 
100 oC in the microwave for 30 min then concentrated in vacuo to remove most of 
the TFA before lyophilizing to give DCHO as an off-white solid (7.2 mg, quantitative). 
Rf = 0.19 (10 % MeOH:DCM); 
1
H NMR (600 MHz, 10 % D2O in H2O) δH 8.02 (s, 
1H, H-8), 5.41 (t, 1H, 3J = 4.8 Hz, CH(OH)2), 4.22 (d, 2H, 
3
J = 4.8 Hz, CH2); 
13
C 
NMR (125.7 MHz, 10 % D2O:H2O) δC 163.5 (q, 
2
J = 35.4 Hz, C(O)CF3), 162.6 (C), 
153.3 (C), 151.0 (C), 143.5 (CH), 116.9 (q, 1J = 291.5 Hz, CF3), 111.6 (C), 88.2 
(CH), 49.4 (CH2);  m/z (ES
+
) 211 (M+H)+; HRMS (ES+) C7H11O2N6 (M+H)
+: calcd 




To a stirred suspension of 2-thiouracil (1.0 g, 7.8 mmol) in dry MeCN (20 mL) under 
N2 (g) was added N,O-bis(trimethylsilyl)acetamide (5.3 mL, 21.8 mmol, 2.8 eq). The 
resulting pale yellow solution was stirred for 5 min before DiPEA (1.4 mL, 8.0 
mmol, 1 eq) then bromoacetaldehyde diethyl acetal (2.1 mL, 8.0 mmol, 1 eq) was 
added and the reaction mixture was stirred at room temperature for 16 h. TLC (10 % 
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MeOH:DCM) indicated the presence of mainly starting material, so a 20 mL aliquot 
of the reaction mixture was removed and heated at 100 oC for 30 min, before KI (0.9 
g, 5.4 mmol) was added and the resulting mixture heated in the microwave at 100 oC 
for a further 30 min. The mixture was then quenched with MeOH (50 mL), 
neutralized with NaHCO3 (3.0 g), and filtered (washing with MeOH) and 
concentrated in vacuo to give a yellow oil which was purified by automated column 
chromatography (50 g column size, 32 CV 10 % MeOH:DCM) to afford 31 as a 
white solid (149 mg, 0.6 mmol, 8 %). Rf = 0.65 (10 % MeOH:DCM); ); IR νmax/ cm
-
1 (neat) 2977 (m), 2876 (m), 2686 (m), 1684 (s), 1278 (s); mp 104-106 oC; 1H NMR 
(360 MHz, CDCl3) δH 11.07 (br s, 1H, NH), 7.77 (d, 1 H, 
3
J = 6.8 Hz, CH), 6.19 (d, 
1 H, 3J = 6.8 Hz, CH), 4.74 (t, 1H, 3J = 5.0 Hz, CH(OEt)2), 3.78 (dq, A of an ABX3 
spin system, 2H, 2JAB = 9.2 Hz, 
3
JAX = 7.1 Hz, OCH2), 3.50 (dq, B of an ABX3 spin 
system, 2H, 2JAB = 9.2 Hz, 
3
JAX = 7.1 Hz, OCH2), 3.31 (d, 2H, 
3
J = 5.0 Hz, NCH2), 
1.12 (t, X3 of an ABX3 spin system, 6H, 
3
JAX = 7.1 Hz, 2 × OCH2CH3); 
13
C NMR 
(150.9 MHz, CDCl3) δC 164.1 (CO), 161.6 (CS), 154.6 (CH), 111.3 (CH), 101.2 
(CH), 62.8 (CH2), 34.1 (CH2), 15.2 (CH3); m/z (ES
-
) 243 (M-H)-; HRMS (EI) for 
C10H16O3N2S (M)





A mixture of xanthine (1.0 g, 6.6 mmol), Cs2CO3 (4.3 g, 13.1 mmol, 2 eq) and 
bromoacetaldehyde diethyl acetal (1.02 mL, 6.6 mmol, 1 eq) in DMF (16 mL) was 
heated at 100 oC in the microwave for 30 min. TLC (10 % MeOH:DCM) showed 
mainly starting material, so the reaction mixture was heated at 130 oC in the 
microwave for a further 30 min then left to stand at room temperature for 40 h. The 
reaction mixture was then filtered (washing with DMF) and concentrated to a white 
solid in vacuo. Attempted recrystallization from hot MeOH was unsuccessful, so the 
suspension in hot MeOH was filtered and pre-adsorbed onto SiO2 by evaporation and 
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purified by column chromatography (2 × 16 cm silica, eluting with 5 % 
MeOH:DCM) to afford 19 mg of a white solid. This 19 mg was sonicated in CD3OD 
(1 mL), transferred to an Eppendorf tube, centrifuged and the supernatant removed 
for analysis by 1H NMR which showed the presence of two isomers; isomer A and 
isomer B in a ratio of ~ 3:1. 2D HMBC NMR showed isomers A and B to be the N7- 
and N3-alkylated products respectively (Figure 6.1). The residual solid was sonicated 
in MeOH (1 mL), then centrifuged and the supernatant removed as before. Upon 
drying the residue in vacuo, a white solid was obtained which was shown to be the 
pure N7-alkylated isomer 32 (5 mg, 19 µmol, 0.3 %). Rf = 0.40 (5 % MeOH:DCM); 
1
H NMR (500 MHz, CD3OD) δH 7.83 (s, 1 H, H-8), 4.83 (t, 1H, 
3
J = 5.0 Hz, 
CH(OEt)2), 4.36 (d, 2H, 
3
J = 5.0 Hz, NCH2), 3.73 (dq, A of an ABX3 spin system, 
2H, 2JAB = 9.5 Hz, 
3
JAX = 7.0 Hz, OCH2), 3.50 (dq, B of an ABX3 spin system, 2H, 
2
JAB = 9.5 Hz, 
3
JAX = 7.0 Hz, OCH2), 1.13 (t, X3 of an ABX3 spin system, 6H, 
3
JAX = 
7.0 Hz, 2 × OCH2CH3); 
13
C NMR (125.7 MHz, CD3OD) δC 157.6 (CO), 153.6 (CO), 
150.8 (C), 145.0 (CH), 108.4 (C), 102.0 (CH), 64.8 (CH2), 49.9 (CH2), 15.7 (CH3); 
m/z (ES
+
) 269 (M+H)+; HRMS (EI) for C11H16O4N4 (M)
+: calcd 268.11650, found 






C HMBC of a mixture of isomers A (major) and B (minor) obtained after 
alkylation of xanthine. Based upon the observed long-range (3 bond) couplings it can be 
concluded that A is the N7-alkylated product, and B is the N3-alkylated product.
209
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2-(Xanthin-9-yl)-ethanal hydrate trifluoroacetate (XCHO) 
 
A solution of 32 (5 mg, 19 µmol) in 1:1 v/v TFA:H2O (500 µL) was heated at 100 
oC 
in the microwave for 30 min then concentrated in vacuo to remove most of the TFA 
before lyophilizing to give XCHO as a white solid (5 mg, 16 µmol, 87 %). Rf = 0.08 
(10 % MeOH:DCM);  1H NMR (600 MHz, 10 % D2O in H2O) δH 10.78 (s, 1H, NH), 
7.93 (s, 1H, H-8), 5.37 (t, 3J = 5.1 Hz, 1H, CH(OH)2), 4.35 (d, 
3
J = 5.1 Hz, 2H, CH2); 
13
C NMR (125.7 MHz, 10 % D2O:H2O) δC 163.5 (q, 
2
J = 35.4 Hz, C(O)CF3), 157.6 
(CO), 153.6 (CO), 149.9 (C), 144.9 (CH), 116.9 (q, 1J = 291.9 Hz, CF3), 108.1 (C), 
88.7 (CH), 52.3 (CH2); m/z (ES
+
) 213 (M+H)+; HRMS (ES+) C7H9O4N4 (M+H)
+: 
calcd 213.06183, found 213.06196; HPLC tR =  1.41 min (method 3). 
 
Ethyl 6-oxo-1,6-dihydro-3-pyridylacetate (33) 
 
6-chloro-3-pyridylacetic acid (1.0 g, 5.8 mmol) was suspended in 10 M KOH aq (10 
mL) and heated in the microwave at 205 oC for 25 min (17 bar pressure). Warning; 
these conditions cause obvious corrosion of the microwave vial, which should be 
disposed of after the reaction.  The resulting black solution was acidified to pH ~ 1 
with 2 M HCl aq and concentrated to a brown solid in vacuo. This was resuspended 
in EtOH (20 mL) with 4 drops of 37 % w/w HCl, and then heated in the microwave 
at 85 oC for 30 min. The reaction mixture was concentrated to a brown solid in 
vacuo, then suspended in saturated NH4Cl aq (20 mL) and water (20 mL) and 
extracted with EtOAc (6 × 50 ml). The combined organics were dried (MgSO4), 
filtered and concentrated in vacuo to yield 33 as a white solid (0.76 g. 4.2 mmol, 72 
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%). Rf  = 0.59 (10 % MeOH:DCM); IR νmax/ cm
-1 (neat) 2804 (m), 1726 (s), 1657 
(s), 1615 (s), 1177 (s); mp 133-135 oC; 1H NMR (500 MHz, CDCl3) δH 12.63 (br s, 
1H, NH), 7.44 (dd, 1H, 4J = 2.0, 3J = 9.5 Hz, H-4), 7.25 (d, 1 H, 4J = 2.0 Hz, H-5), 
6.57 (d, 1H, 3J = 9.5 Hz, H-2), 4.16 (q, 2 H, 3J = 7.2 Hz, OCH2), 3.37 (s, 2H, CH2), 
1.26 (t, 3 H, 3J = 7.2 Hz, CH3); 
13
C NMR (125.7 MHz, CDCl3) δC 170.8 (CO), 164.4 
(CO), 143.4 (CH), 133.5 (CH), 120.4 (CH), 113.0 (C), 61.2 (CH2) 36.9 (CH2), 14.2 
(CH3);  m/z (ES
+
) 182 (M+H)+, 204 (M+Na)+; HRMS (EI+) for C9H11O3N (M)
+: 
calcd 181.07324, found 181.07334; HPLC tR =  2.75 min (method 3). 
 
6-Oxo-1,6-dihydro-3-pyridylacetaldehyde hydrate (T*CHO) 
 
A stirred solution of 33 (25 mg, 0.14 mmol) in anhydrous DCM (1.4 mL) was cooled 
to -78 oC under N2 (g) and 1 M DIBAL-H in n-hexane (0.21 mL, 0.21 mmol) was 
added dropwise. The reaction mixture was stirred at -78 oC for 2 h, then quenched 
with a solution of 37 % w/w HCl (40 µL) in THF (0.31 mL) before DCM (3 mL) 
was added and the mixture washed with water. TLC showed aldehyde in the aqueous 
phase only. Attempted extractions of the aqueous phase (with EtOAC and CHCl3) 
were unsuccessful, so the water was removed in vacuo to afford a white solid (110 
mg) which was purified by preparative HPLC (method 2) to yield T*CHO as a yellow 
solid (8 mg, 0.05 mmol based on mass of hydrated product, 36 %). NMR showed 
peaks attributed to both the hydrated (major) and aldehydic (minor) products. Rf = 
0.19 (10 % MeOH:DCM); IR νmax/ cm
-1 (neat) 3228 (m), 3131 (m), 1655 (s), 1593 
(s), 1055 (s); mp decomp. > 250 oC; 1H NMR (500 MHz, 10 % D2O in H2O) 
hydrate: δH 7.67 (dd, 1H, 
4
J = 2.0, 3J = 9.5 Hz, H-4), 7.42 (d, 1 H, 4J = 2.0 Hz, H-5), 
6.61 (d, 1H, 3J = 9.5 Hz, H-2), 5.17 (t, 1 H, 3J = 5.5 Hz, OCH) and 2.74 (d, 2H, 3J = 
5.5 Hz, CH2); aldehyde: δH 9.70 (s, 1H, CHO), 7.58 (dd, 1H, 
4
J = 2.0, 3J = 9.5 Hz, H-
4), 7.42 (d, 1 H, 4J = 2.0 Hz, H-5), 6.64 (d, 1H, 3J = 9.5 Hz, H-2), 3.77 (s, 2H, CH2); 
13
C NMR (125.7 MHz, 10 % D2O in H2O) hydrate: δC 164.6 (CO), 146.7 (CH), 
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134.9 (CH), 119.0 (CH), 118.6 (C), 91.2 (CH), 39.7 (CH2); aldehyde: δC 204.6 (CO), 
164.6 (CO), 146.5 (CH), 135.5 (CH), 119.4 (CH), 114.3 (C), 45.6 (CH2); m/z (ES
+
) 
138 (M+H)+, 156 (M+H3O)
+; HRMS (ES+) for C7H8O2N (M+H)
+: calcd 138.05496, 
found 138.05496; HPLC tR =  1.86 min (method 3). 
 
(ii) Dynamic incorporation of non-natural aldehydes in the presence of 
their natural counterparts (Figure 4.5 and 4.6, Graph 4.2 and Table 4.1) 
Aqueous solutions of aldehydes DCHO, XCHO and T*CHO were prepared and 
concentrations confirmed by 1H NMR in 10 % D2O:H2O using an internal standard 
(ACHO was used as a standard for DCHO and XCHO, and 6-chloro-3-pyridylacetic acid 
for T*CHO). Dynamic incorporation of each non-natural nucleobase aldehyde was 
investigated in separate experiments using PNA P1 (Chapter 2, Table 2.1) and the 
‘correct’ DNA template (III for DCHO, II for XCHO and T*CHO; Chapter 2, Table 2.2). 
The standard protocol described above was followed (Chapter 6.3.3(i)) but the 
natural nucleobase aldehydes were replaced with an equimolar mixture of the non-
natural nucleobase under investigation (3.2 µL, 1.7 mM) and its natural counterpart 
(3.2 µL, 1.7 mM). For MALDI-TOF analysis, +D, +X, and +T* incorporation result 
in mass increases of +176, +178, and +121 Da respectively. 
 For the investigation of the selectivity for T*CHO against mis-incorporation, 
four separate experiments using PNA P1 (Chapter 2, Table 2.1) and one of the four 
DNA templates I-IV (Chapter 2, Table 2.2; templating bases are G, A, T and C 
respectively) were performed according to the standard protocol described above 
(Chapter 6.3.3(i)), but with T*CHO in place of TCHO. 
 
6.5.3 Comparison of Dynamic Incorporation Results with Tm Values for 
T* (Chapter 4.4) 
 
(i) PNA synthesis (Table 4.2 and Figure 4.7) 
PNA oligomers P9-12 were synthesized on Rink amide PS (25 mg each, 7.4 µmol; 
Chapter 6.4.1, method as for P7-8). The non-natural nucleobase T* was added using 
monomer 36, which was synthesized as detailed below. Yields are based upon UV 
determination of the concentration of a solution of the total PNA dissolved in water. 
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For the pyridone monomer, the extinction coefficient at 260 nm (ε260) was estimated 
to be 0.8 mLµmol-1cm-1 (see Graph 6.1). 
 
Graph 6.1 Effect of concentration on the A260 of ethyl 6-oxo-1,6-dihydro-3-pyridylacetate 33, 
used to estimate the extinction coefficient of T*. Measurements were made at 28 
o
C. The 
extinction coefficient at 260 nm, ε260 = (Absorbance at 260 nm, A260 /(concentration, c x path 








 (since path length, l = 1 cm). 
 
Crude PNA oligomers P10-12 were purified by preparative HPLC (method 1). P9 
was used directly without purification. 
P9: m/z (MALDI-TOF MS); for C114H149N60O31 (M+H)
+: calcd 2855.19, found 
2855.26; HPLC tR =  12.90 min (method 7); Yield = 16 % (85 % per monomer). 
P10: m/z (MALDI-TOF MS); for C114H148N59O30 (M+H)
+: calcd 2824.19, found 
2824.64; HPLC tR =  12.70 min (method 7); Yield = 4 % (75 % per monomer). 
P11: m/z (MALDI-TOF MS); for C114H147N58O29 (M+H)
+: calcd 2793.18, found 
2793.79; HPLC tR =  12.50 min (method 7); Yield = 6 % (77 % per monomer). 
P12: m/z (MALDI-TOF MS); for C114H146N57O28 (M+H)
+: calcd 2762.18, found 
2762.17; HPLC tR =  12.13 min (method 7); Yield = 7 % (79 % per monomer).  
 






6-chloro-3-pyridylacetic acid (4.0 g, 23 mmol) was suspended in 10 M KOH aq (10 
mL) and heated in the microwave at 205 oC for 25 min (18 bar pressure). Warning; 
these conditions cause obvious corrosion of the microwave vial, which should be 
disposed of after the reaction.  The resulting black solution was acidified to pH ~ 1-2 
with 2 M HCl aq, and the resulting precipitate was collected by suction filtration, 
washed with H2O, and dried in vacuo overnight to afford 34 as a brown solid (3.6 g, 
23 mmol, quantitative). Rf = 0.04 (10 % MeOH:DCM); IR νmax/ cm
-1 (neat) 3066 
(w), 2896 (w), 1703 (m), 1605 (s), 1080 (s); mp 249 oC decomp.; 1H NMR (500 
MHz, d6-DMSO) δH 11.90 (br s, 2H, NH/CO2H), 7.33 (dd, 1H, 
4
J = 2.5, 3J = 9.0 Hz, 
H-4), 7.23 (d, 1 H, 4J = 2.5 Hz, H-5), 6.28 (d, 1H, 3J = 9.0 Hz, H-2), 3.33 (s, 2 H, 
CH2); 
13
C NMR (125.7 MHz, d6-DMSO) δC 172.7 (CO), 161.7 (CO), 143.2 (CH), 
134.2 (CH), 119.3 (CH), 111.8 (C), 35.6 (CH2);  m/z (ES
+
) 152 (M-H)-; HRMS 
(EI
+
) for C7H7O2N M






A suspension of 34 (53 mg, 0.35 mmol), oxyma (49 mg, 0.35 mmol), N,N’-
dicyclohexylcarbodiimide (71 mg, 0.34 mmol) and diisopropylethylamine (0.05 mL) 
in DMF (2.3 mL) was heated in the microwave at 60 oC for 2 min, then tert-butyl N-
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[2-(N-9-fluorenylmethoxycarbonyl)-aminoethyl]-glycinate hydrochloride (100 mg, 
0.23 mmol) was added and the reaction mixture was heated in the microwave at 60 
oC for a further 30 min. The resulting suspension was filtered (washed with DMF) 
and concentrated to an oily orange solid in vacuo. The crude product was purified by 
flash chromatography (2 × 15 cm SiO2, eluting with 5 % MeOH:DCM) to afford 35 
(91 mg, 0.17 mmol, 74 %) as a white solid. Rf  = 0.11 (5 % MeOH:DCM); IR νmax/ 
cm-1 (neat) 2975 (w), 2930 (w), 1715 (m), 1659 (s), 1150 (s); mp 101-102 oC; 1H 
NMR (500 MHz, CDCl3) two rotamers: δH 12.68 (br s, 1H, NH), 7.75 and 7.74 (d, 
2H, 3J = 7.4 Hz, Ar-H), 7.59-7.57 (m, 2 H, Ar-H), 7.38 (t, 2 H, 3J = 7.4 Hz, Ar-H), 
7.34 (d, 1 H, 3J  = 9.4 Hz, Ar-H), 7.28 (t, 2H, 3J = 7.4 Hz, Ar-H), 7.14 and 7.13 (s, 
1H, Ar-H), 6.51 and 6.48 (d, 1H, 3J = 9.4 Hz, Ar-H), 6.03 and 5.69 (br s, 1H, NH), 
4.40 and 4.33 (d, 2H, 3J = 7.0 Hz, CH2O), 4.20 and 4.18 (t, 1H, 
3
J = 7.0 Hz, 
CHCH2O), 3.99 and 3.90 (s, 2H, CH2CO), 3.55-3.48 (m, 2H, NCH2), 3.39 and 3.29 
(s, 2H, CH2CO), 3.37-3.33 (m, 2H, NCH2), 1.48 and 1.47 (s, 9 H, CH3); 
13
C NMR 
(125.7 MHz, CDCl3) two rotamers: δC 171.5 and 170.8 (CO), 169.2 and 168.5 (CO), 
164.4 and 164.3 (CO), 156.7 and 156.6 (CO), 143.9 and 143.6 (C), 143.8 and 143.7 
(CH), 141.2 and 141.2 (C), 133.6 and 133.5 (CH), 127.7 and 127.6 (CH), 127.1 and 
127.0 (CH), 125.1 and 125.0 (CH), 120.1 and 120.0 (CH), 119.9 (CH), 113.6 and 
113.4 (C), 83.3 and 82.4 (C), 66.9 and 66.7 (CH2), 51.5 and 49.8 (CH2), 49.4 and 
48.4 (CH2), 47.2 and 47.1 (CH), 39.3 and 39.2 (CH2), 35.6 and 35.2 (CH2), 28.0 
(CH3);  m/z (ES
+
) 532 (M+H)+, 554 (M+Na)+; HRMS (ES+) for C30H34O6N3 
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35 (578 mg, 1.1 mmol) was dissolved in 50 % v/v TFA/DCM (30 mL) and stirred at 
room temperature for 8 h. The mixture was then concentrated to an oily solid in 
vacuo and  purified by column chromatography (4 × 16 cm SiO2, eluting with 10 % 
MeOH:DCM containing 0.4 % FA) to afford an off-white solid which was 
resuspended in water (50 mL) and lyophilized to give 36 as an off-white solid (526 
mg, 1.1 mmol, quantitative). Rf  = 0.30 (10 % MeOH:DCM); IR νmax/ cm
-1 (neat) 
2945 (w), 1699 (m), 1654 (s), 1607 (s); mp 129-130 oC; 1H NMR (500 MHz, 
CD3OD) two rotamers: δH 7.80 (d, 2H, 
3
J = 7.4 Hz, Ar-H), 7.72-7.54 (m, 2 H, Ar-H), 
7.46 (d, 1 H, 3J  = 9.5 Hz, Ar-H), 7.40-7.33 (m, 2H, Ar-H), 7.33- 7.23 (m, 3H, Ar-H), 
6.47 and 6.46 (d, 1H, 3J = 9.5 Hz, Ar-H), 4.40 and 4.35 (d, 2H, 3J = 7.0 Hz, CH2O), 
4.22 and 4.07 (s, 2H, CH2CO), 4.21- 4.18 (m, 1H, CHCH2O), 3.59 and 3.46 (s, 2H, 
NCH2), 3.54-3.48 (m, 2H, NCH2), 3.35-3.32 (m, 2H, NCH2); 
13
C NMR (125.7 MHz, 
CDCl3) two rotamers: δC 173.9 and 173.4 (CO), 173.0 (CO), 164.9 (CO), 158.9 
(CO), 146.2 and 146.0 (C), 145.2 and 145.1 (CH), 142.6 (C), 135.3 and 135.1 (CH), 
128.8 and 128.2 (CH), 126.2 and 126.1 (CH), 125.0 (CH), 121.0 (CH), 120.3 and 
120.1 (CH), 116.5 and 116.4 (C), 67.8 and 67.7 (CH2), 51.5 and 49.9 (CH2), 49.3 and 
48.9 (CH2), 48.4 (CH), 40.0 and 39.6 (CH2), 36.1 and 35.8 (CH2);  m/z (ES
+
) 476 
(M+H)+, 951 (2M+H)+; HRMS (ES+) for C26H26O6N3 (M+H)
+: calcd 476.18161, 
found 476.18183; HPLC tR =  4.04 min (method 3). 
 
(ii) Tm measurements (Table 4.2) 
Tm values were determined as before (Chapter 6.3.2) using five heating-cooling 
cycles over the range 15-90 oC. The reported Tm values were averaged across the 
latter four heating cycles (the first heating cooling cycle was used to permit full 
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6.6 Chapter 5 Experimental 
6.6.1 Synthesis of a Thymine PNA Aldehyde (Chapter 5.2) 
N-(2-aminoethyl)glycine (37)83 
 
1,2-diaminoethane (142 mL, 2.1 mol, 10 eq) was cooled to 10 oC and 2-chloroacetic 
acid (20.0 g, 0.21 mol) was added portionwise with stirring. After the acid had 
dissolved, the reaction mixture was warmed to room temperature and stirred for 16 h, 
then concentrated in vacuo (at 50 oC – higher temperatures lead to decomposition of 
the target) to a colourless oil. DMSO (500 mL) was added and the mixture was 
swirled, sonicated and left to stand at room temperature for 1 h. The resulting white 
precipitate was collected by suction filtration, washed with DMSO (3 × 100 mL) 
then Et2O (2 × 50 mL) and dried in vacuo at 40 
oC to afford the target as a white 
solid (14.4 g). A second crop of target (3.7 g) was collected by filtration of the 
DMSO washings which had been left to stand at room temperature overnight. This 
second crop was washed with DMSO (2 × 50 mL) then Et2O (2 × 50 mL), dried in 
vacuo at 40 oC and combined with the first crop (total yield 18.1 g, 0.15 mol, 72 %). 
1
H NMR (600 MHz, D2O) δH 3.30 (s, 2H,  CH2CO2H), 3.06 (t, 2H, 
3
J = 6.3 Hz, 
NH2CH2), 2.93 (t, 2H, 
3
J = 6.3 Hz, CH2NH); 
13
C NMR (125.7 MHz, D2O) δC 178.5 
(CO), 51.8 (CH2), 46.8 (CH2), 38.8 (CH2); m/z (ES
+
) 119 (M+H)+, 141 (M+Na)+;  





To a stirred suspension of 37 (13.0 g, 0.11 mol) in MeOH (156 mL) at -5 oC under 
N2 (g) was added thionyl chloride (80.5 mL, 1.1 mol, 10 eq) slowly over 5 h 
(caution; this is a violent reaction liberating HCl (g)). The reaction mixture was then 
refluxed for 15 h before it was cooled to -5 oC. The resulting precipitate was 
collected by filtration and washed with 1:1 v/v MeOH:DCM then Et2O, and dried 
under vacuum at 40 oC overnight to yield 38 as a white solid (20.3 g, 0.10 mol, 90 
%). 1H NMR (500 MHz, D2O) δH 4.12 (s, 2H, CH2CO), 3.84 (s, 3H, CH3), 3.55-3.41 
Chapter 6: Experimental 
 148 
(m, 4H, 2 × NCH2);
 13
C NMR (125.7 MHz, D2O) δC 168.0 (CO), 54.3 (CH3), 48.3 
(CH2), 44.7 (CH2), 36.0 (CH2); m/z (ES
+
) 133 (M+H)+, 155 (M+Na)+;  HPLC tR = 






To a stirred solution of dimedone (20.0 g, 143 mmol), DCC (29.5 g, 143 mmol, 1 eq) 
and DMAP (1.74 g, 14.2 mmol, 0.1 eq) in DMF (350 mL) was added glacial acetic 
acid (8.2 mL, 143 mmol, 1 eq). Stirring was continued for 44 h, then the 
dicyclohexylurea precipitate was removed by filtration and the filtrate was 
concentrated in vacuo to remove the DMF solvent. EtOAc (150 mL) was added to 
the residue, which was filtered and washed with 1 M KHSO4 aq (3 × 150 mL), dried 
(MgSO4), filtered again and concentrated in vacuo to afford the crude product as an 
orange oil which crystallized on standing. Purification by column chromatography 
(7.5 × 14.5 cm silica, eluting with 5 % EtOAc:DCM) gave 39 as an orange oil (19.1 
g, 105 mmol, 73 %). Rf 0.67 (5 % EtOAC:DCM); 
1
H NMR (250 MHz, CDCl3) δH 
2.60 (s, 3H, C=C(OH)CH3), 2.53 (s, 2H, CH2CO), 2.35 (s, 2H, CH2CO), 1.07 (s, 6H, 
C(CH3)2);
 13
C NMR (125.7 MHz, CDCl3) δC 202.1 (C), 197.6 (CO), 194.8 (CO), 
112.0 (C), 52.1 (CH2), 46.6 (CH2), 30.3 (C), 28.2 (CH3), 27.9 (CH3); m/z (ES
+
) 183 







To a stirred solution of 38 (11.5 g, 56 mmol) and DiPEA (20.5 mL, 118 mmol, 2.1 
eq) in DCM (200 mL) was added a solution of crude 39 (10.2 g, 56 mmol, 1 eq). 
Some of 38 remained undissolved, so EtOH (20 mL) was added and the reaction 
mixture was sonicated to aid dissolution. The mixture was then left to stir at room 
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temperature for 16 h, before it was filtered (washed with DCM) and concentrated in 
vacuo to an orange oil. This was redissolved in EtOAc (150 mL) and washed with 1 
M KHSO4 aq (4 × 25 mL). The aqueous washes were combined, brought to pH 9 
with saturated NaHCO3 aq, then back-extracted with EtOAc (4 × 50 mL). The 
combined organics were washed with brine (50 mL), dried (MgSO4), filtered and 
concentrated in vacuo to afford the crude product as an orange oil. Purification by 
column chromatography (7 × 16 cm silica, eluting with 0 → 5 % MeOH:DCM) gave 
40 as an orange/brown oil (2.54 g, 8 mmol, 15 %). Rf 0.42 (10 % MeOH:DCM); 
1
H 
NMR (600 MHz, CDCl3) δH 13.50 ( br s, 1H, Dde-NH), 3.73 (s, 3H, OCH3), 3.48-
3.47 (m, 4H, 2 × NCH2), 2.94 (t, 2 H, 
3
J = 6.0 Hz, CH2), 2.57 (s, 3H, C=C(NH)CH3), 
2.36 (br s, 4H, 2 × CH2CO), 1.68 (br s, 1H, NHCH2CO), 1.02 (s, 6H, C(CH3)2); 
13
C 
NMR (125.7 MHz, CDCl3) δC 197.1 (CO), 173.3 (C), 172.6 (CO), 107.9 (C), 52.7 
(CH2), 51.8 (CH3), 50.1 (CH2), 47.5 (CH2), 43.3 (CH2), 29.9 (C), 28.1 (CH3), 18.0 
(CH3); m/z (ES
+
) 297 (M+H)+, 319 (M+Na)+; HPLC tR = 2.33 min (method 1). 
 




To a stirred suspension of thymine (10 g, 79 mmol) in DMF (240 mL) was added 
K2CO3 (11 g, 80 mmol) followed by methyl 2-bromoacetate (10 mL, 106 mmol). 
The reaction mixture was left to stir vigorously at room temperature under N2 (g) for 
16 h, and the resulting suspension was filtered and concentrated in vacuo to afford a 
white solid. Cold H2O at ~ 0 
oC was added, followed by 1 M KHSO4 aq (5 mL). The 
mixture was stirred with cooling on ice for 40 min, then the white precipitate was 
collected by filtration. This was dissolved in a mixture of H2O (100 mL) and 2 M 
NaOH aq (50 mL), then refluxed for 3 h. The reaction mixture was again cooled to ~ 
0 oC, acidified with 1 M KHSO4 aq (120 mL) and stirred at 0 
oC for 30 min. The 
resulting precipitate was collected by filtration, washed with water (3 × 50 mL) and 
dried under vacuum overnight to afford 41 as a white solid (8.3 g, 45 mmol, 57 %). 
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1
H NMR (500 MHz, d6-DMSO) δH 13.14 ( br s, 1H, CO2H), 11.34 (s, 1H, NH), 7.49 
(s, 1H, C=CH), 4.36 (s, 2H, CH2), 1.75 (s, 3 H, CH3);
 13
C NMR (125.7 MHz, d6-
DMSO) δC 169.6 (CO), 164.3 (CO), 151.0 (CO), 141.8 (CH), 108.3 (C), 48.4 (CH2), 
11.9 (CH3);  m/z (ES
+







To a stirred solution of 41 (1.74 g, 9.4 mmol, 1.1 eq) in DMF (50 mL) at room 
temperature was added HOBt.H2O (1.16 g, 8.6 mmol). Stirring was continued for 10 
min, before DCC (1.77 g, 8.6 mmol) was added followed by 40 (2.54 g, 8.6 mmol, 1 
eq) as a solution in DMF (40 mL). Stirring was continued for 16 h, then the reaction 
mixture was filtered and concentrated to dryness in vacuo to an oily orange/brown 
solid. This was redissolved in DCM (270 mL), then washed with 1 M KHSO4 aq (90 
mL), 1 M NaHCO3 aq (90 mL) and brine (90 mL), then the organic phase was dried 
(MgSO4), filtered and concentrated in vacuo to afford a sticky off-white solid. This 
was redissolved in Et2O (~ 50 mL) and concentrated in vacuo to yield an off-white 
solid which was triturated with 10 % MeOH:EtOAc, collected by filtration and dried 
in vacuo at 40 oC overnight to afford 42 as a white solid (2.36 g, 5.1 mmol, 59 %). 
1
H NMR (600 MHz, d6-acetone) two rotamers: δH 13.57 and 13.42 (br s, 1H,  Dde-
NH), 9.98 (br s, 1H, OCNHCO), 7.37 and 7.31 (s, 1H, C=CH), 4.78 and 4.62 (s, 2H, 
CH2CO2Me), 4.46 and 4.20 (s, 2H, CH2C(O)N), 3.90 and 3.70 (s, 4H, 2 × CH2N), 
3.76 and 3.66 (s, 3H, OCH3), 2.61 and 2.55 (s, 3H, C=C(NH)CH3), 2.34 and 2.30 (br 
s, 4H, Dde-CH2), 1.83 and 1.82 (s, 3H, C=C(CO)CH3), 1.00 and 0.99 (s, 6H, 
C(CH3)2);
 13
C NMR (125.7 MHz, d6-acetone) two rotamers: δC 175.5 and 175.2 
(CO), 171.6 (CO), 171.3 (CO), 170.1 and 169.4 (CO), 165.8 (C), 153.0 and 152.9 
(CO), 143.6 (CH), 110.8 and 110.7 (C), 109.6 and 109.5 (C), 53.8 and 53.3 (CH3), 
51.1 (CH2), 49.7 and 49.6 (CH2), 49.5 (CH2), 49.1 and 48.9 (CH2), 42.3 and 42.1 
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(CH2), 35.5 (C), 27.5 and 26.7 (CH3), 18.8 and 18.6 (CH3), 13.4 (CH3); m/z (ES
+
) 







To 42 (750 mg, 1.6 mmol) was added MeOH (7.5 mL) and 2 M Cs2CO3 aq (7.5 mL). 
The suspension was stirred at room temperature for 4.5 h, then the MeOH was 
removed in vacuo and the resulting slurry was acidified to pH 1 with 2 M HCl aq 
The solvents were then removed in vacuo to afford a white solid which was 
sonicated with H2O (5 mL), filtered and dried overnight in vacuo at 40 
oC to give 43 
as a white solid (486 mg, 1.1 mmol, 67 %). Rf 0.13 (10 % MeOH:DCM + 1 % 
AcOH); 1H NMR (500 MHz, d6-acetone) two rotamers: δH 13.56 and 13.40 (br s, 
1H,  Dde-NH), 9.96 (br s, 1H, OCNHCO), 7.37 and 7.32 (s, 1H, C=CH), 4.78 and 
4.64 (s, 2H, CH2CO2Me), 4.38 and 4.20 (s, 2H, CH2C(O)N), 3.90 and 3.70 (s, 4H, 2 
× CH2N), 2.61 and 2.56 (s, 3H, C=C(NH)CH3), 2.33 and 2.30 (br s, 4H, Dde-CH2), 
1.83 and 1.82 (s, 3H, C=C(CO) CH3) and 1.00 and 0.99 (s, 6H, C(CH3)2); 
13
C NMR 
(125.7 MHz, d6-acetone) two rotamers: δC196.9 and 196.7 (CO), 173.6 (CO), 171.2 
and 170.8 (CO), 168.6 and 167.8 (CO), 164.8 (C), 151.5 and 151.4 (CO), 142.5 and 
142.4 (CH), 108.6 (C), 107.9 and 107.7 (C), 52.9 (2 x CH2), 49.4 (CH2), 48.1 and 
46.9 (CH2), 41.4 (CH2), 30.2 (C), 28.3 (CH3), 17.8 and 17.7 (CH3), 12.5 and 12.4 
(CH3); m/z (ES
+











By reduction of Weinreb amide 45 
To a stirred solution of 45 (50 mg, 0.10 mmol) in dry THF (3 mL) at room 
temperature under N2 (g) was added a 1.0 M solution of LiAlH(O-t-Bu)3 in THF (0.3 
mL, 0.30 mmol, 3 eq). After stirring for 95 min, the reaction mixture was added 
dropwise to stirred 5 % w/w aq KHSO4 (1.2 mL), then extracted with EtOAc (4 × 8 
mL). The organic extracts were combined and washed with saturated NaHCO3 aq (3 
× 5 mL), brine (3 × 3 mL) then dried (Na2SO4), filtered and concentrated in vacuo to 
afford crude 44 as a white solid (22 mg). HPLC shows approximately 65 % 
conversion of 44 to aldehyde 45. An analytically pure sample of 44 (3.8 mg) was 
obtained by preparative HPLC (method 3).† Rf = 0.32 (10 % MeOH:DCM, spot turns 
orange using 2,4-dinitrophenylhydrazine dip); 1H NMR (600 MHz, d6-acetone) two 
rotamers: δH 13.62 and 13.44 (br s, 1H,  Dde-NH), 9.94 (br s, 1H, OCNHCO), 9.72 
and 9.49 (s, 1H, CHO), 7.39 and 7.32 (s, 1H, C=CH), 4.84 and 4.69 (s, 2H, CH2-
CHO), 4.52 and 4.23 (s, 2H, CH2CO), 3.95-3.85 (m, 2H, CH2N), 3.67 (br s, 2H, 
CH2N), 2.61 and 2.55 (s, 3H, C=C(NH)CH3), 2.42-2.26 (m, 4 H, Dde-CH2), 1.82 (s, 
3H, C=C(CO)CH3) and 1.00 and 0.99 (s, 6H, C(CH3)2); m/z (ES
+
) 433 (M+H)+, 455 
(M+Na)+; HRMS (ES+) for C21H29O6N4 (M+H)
+: calcd 433.20816, found 
433.20713; HPLC tR = 2.36 min (method 1). 
By reduction of S-benzyl thioester 46 
To a stirred suspension of 46 (50 mg, 0.09 mmol) and 10 wt % Pd/C (24 mg, 25 mol 
% Pd) in anhydrous THF (0.75 mL) under N2 (g) was added triethylsilane (6.0 eq, 
0.54 mmol, 86 µL) and acetone (dried over molecular sieves, 43 µL). A further 
portion of 10 wt % Pd/C was added after 2h 10 min (72 mg, 75 mol % Pd), and 
                                                 
† Only partial characterization was achieved as a result of the poor stability of this compound and the 
small amount isolated. Preparative HPLC peformed by Dr Ivan Trkulja. 
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further triethylsilane (86 µL, 0.54 mmol, 6 eq) was added after another 2h. Stirring 
was continued for 16 h, before the reaction mixture was filtered through celite and 
concentrated in vacuo to afford an oily yellow solid which was triturated with Et2O 
(2 × 15 mL) and filtered to afford crude 44 as a pale brown solid (20 mg). Rf and 
1H 
NMR as for Method A above. HPLC tR = 2.36 min (method 1), approximate 
conversion = 83 %. 
By acetal deprotection of 50 
50 (12 mg, 24 µmol) was stirred in 90 % TFA in H2O (0.5 mL) for 1 h at a 
temperature maintained between 0 and -10 oC (dry ice/acetone bath), then blown 
down with N2 (g) to a viscous oil which was basified with saturated NaHCO3 aq (1.5 
mL) at – 5 oC and extracted with EtOAc (10 mL then 2 × 5 mL). The combined 
organics were dried (Na2SO4), filtered and concentrated in vacuo to afford crude 44 
as a white solid (11 mg).  HPLC tR = 2.35 min (method 1), approximate conversion 






To a stirred solution of 43 (250 mg, 0.56 mmol), HOBt.H2O (1.6 eq, 0.90 mmol, 121 
mg) and N, O-dimethylhydroxylamine.HCl (87 mg, 0.90 mmol, 1.6 eq) in DMF (5 
mL) was added triethylamine (289 µL, 2.07 mmol, 3.7 eq), followed by EDC.HCl 
(215 mg, 1.12 mmol, 2.0 eq) with DMF washings (3.5 mL). The reaction mixture 
was left to stir at room temperature for 20 h, before it was filtered and concentrated 
in vacuo to afford a yellow oil. This was dissolved in EtOAc (50 mL), then washed 
with 1 M KHSO4 aq (10 mL). The aqueous phase was back-extracted with EtOAc (2 
× 10 mL), and the combined organics were washed with saturated NaHCO3 aq (10 
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mL), brine (10 mL) and dried (Na2SO4), then filtered and concentrated in vacuo to 
afford an oily solid. This was resuspended in Et2O (30 mL) and concentrated in 
vacuo to afford 45 as a white solid (251 mg, 92 %). The crude product was used in 
subsequent reactions without purification. An analytical sample (20 mg) was 
obtained by column chromatography (2 × 14 cm silica, eluting with 10 % 
MeOH:DCM). Rf = 0.33 (10 % v/v MeOH:DCM); mp 198-200 
oC; IR νmax/ cm
-1 
(neat) 2930 (w), 1668 (s), 1566 (s), 1462 (m), 725 (m); 1H NMR (500 MHz, d6-
acetone) two rotamers: δH 13.55 and 13.44 (br s, 1H,  Dde-NH), 9.94 (br s, 1H, 
OCNHCO), 7.37 and 7.28 (s, 1H, C=CH), 4.77 and 4.60 (s, 2H, CH2-
CON(OMe)Me), 4.55 and 4.38 (s, 2H, CH2CO), 3.88-3.86 (m, 2H, CH2N), 3.81 and 
3.75 (s, 3H, NOCH3), 3.69-3.65 (m, 2H, CH2N), 3.20 and 3.12 (s, 3H, N(OMe)CH3), 
2.61 and 2.55 (s, 3H, C=C(NH)CH3), 2.33 and 2.30 (br s, 4H, Dde-CH2), 1.83 (s, 3H, 
C=C(CO)CH3), 1.00 and 0.99 (s, 6H, C(CH3)2); 
13
C NMR (90.6 MHz, CDCl3) two 
rotamers: δC 207.4 (CO), 198.2 (CO), 174.3 and 173.7 (CO), 168.7 and 168.6 (CO), 
167.4 (C), 164.2 and 164.1 (CO), 151.2 (CO), 141.4 and 141.1 (CH), 110.9 and 
110.7 (C), 108.6 and 108.4 (C), 61.9 and 61.6 (CH3), 53.6 and 53.0 (CH2), 50.5 
(CH2), 48.9 (CH2), 48.5 and 48.4 (CH2), 47.7 and 47.6 (CH2), 41.5 and 41.2 (CH2), 
32.8 (C), 30.2 (CH3), 28.4 (CH3), 18.1 and 18.0 (CH3), 12.5 (CH3); m/z (ES
+
) 492 
(M+H)+, 514 (M+Na)+; HRMS (ES+) for C23H34O7N5 (M+H)
+: calcd 492.24527, 




S-benzyl ester (46) 
 
To a stirred suspension of 43 (368 mg, 0.8 mmol) and benzyl mercaptan (194 µL 1.6 
mmol, 2 eq) in anhydrous DMF (9 mL) under N2 (g) at room temperature was added 
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DMAP (11 mg, 0.08 mmol, 0.1 eq) followed by DCC (186 mg, 0.90 mmol, 1.1 eq). 
The reaction mixture was stirred at room temperature under N2 (g) for 22 h, before it 
was filtered and concentrated to dryness in vacuo to afford an oily solid. This was 
suspended in EtOAC (45 mL) and washed with 1 M KHSO4 aq (2 × 7 mL). The 
combined aqueous phases were back-extracted with EtOAc (2 × 45 mL), then the 
combined organics were washed with brine (14 mL), dried (Na2SO4), filtered and 
concentrated in vacuo to give a glassy solid. This was sonicated with Et2O (10 mL) 
and decanted from the solvent to give the crude target as a white solid. Purification 
by column chromatography (3 × 15 cm silica, 2 → 5 % MeOH:EtOAc, crude 
material pre-adsorbed onto silica from DCM) afforded 46 as a white solid (306 mg, 
0.55 mmol, 67 %). Rf = 0.27 (5 % MeOH:EtOAc); mp 156-158 
oC; IR νmax/ cm
-1 
(neat) 2953 (w), 1669 (s), 1565 (s), 1455 (m), 1332 (m); 1H NMR (500 MHz, d6-
acetone) two rotamers: δH 13.58 and 13.42 (br s, 1H,  Dde-NH), 9.98 (br s, 1H, 
OCNHCO), 7.37-7.24 (m, 6H, CH and Ar-H), 4.84 and 4.68 (s, 2H, CH2COS), 4.64 
and 4.44 (s, 2H, CH2CO), 4.25 and 4.16 (s, 2H, CH2Ar), 3.95-3.89 (m, 2H, CH2N), 
3.75-3.68 (m, 2H, CH2N), 2.59 and 2.54 (s, 3H, C=C(NH)CH3), 2.30 (br s, 4 H, Dde-
CH2), 1.82 (s, 3H, C=C(CO)CH3), 1.00 and 0.99 (s, 6H, C(CH3)2); 
13
C NMR (62.9 
MHz, CDCl3) two rotamers: δC 198.1 (CO), 195.5 and 194.7 (CO), 173.9 and 173.8 
(CO), 168.0 (CO), 167.3 (C), 164.4 (CO), 151.3 and 151.2 (CO), , 141.1 and 140.7 
(CH), 136.4 and 136.1 (C), 128.7 (CH), 128.5 (CH), 127.6 and 127.4 (CH), 110.7 
and 110.6 (C), 108.2 and 108.1 (C), 57.6 (CH2), 55.6 (CH2) 52.7 (CH2), 48.0 and 
47.8 (CH2), 47.6 and 47.5 (CH2), 41.1 and 40.5 (CH2), 33.3 and 33.0 (CH2), 29.9 (C), 
28.1 (CH3), 17.8 and 17.6 (CH3), 12.2 (CH3); m/z (ES
+
) 555 (M+H)+, 577 (M+Na)+; 
HRMS (ES+) for C28H35O6N4S (M+H)
+: calcd 555.22775, found 555.22718; HPLC 





To a stirred solution of 2-(2-aminoethylamino)ethanol (2.4 mL, 24 mmol) in DCM 
(30 mL) under N2 (g) was added a solution of Dde-OH (39, 4.4 g, 24 mmol, 1 eq) in 
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DCM (10 mL + 20 mL washings). Stirring was continued at room temperature for 16 
h. The reaction mixture was then separated from the layer of water which had 
formed, and concentrated in vacuo to afford a yellow oil which solidified on 
standing. Purification by column chromatography (7 × 16 cm silica, eluting with 10 
% MeOH:DCM) afforded 47 as a yellow solid (6.4 g, 24 mmol, 100 %). Rf = 0.36 
(10 % MeOH:EtOAc); IR νmax/ cm
-1 (neat) 3316 (w), 2924 (w), 2867 (w), 1623 (m), 
1565 (s); 1H NMR (500 MHz, CDCl3) δH 3.66 (t, 2H, 
3
J = 5.0 Hz, CH2OH), 3.50-
3.46 (m, 2H, Dde-NHCH2), 2.97 (t, 2H, 
3
J = 6.0 Hz, Dde-NHCH2CH2), 2.85 (t, 2H, 
3
J = 5.0 Hz, CH2CH2OH), 2.57 (s, 3H, CH3), 2.36 (br s, 4 H, 2 × Dde-CH2), 1.02 (s, 
6H, C(CH3)2); 
13
C NMR (90.6 MHz, CDCl3) two rotamers: δC 197.9 (CO), 173.2 
(C), 108.0 (C), 61.0 (CH2), 52.8 (CH2), 50.9 (CH2), 47.2 (CH2), 43.2 (CH2), 30.0 (C), 
28.2 (CH3), 18.2 (CH3); m/z (ES
+
) 269 (M+H)+, 291 (M+Na)+; HRMS (ES+) for 
C14H25O3N2 (M+H)







To a stirred suspension of 47 (250 mg, 0.93 mmol) and 41 (172 mg, 0.93 mmol, 1 
eq) in DCM (2.1 mL) at -5 oC under N2 (g) was added DiPEA (324 µL, 1.86 mmol, 2 
eq) at -5 oC and PyBOP (434 mg, 0.93 mmol, 1 eq). Cooling was removed and 
stirring was continued at room temperature under N2 (g) for 2 h. The reaction 
mixture was then washed with 1 M KHSO4 aq (5 mL), 1 M NaHCO3 aq (5 mL), and 
brine (5 mL) before it was dried (MgSO4), filtered and concentrated in vacuo to 
afford an off-white solid. Purification by column chromatography (3 × 16 cm silica, 
eluting with 10 % MeOH:DCM) afforded 48 as a white solid (60 mg, 0.14 mmol, 15 
%). Rf = 0.33 (10 % MeOH:DCM); mp 168-169 
oC; IR νmax/ cm
-1 (neat) 3325 (w), 
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3236 (w), 2930 (w), 1704 (m), 1687 (s), 1565 (s); 1H NMR (500 MHz, d6-acetone) 
two rotamers: δH 13.55 and 13.42 (br s, 1H,  Dde-NH), 9.94 (br s, 1H, OCNHCO), 
7.36 and 7.31 (s, 2H, C=CH), 4.78 and 4.72 (s, 2H, CH2CO), 3.93-3.54 (m, 8H, 4 × 
CH2), 2.61 and 2.55 (s, 3H, C=C(NH)CH3), 2.30 (br s, 4 H, Dde-CH2), 1.82 (s, 3H, 
C=C(CO)CH3), 0.99 (s, 6H, C(CH3)2); 
13
C NMR (90.6 MHz, acetone-d6) two 
rotamers: δC 180.7 (CO), 156.9 and 155.3 (CO), 151.2 (C), 147.8 (CO), 124.7 and 
124.6 (CH), 91.6 (C), 89.9 (C), 41.4 (CH2), 34.3 (CH2), 31.9 (CH2), 30.8 (CH2), 27.6 
(CH2), 22.5 (CH2), 11.9 (C), 9.2 (CH3), -0.9 (CH3) and -6.8 (CH3); m/z (ES
+
) 435 
(M+H)+, 457 (M+Na)+; HRMS (ES+) for C21H31O6N4 (M+H)
+: calcd 435.22381, 





A mixture of 1,2-diaminoethane (0.74 mL, 11 mmol), bromoacetaldehyde diethyl 
acetal (1.7 mL, 11 mmol, 1 eq) and K2CO3 (3 g, 22 mmol, 2 eq) in MeCN (15 mL) 
was heated at 130 oC in the microwave (pressure = 5 bar) for 30 min. This reaction 
was repeated × 5. The reaction mixtures were then combined and filtered, washing 
with DCM. The filtrate was concentrated in vacuo to a brown oil which was 
resuspended in DCM (70 mL) and a white precipitate was removed by filtration, 
washing with more DCM (30 mL). To the resulting dark brown solution was added a 
solution of Dde-OH (39, 10 g, 55 mmol, 1 eq) in DCM (50 mL), and the reaction 
mixture was stirred at room temperature under N2 (g) for 16 h. The mixture was then 
concentrated in vacuo to a dark brown oil which was purified by column 
chromatography (7.5 × 14 cm silica, eluting with 5 → 10 % MeOH:DCM) to afford 
49 as an orange/brown oil (5.6 g, 16 mmol, 30 %). Rf = 0.41 (10 % MeOH:DCM); 
IR νmax/ cm
-1 (neat) 2955 (w), 2868 (w), 1636 (m), 1570 (s), 1457 (m); 1H NMR 
(500 MHz, CDCl3) δH 13.39 (br s, 1H,  Dde-NH), 4.52 (t, 1H, 
3
J = 5.5 Hz, 
CH(OEt)2), 3.66-3.60 (m, 2H, OCH2), 3.50-3.43 (m, 2H, OCH2), 3.41 (q, 2H, 
3
J = 
6.0 Hz, Dde-NHCH2), 2.87 (t, 2H, 
3
J = 6.0 Hz, CH2NHCH2CH(OEt)2), 2.70 (d, 2H, 
3
J = 5.5 Hz, CH2CH(OEt)2), 2.50 (s, 3H, C=C(NH)CH3), 2.28 (br s, 4H, 2 × Dde-
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CH2), 1.13 (t, 6H, 
3
J = 7.0 Hz, 2 × OCH2CH3), 0.95 (s, 6H, C(CH3)2); 
13
C NMR 
(62.9 MHz, CDCl3) δC 196.8 (CO), 173.4 (C), 107.9 (C), 102.0 (CH), 62.6 (CH2), 
52.8 (CH2), 51.8 (CH2), 48.0 (CH2), 43.5 (CH2), 30.0 (C), 28.2 (CH2), 18.1 (CH3), 
15.4 (CH3); m/z (EI) 340 (M)
+; HRMS (EI) for C18H32O4N2 (M)
+: calcd 340.23566, 






To a solution of 41 (381 mg, 2.1 mmol, 1.1 eq) in DMF (10 mL) under N2 (g) was 
added HOBt.H2O (254 mg, 1.9 mmol, 1 eq) followed by DCC (388 mg, 1.9 mmol, 1 
eq) and a solution of 49 (640 mg, 1.9 mmol, 1 eq) in DMF (5 mL). The reaction 
mixture was heated at 60 oC in the microwave for 30 min, then concentrated in vacuo 
to afford a brown oil which was resuspended in Et2O and again concentrated in 
vacuo to afford an oily off-white solid. This was redissolved in DCM (60 mL) and 
washed with saturated NaHCO3 aq (20 mL) and brine (20 mL), then dried (Na2SO4), 
filtered and concentrated in vacuo to afford the crude product as an off-white solid. 
Purification by column chromatography (4.5 × 14 cm silica, eluting with 5 % 
MeOH:DCM, crude product dissolved in MeOH/DCM and pre-adsorbed on silica by 
evaporation) afforded 50 as an off-white solid (443 mg, 0.87 mmol, 46 %). Rf = 0.61 
(10 % MeOH:DCM); mp 178-181 oC; IR νmax/ cm
-1 (neat) 3153 (w), 2974 (w), 1695 
(s), 1659 (s), 1562 (s); 1H NMR (500 MHz, CDCl3) two rotamers: δH 13.62 and 
13.46 (br s, 1H,  Dde-NH), 8.08 (br s, 1H, OCNHCO), 7.32 and 7.05 (s, 1H, C=CH), 
4.72 and 4.61 (t, 1H, 3J = 5.5 Hz, CH(OEt)2), 3.81-3.52 (m, 8H, 2 ×OCH2 and 2 × 
NCH2), 3.49 and 3.41 (d, 2H, 
3
J = 5.0 Hz, CH2CH(OEt)2), 2.60 and 2.57 (s, 3H, 
C=C(NH)CH3), 2.36 (br s, 4H, 2 × Dde-CH2),  1.94 and 1.93 (s, 3H, C=C(CO)CH3), 
1.25 and 1.17 (t, 6H, 3J = 7.0 Hz, 2 × OCH2CH3), 1.03 (s, 6H, C(CH3)2); 
13
C NMR 
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(62.9 MHz, CDCl3) two rotamers: δC 198.3 (CO), 174.2 and 173.8 (CO), 168.3 and 
167.3 (C), 164.4 (CO), 151.4 and 151.3 (CO), 141.4 and 141.2 (CH), 110.7 and 
110.6 (C), 108.3 (C), 101.2 and 100.6 (CH), 64.6 (CH2), 53.0 (CH2), 51.5 and 50.4 
(CH2), 48.4 (CH2), 47.9 and 47.6 (CH2), 47.3 (CH2), 41.0 and 40.4 (CH2), 31.0 
(CH3), 30.1 (C), 28.3 (CH2), 18.1 and 18.0 (CH3), 15.4 (CH3), 12.5 (CH3); m/z (ES
+
) 
507 (M+H)+, 529 (M+Na)+; HRMS (ES+) for C25H39O7N4 (M+H)
+: calcd 
507.28133, found 507.28072; HPLC tR = 2.95 min (method 3). 
 
6.6.2 Resin Capture of a Thymine PNA Aldehyde (Chapter 5.3) 




Aminomethyl NovaGel HL (200 mg, 0.76 mmol/g, 0.15 mmol) was swollen with 
DMF over 10 min. Meanwhile, DIPEA (132 µL, 0.76 mmol, 5 eq) was added to a 
solution of Fmoc-Thr(t-Bu)-OH (32 mg, 0.76 mmol, 5 eq) and TBTU (239 mg, 0.74 
mmol, 4.9 eq) in DMF (1 mL), and the reaction mixture was shaken for 5 min. The 
solution of activated protected threonine was then added to the swollen resin and 
shaken at room temperature for 2h. The resin was washed with DMF (5 ×), THF (5 
×) and DCM (5 ×), then dried in vacuo at 40 oC overnight. Completion of the 
coupling was verified using a qualitative ninhydrin test. The resin was then swollen 
in DMF for 10 min and shaken with 20 % v/v piperidine in DMF (2 mL) for 40 min 
(repeated once for 20 min). The resin was washed with DMF (3 ×), THF (5 ×) and 
DCM (5 ×) then shaken with 80 % v/v TFA in DCM (2.5 mL) for 30 min (repeated 
once). The resin was washed with DCM (5 ×) and dried in vacuo at 40 oC. Assuming 
quantitative conversion, new loading NL = 0.71 mmol/g.  
 
Purification of 3-phenylpropionaldehyde by capture-release 
NovaGel HL-based threonyl scavenging resin (150 mg, 85 µmol based on 0.71 
mmol/g loading) was swollen with DMF for 30 min then heated at 60 oC in the 
microwave for 1 h with an equimolar mixture of 3-phenylpropionaldehyde (6.6 µL, 
50 µmol) and 3-phenylpropan-1-ol (6.8 µL, 50 µmol) in MeOH (1.5 mL) and DiPEA 
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(10 µL). HPLC (method 1) of the resulting supernatant showed the presence of 3-
phenylpropan-1-ol (tR = 2.98 min) only and no 3-phenylpropionaldehyde (tR = 3.20 
min). The resin was washed with MeOH (5 ×) and stored in a refrigerator for 16 h. 
The resin was then swollen with DMF for 20 min, washed with DCM (5 ×) and 
MeOH (5 ×) and heated at 60 oC in the microwave for 30 min with 60:40:1 v/v/v 
MeCN:H2O:TFA (1 mL, repeated three times). HPLC (method 1) of the cleavage 
cocktail showed the presence of 3-phenylpropionaldehyde with trace impurities.  
 
Purification of aldehyde 44 by capture-release 
Capture
188 
To the deprotected NovaGel HL-based threonyl scavenging resin (120 mg, 85 µmol 
based on 0.71 mmol/g loading) was added a solution of crude aldehyde 2 (18 mg, ~ 
27 µmol based on 65 % purity) in a mixture of anhydrous MeOH/DCM/DMF/AcOH 
(86/9/6/1 v/v, 2 mL). The mixture was shaken at room temperature for 1 h, then the 
resin was filtered and washed with DCM (3 ×). 
Release
188 
The resin was shaken with a mixture of AcOH/H2O/DCM/MeOH (10/5/5/80 v/v, 2 
mL) for 20 min (repeated once for 1 h). The resin was then washed with DMF (5 ×), 
DCM (5 ×) and Et2O (5 ×) and dried in vacuo at 40 
oC. All cleavage filtrates and 
washes were combined and concentrated in vacuo to afford a brown oil which was 
triturated with Et2O and filtered to give 2 mg of a white solid. HPLC (method 1) 
shows target aldehyde 44 (tR = 2.36 min) with reduced concentration of Weinreb 
amide impurity, but other impurities remain. 
 
6.6.3 Synthesis and Templated Terminal Extension of a PNA Oligomer 
(Chapter 5.4) 
 
Probe P13 was synthesized as described as above (Chapter 6.2.2). 
 
P13: m/z (MALDI-TOF MS); for C127H166N57O41 (M+H)
+: calcd 3146.26, found 
3146.07; HPLC tR =  10.60 min (method 6). 
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Templated extension protocol (Figure 5.4) 
A sample of acetal 50 (1.6 mg, 3.2 mmol) was hydrolyzed in 90 % TFA:H2O (300 
µL) for 1 h at a temperature maintained between 0 and -10 oC, then blown down with 
N2 (g) to a yellow oil. Et2O (1 mL) was added and blown down with N2 (g) × 2 to 
afford a white solid which was dissolved in H2O (316 µL) to give a concentration of 
approximately 10 mM of crude aldehyde 44. Mass spectrometric and HPLC analysis 
confirmed the presence of aldehyde 44 (see Chapter 6.5.1) and a spot of the aqueous 
solution on a silica TLC plate turned orange on treatment with 2,4-DNP dip 
(confirming the presence of aldehydic functionality). This solution could not be 
stored, and was used directly in templated extension reactions. 
 For templated extension, the conditions described in Chapter 6.3.3(i) were 
employed, but using 6.4 µL of the solution of aldehyde 44 (approximately 10 mM) 
prepared as described in place of the nucleobase aldehyde solutions. One reaction 
was performed in which the aldehyde was added after the initial hybridization at 80 
oC (Figure 5.4a) and one in which the aldehyde was present from the start (Figure 
5.4b). A control reaction was performed in which water was used in place of the 
DNA solution (Figure 5.4c). For MALDI-TOF analysis, +44 incorporation resulted 
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Calculation of the Number of Moles of DNA Template 
Obtained by Isolation from a Buccal Swab 
 
There is one copy of the CFTR gene in the haploid human genome. The amount of 
template present for analysis in the DNA derived from a buccal swab thus equates to 
the number of haploid genomes present. Given that the haploid human genome 
contains 3 × 109 base pairs with a GC content of approximately 40 %‡ and the 
Isohelix kit manufacturer’s claim of 2 – 10 µg of DNA per swab, then (neglecting 
contributions from mitochondrial and any bacterial DNA present): 
Formula weight (fwt) of an AT base pair = 615.4 g/mol 
Formula weight (fwt) of a GC base pair = 616.4 g/mol 
Mean fwt of a base pair  = (0.6 × 615.4) g/mol + (0.4 × 616.4) g/mol 
  = 615.8 g/mol 
Fwt of (haploid) genomic DNA   = (No. of base-pairs) × (Fwt of a base-pair) 
    = (3 × 109) × 615.8 g/mol 
    = 1.85 × 1012 g/mol 
 
Number of moles in 2 µg extracted DNA  = (Mass) / (Fwt of genomic DNA) 
   = (2 × 10-6 g) / (1.85 × 1012 g/mol) 
   = 1 × 10-18 mol 
   = 1 attomole 
 
Number of moles in 10 µg extracted DNA  = (Mass) / (Mass of 1 mole) 
   = (10 × 10-6 g) / (1.85 × 1012 g/mol) 
   = 5 × 10-18 mol 
   = 5 attomoles 
∴ Range of moles of DNA template isolatable by Isohelix kit (according to the 
manufacturer) = 1 - 5 attomoles (or (1-5) × 10-18 moles) 
                                                 
‡ R. Horton, L. A. Moran, G. Scrimgeour, M. Perry and D. Rawn, in Principles of Biochemistry, 




Calculation of the Number of Moles of DNA Template 
Obtained After Asymmetric PCR 
 
Mean formula weight (fwt) of a base pair = 615.8 g/mol (see Appendix 2) 
Approximate fwt of a 92 bp (G551D) amplicon  = (No. of bp) × (Fwt of a bp) 
     = 92 × 615.8 g/mol 
     = 5.7 × 104 g/mol 
Sample volume used for analysis = 26 µL 
For sample FB: 
DNA concentration after symmetric PCR = 97 ng/µL (see Table 3.4) 
Mass of DNA template present = Concentration × Volume  
    = 97 ng/µL × 26 µL 
    = 2,522 ng 
    = 2.5 µg 
 
Number of moles of templating DNA  = (Mass) / (Approx. fwt of G551D amplicon) 
   = (2.5 × 10-6 g) / (5.7 × 104 g/mol) 
   = 4.4 × 10-11 mol 
   = 44 picomoles 
 
For sample JJ: 
DNA concentration after symmetric PCR = 108 ng/µL (see Table 3.5) 
Mass of DNA template present = Concentration × Volume  
    = 108 ng/µL × 26 µL 
    = 2,808 ng 
    =  2.8 µg 
Number of moles of templating DNA  = (Mass) / (Approx. fwt of G551D amplicon) 
   = (2.8 × 10-6 g) / (5.7 × 104 g/mol) 
   = 4.9 × 10-11 mol 




Spreadsheets of Raw Peak Table Data for the Genotyping of 
Clinical Cystic Fibrosis Samples 
 
Presented below are the output from spreadsheets after the input of raw peak table 
data (for peaks > 5 % relative intensity) into Microsoft Excel. Representative 
examples for each clinical CF sample are given, together with the formulae used to 










1 3966.810891 100 P7 DF508/N 
2 3967.818546 92.45 P7  
3 3983.029162 12.1 X  
4 4128.043848 81.54 DF508  
5 4128.394273 80.66 DF508  
6 4129.358563 66.62 DF508  
7 4241.923812 48.29 P8  
8 4418.934391 61.01 wt508  
9 4419.905466 52.46 wt508  








1 3917.426522 99.61 P5 G551D/N 
2 3918.334878 100 P5  
3 3921.89034 26.94 P5  
4 3923.592319 12.22 X  
5 4056.190367 21.15 wt551  
6 4057.775898 13.71 wt551  
7 4068.785866 7.21 G551D  
8 4069.53848 11.2 G551D  










1 3965.972546 56.3 P7 DF508/N 
2 3967.050118 74.44 P7  
3 3967.946466 66.17 P7  
4 3968.982236 44.64 P7  
5 4127.04115 53.29 DF508  
6 4128.027786 76.88 DF508  
7 4129.025653 67.76 DF508  
8 4241.127068 64 P8  
9 4242.133299 96.62 P8  
10 4243.097441 97.09 P8  
11 4418.216332 60.52 wt508  
12 4419.203163 94.08 wt508  
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13 4420.102237 100 wt508  








1 2027.504879 5.97 X G551D/N 
2 2049.514874 6.32 X  
3 2083.437109 5.26 X  
4 3917.367294 54.74 P5  
5 3918.110703 49.47 P5  
6 3918.875128 49.83 P5  
7 3920.954942 11.58 P5  
8 3931.639044 7.72 X  
9 4054.21074 100 wt551  
10 4055.048381 98.94 wt551  
11 4058.685684 17.19 wt551  
12 4069.155729 22.81 G551D  
13 4070.256402 25.26 G551D  
14 4071.394952 25.61 G551D  










1 3966.321635 100 P7 DF508/N 
2 3967.050265 92.13 P7  
3 3968.105076 72.62 P7  
4 3979.321628 9.24 X  
5 3980.25447 10.95 X  
6 4127.084941 66.33 DF508  
7 4128.09606 70.71 DF508  
8 4128.95638 65.37 DF508  
9 4132.521468 10.61 DF508  
10 4241.054795 33.61 P8  
11 4242.107886 40.66 P8  
12 4242.595098 43.94 P8  
13 4243.308503 35.66 P8  
14 4419.43804 41.62 wt508  
15 4420.042289 41.27 wt508  








1 3916.457 65.31 P5 G551D/N 
2 3917.453125 100 P5  
3 3918.23475 97.45 P5  
4 3919.521072 65.14 P5  
5 3923.308244 10.38 X  
6 3930.334713 7.82 X  
7 4054.032003 71.77 wt551  
8 4054.46543 93.88 wt551  
9 4055.530693 84.52 wt551  
10 4060.872586 11.57 X  
11 4068.624407 55.1 G551D  
12 4069.64724 75.17 G551D  
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13 4070.335856 70.07 G551D  










1 3966.90709 97.8 P7 DF508/DF508 
2 3967.373764 94.81 P7  
3 3968.019263 83.78 P7  
4 3972.98992 8.82 X  
5 3980.078698 10.24 X  
6 3981.754657 8.82 X  
7 3982.591526 8.03 X  
8 3983.541533 7.25 X  
9 3984.87579 5.04 X  
10 4037.699634 5.04 X  
11 4128.173998 70.39 DF508  
12 4134.270038 6.93 X  
13 4135.144132 7.25 X  
14 4135.951949 6.46 X  
15 4242.638694 38.74 P8  
16 4245.619725 13.7 P8  
17 4256.469973 5.98 X  








1 3917.758854 100 P5 N/N 
2 3919.091798 93.31 P5  
3 3985.793224 6.42 X  
4 4055.244417 89.37 wt551  










1 3967.650682 100 P7 N/N 
2 3968.59487 89.36 P7  
3 3970.649816 42.4 P7  
4 4036.081811 9.27 X  
5 4037.571882 9.12 X  
6 4242.256111 19.3 P8  
7 4243.771475 19.46 P8  
8 4244.674436 15.2 P8  
9 4418.717174 18.85 wt508  
10 4419.763378 27.81 wt508  
11 4420.738527 29.64 wt508  
12 4421.433853 27.05 wt508  








1 2000.330403 9.11 X G551D/G551D 
2 2011.976627 7.97 X  
3 2015.812968 7.97 X  
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4 2017.765048 7.29 X  
5 2030.411167 6.15 X  
6 2046.891048 12.53 X  
7 2047.894361 15.26 X  
8 2048.943374 34.17 X  
9 2049.953232 40.55 X  
10 2050.919032 27.79 X  
11 2056.216034 9.11 X  
12 2058.712358 8.66 X  
13 2060.59043 11.16 X  
14 2065.837476 9.11 X  
15 2089.302499 8.43 X  
16 2110.259203 7.52 X  
17 2130.952018 7.97 X  
18 2188.935372 5.92 X  
19 2217.307016 6.6 X  
20 2271.413417 6.61 X  
21 2344.390998 6.15 X  
22 2377.673951 6.15 X  
23 2496.183939 5.24 X  
24 2739.692873 5.24 X  
25 3493.581087 5.01 X  
26 3877.198144 5.47 X  
27 3916.648971 100 P5  
28 3917.44937 94.53 P5  
29 3919.810669 38.5 P5  
30 3921.492569 16.63 P5  
31 4068.451383 16.4 G551D  










1 3966.981282 100 P7 N/N 
2 3982.63414 8.55 X  
3 4035.476547 8.12 X  
4 4242.069333 35.06 P8  
5 4419.699533 59.94 wt508  








1 3916.712815 81.73 P5 G551D/N 
2 3917.832442 100 P5  
3 3918.762163 90.99 P5  
4 3922.923315 11.01 X  
5 4054.952408 33.29 wt551  
6 4055.674562 31.92 wt551  
7 4056.879448 23.03 wt551  
8 4069.229655 14.77 G551D  













1 3965.271816 100 P7 DF508/N 
2 3966.141573 95.8 P7  
3 3967.288353 75.37 P7  
4 3970.936195 11.11 P7  
5 3991.10737 5.41 X  
6 4033.799095 7.21 X  
7 4035.649593 8.41 X  
8 4108.108563 5.71 X  
9 4108.908582 6.01 X  
10 4124.304301 8.11 DF508  
11 4125.373278 24.32 DF508  
12 4126.250146 31.23 DF508  
13 4127.812577 26.13 DF508  
14 4129.218446 17.42 DF508  
15 4239.240033 33.93 X  
16 4240.279205 45.34 P8  
17 4241.032609 43.85 P8  
18 4243.318807 22.22 P8  
19 4245.198725 8.41 P8  
20 4309.429831 6.91 X  
21 4417.521421 27.33 wt508  
22 4419.024048 25.83 wt508  
23 4419.615081 24.93 wt508  
24 4420.607306 13.51 wt508  








1 3918.368568 100 P5 G551D/N 
2 3923.58215 6.05 X  
3 3987.592872 5.01 X  
4 4054.323249 12.84 wt551  
5 4055.362795 15.21 wt551  
6 4056.207267 13.92 wt551  
7 4069.160193 5.79 G551D  
8 4070.19426 5.64 G551D  










1 3965.75527 81.59 P7 N/N 
2 3966.751143 100 P7  
3 3967.531055 98.71 P7  
4 3968.600941 72.98 P7  
5 3972.53592 9.27 X  
6 4035.440709 8.75 X  
7 4037.660848 9.27 X  
8 4240.805064 23.17 P8  
9 4241.852771 27.16 P8  
10 4242.747324 28.19 P8  
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11 4243.795387 22.14 P8  
12 4245.871481 7.85 P8  
13 4418.133485 8.37 wt508  
14 4419.089855 13.9 wt508  
15 4419.702991 14.16 wt508  
16 4420.761652 11.33 wt508  
17 4421.838635 8.75 wt508  








1 3875.717426 6.95 X G551D/N 
2 3876.647004 7.87 X  
3 3917.592608 95.71 P5  
4 3917.942364 100 P5  
5 3919.447771 80.49 P5  
6 3921.131645 34.42 P5  
7 4054.620928 36.47 wt551  
8 4055.134477 36.47 wt551  
9 4055.627643 35.55 wt551  
10 4056.318533 28.4 wt551  
11 4058.346363 14.3 wt551  
12 4059.936464 7.05 X  
13 4068.277435 11.85 G551D  
14 4069.474072 15.32 G551D  
15 4071.146326 15.12 G551D  










1 3967.19636 78.15 P7 DF508/DF508 
2 3968.161302 69.04 P7  
3 3972.225868 14.9 X  
4 4128.586172 100 DF508  
5 4129.541257 84.94 DF508  
6 4138.809581 11.26 X  
7 4241.884773 53.15 P8  
8 4243.058207 56.62 P8  
9 4245.287982 31.13 P8  
10 4255.254261 8.61 X  








1 3917.532034 75 P5 N/N 
2 3920.152722 29.8 P5  
3 4053.597879 80.14 wt551  
4 4054.465376 100 wt551  










1 3965.470194 5.82 P7 DF508/DF508 
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2 3967.175935 21.87 P7  
3 3968.112052 22.27 P7  
4 4128.442136 98.31 DF508  
5 4129.198417 100 DF508  
6 4130.070862 85.74 DF508  
7 4241.896098 19.49 P8  
8 4242.450061 21.87 P8  
9 4243.84993 18.39 P8  








1 3914.008647 11.04 P5 N/N 
2 3915.576769 20.93 P5  
3 3917.067715 16.03 P5  
4 3917.790575 12.51 P5  
5 3918.794531 7.85 P5  
6 4051.386989 46.2 wt551  
7 4052.266685 81.44 wt551  
8 4053.284947 100 wt551  
9 4053.837413 72.37 wt551  
10 4054.186478 70.65 wt551  
11 4054.896142 52.66 wt551  










1 3969.08479 10.89 P7 DF508/DF508 
2 4128.364824 97.88 DF508  
3 4129.170679 100 DF508  
4 4241.708599 9.08 P8  
5 4243.449123 12.95 P8  








1 2026.990876 5.91 X N/N 
2 3914.73384 11.83 P5  
3 3915.70913 20.5 P5  
4 3916.712561 19.05 P5  
5 3917.676266 12.22 P5  
6 4050.798617 22.34 wt551  
7 4051.827167 64.52 wt551  
8 4052.814675 100 wt551  
9 4053.558776 89.62 wt551  
10 4056.768344 19.58 wt551  










1 3966.129543 9.32 P7 DF508/DF508 
2 3967.197871 11.41 P7  
3 3968.182063 6.92 P7  
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4 4126.281945 34.13 DF508  
5 4127.271572 79.34 DF508  
6 4128.274615 100 DF508  
7 4129.258145 90.68 DF508  
8 4130.24975 53.02 DF508  
9 4131.21924 31.79 DF508  
10 4132.251173 15.3 DF508  
11 4241.366167 6.92 P8  
12 4242.351448 10.07 P8  
13 4243.325138 8.83 P8  








1 3915.827013 33.29 P5 N/N 
2 3916.952678 44.38 P5  
3 3917.763194 40.31 P5  
4 3918.476601 27.81 P5  
5 4053.946749 100 wt551  










1 3915.374977 10.6 P5 DF508/N 
2 3916.333324 31.85 P5 G551D/N 
3 3917.319613 36.52 P5  
4 3918.273589 29.15 P5  
5 3919.239299 18.7 P5  
6 4052.368543 32.26 wt551  
7 4053.442433 80.78 wt551  
8 4054.406778 100 wt551  
9 4055.339504 86.18 wt551  
10 4056.252441 55.38 wt551  
11 4067.50691 8.57 G551D  
12 4068.401288 19.9 G551D  
13 4069.352807 24.99 G551D  
14 4070.296081 23.9 G551D  
15 4071.478928 13.92 G551D  
16 4072.485329 5.77 G551D  
17 4126.465614 14.23 DF508  
18 4127.505489 39.74 DF508  
19 4128.462542 52.78 DF508  
20 4129.364879 43.74 DF508  
21 4130.343941 29.2 DF508  
22 4131.241096 16 DF508  
23 4241.724751 6.81 P8  
24 4242.634432 9.45 P8  
25 4243.454839 7.79 P8  
26 4417.630675 10.7 wt508  
27 4418.857024 35.38 wt508  
28 4419.623937 51.33 wt508  
29 4420.571047 45.82 wt508  
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30 4421.464937 31.53 wt508  
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